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Abstract 
Spinal cord regeneration following injury represents a major clinical 
challenge. Over recent years, stem cells have demonstrated promise for 
promoting spinal repair in the lab and in early stage clinical trials through 
functional replacement of neuronal and glial cells and through secondary 
trophic mechanisms to promote endogenous regeneration. Research has 
primarily focused on the use of embryonic tissue-derived stem cells of 
potentially limited therapeutic application due to related ethical concerns. The 
dental pulp harbours a source of easily accessible progenitor cells that have 
demonstrated early promise in improving functional outcome of experimental 
models of spinal cord injury via growth factor release. This thesis explores 
the potential of dental pulp progenitor cells (DPPCs) to promote spinal repair 
through direct cellular replacement. Progenitor cells isolated from murine 
incisors were found to express early stage neural and glial markers. Specific 
protocols were developed demonstrating the ability of DPPCs to differentiate 
in vitro into neuronal-like and oligodendrocyte-like cells with appropriate 
morphology and expression of mature markers. Electrophysiological testing 
revealed that DPPC-derived neuronal-like cells were of an immature non-
functional phenotype. Undifferentiated DPPCs injected into an ex vivo spinal 
cord slice model showed signs of proliferation, migration and spontaneous 
differentiation within spinal tissue. DPPCs pre-differentiated into 
oligodendrocyte-like cells failed to survive transplantation but neuronally pre-
differentiated cells survived, showing signs of integration into endogenous 
neuronal pathways. In a small scale pilot study, neuronally pre-differentiated 
DPPCs were transplanted into a clinically relevant in vivo model of spinal 
cord injury. DPPCs maintained expression of neuronal markers four weeks 
after grafting into the injured spinal cord. Axonal projections towards grafted 
cells and synaptic protein expression suggested possible integration into 
neuronal pathways, albeit without an associated statistical functional 
improvement. The results presented in this thesis provide a strong case for 
the potential of DPPCs to facilitate functional recovery through direct cell 
replacement mechanisms. 
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1.1 Introduction 
Over recent years, substantial progress has been made in the field of stem 
cell research. Stem cells, and more lineage-restricted progenitor cells, 
possess increased self-renewal capabilities and the ability to differentiate into 
multiple cell types, depending upon their tissue of origin. A wide range of 
therapeutic applications have been proposed for stem cells including the 
treatment of diabetes mellitus, cancer and heart damage. 
Spinal cord injury (SCI) represents one such clinical challenge as no natural 
repair or regeneration is seen following injury and victims are left severely 
debilitated with motor and sensory deficits (Thumbikat et al., 2009). 
Substantial evidence suggests that stem cells are able to promote a degree 
of recovery from such damage (Kim and de Vellis, 2009). There are two 
proposed mechanisms as to how transplanted stem cells are able to exert 
this effect. The first is through the release of soluble factors that minimise the 
extent of damage, recruit endogenous cells and promote natural repair and 
regeneration. Others suggest that grafted cells can differentiate into neuronal 
and glial cell types to directly replace those lost following injury. Clinical trials 
have commenced investigating stem cells isolated from embryonic 
(Keirstead et al., 2005), neural (Gupta et al., 2012) and bone marrow (Park 
et al., 2012) tissues as treatments for SCI. However, the use of embryonic or 
neural stem cells derived from foetal tissue remains a highly controversial 
ethical issue that will unlikely ever be satisfactorily resolved, and the isolation 
of bone marrow stem cells involves invasive and painful surgical procedures. 
As such, alternative sources from which stem/progenitor cells can be 
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painlessly isolated, without the destruction of embryonic tissue, are actively 
sought. 
The dental pulp harbours progenitor cells that can be easily accessed as part 
of routine orthodontic treatment, and cryogenically preserved to create a pool 
of patient-matched cells that are readily-available for future use (Woods et 
al., 2009). Early animal studies have demonstrated promise for the ability of 
dental pulp progenitor cells (DPPCs) to improve functional outcome following 
damage to the spinal cord (de Almeida et al., 2011; Sakai et al., 2012). 
These effects appear to be mostly protective and mediated through growth 
factor release. It is, as yet, unclear whether DPPCs are capable of 
differentiation into neuronal and glial cell types in the injured spinal cord. 
Against this background, the overall aim of this thesis is to assess the 
potential of DPPCs to functionally replace neurons and oligodendrocytes lost 
following SCI. 
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1.2 The peripheral and central nervous systems 
In order to understand neuronal damage, and the lack of subsequent 
regeneration, the basic fundamentals of central nervous system (CNS) 
functionality and the contributions made by each specialised cell type must 
be discussed. The CNS, comprising of the brain and spinal cord, acts as the 
control centre of the human body. It receives and processes sensory 
information from the peripheral nervous system (PNS) and returns electrical 
signals, coordinating bodily functions. Resident cells of the PNS and CNS 
broadly fall under one of two categories: neuronal or glial cells. 
1.2.1 Cell types 
1.2.1.1 Neurons 
Neurons are responsible for the transmission of electrical signals between 
the CNS and all tissues via highly a highly connected neuronal network. 
Neuronal cells are often identified by the presence of structural proteins such 
as βIII-tubulin, microtubule associated protein 2 (Map2) (Cáceres et al., 
1986) and subtypes of neurofilament (NF) (Lee and Cleveland, 1996). There 
are many classes of neuron, differing in morphology, electrophysiological 
properties, neurotransmitter signalling molecules and precise functions. 
Typically multipolar, neuronal cells often possess dense networks of 
dendrites, surrounding a small cell body, which act to receive chemical 
signals from other interconnected neurons. Neurons may then relay these 
signals via axonal projections which extend over long distances to other 
cells. 
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The key property of neuronal cells that enables them to function in this 
manner is an electrically excitable membrane that allows the generation of 
action potentials (Figure 1.1). Our knowledge of the ionic basis of events 
underlying action potentials is based on a series of electrical recordings 
taken from the giant axons of squid by Hodgkin and Huxley (1952). Although 
it is now known that there is a huge diversity in action potential dynamics, 
depending upon neuronal type and even the location on the cell at which a 
recording is taken from (reviewed by Bean, 2007), the basic principles of 
Hodgkin and Huxley’s model still hold true. At rest, neuronal membranes are 
held at a low potential, with high intracellular levels of K+ and low Na+, and 
contain many voltage-gated ion channels. Depolarisation of the cell 
membrane, following an appropriate chemical stimulation, results in the 
opening of voltage-activated channels and influx of Na+ ions into the cell. 
This change in membrane potential results in further depolarisation and 
activation of more Na+ channels. After a sustained opening period, Na+ 
channels inactivate and the efflux of K+ ions through voltage-activated 
channels begins to predominate, reducing the membrane potential towards 
resting levels (Figure 1.1 A). During repolarisation, efflux of K+ often results 
in a small period of hyperpolarisation, where the membrane potential is at a 
lower voltage than at rest. Passive leakage of potassium down its 
electrochemical gradient slowly brings the membrane voltage back to resting 
levels. Whilst sodium channels remain inactive, further action potentials 
cannot be evoked, this is known as the refractory period and allows the 
unidirectional propagation of action potentials. Action potentials travel as a 
wave along the length of axons, whereby the excitation of one region results 
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in the depolarisation, and subsequent excitation, of adjacent regions. This 
process continues until the action potential reaches an axon terminal/cell 
body. Action potentials cannot be evoked in recently excited regions of 
membrane that are refractory and so the electrical signals travel in one 
direction only (Figure 1.1 B). Upon reaching an axon terminus, membrane 
depolarisation results in the activation of voltage-sensitive Ca2+ channels 
allowing the influx of Ca2+ ions (reviewed by Rusakov, 2006). Increased 
intracellular calcium initiates the process of neurotransmitter release, 
whereby vesicles bind to the membrane and release their neurotransmitter 
contents into the synaptic cleft. The neurotransmitters then bind with 
complimentary receptors on the membrane of connected target cells to exert 
their specific effects. 
 Figure 1.1 – Generation and propagation of neuronal action potentials 
A) Neuronal action potentials are generated following an appropriate stimulus to 
depolarise the membrane resulting in the opening of voltage-activated Na+ and K+ 
channels. Initially Na+ currents predominate, resulting in further membrane 
depolarisation until sodium channels become inactivated. The cell membrane then 
repolarises through the efflux of K+ ions. During the refractory period, while sodium 
channels remain inactive, the membrane is unable to be further excited to generate 
another action potential. B) Action potentials are propagated unidirectionally along the 
lengths of axons either from cell bodies towards nerve terminals, or in reverse. 
Depolarisation of the axonal membrane, during an action potential, results in 
depolarisation and excitation of adjacent sections. Recently excited membrane regions 
remain refractory and so the action potential is unable to travel back in the direction 
from where it came. 
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1.2.1.2 Glial cells 
Neuronal cells are able to function in this specialised signalling role thanks to 
a diverse cast of supporting cells – the glia. Each type of glial cell plays a 
specific well-defined role. 
Microglia are the resident immune cells of the brain and spinal cord, and can 
be identified by expression of cell surface markers such as CD11b, CD45 
and IBA-1 (Sedgwick et al., 1991; Hirasawa et al., 2005). Their function is 
analogous to that of macrophages within other body tissues, scavenging and 
phagocytosing cellular debris and invading pathogens (reviewed by Napoli 
and Neumann, 2009). 
Astrocytes provide homeostatic support to neuronal cells and are often 
identified by the expression of glial fibrillary acidic protein (GFAP) and S100b 
calcium-binding protein (Nolte et al., 2001; Ogata and Kosaka, 2002). 
Astrocytes assist in maintaining a favourable environment for neuronal 
survival and function via numerous mechanisms including: the release of 
growth factors (Dreyfus et al., 1999), production of matrix proteins to provide 
structural support (Liesi et al., 1983), K+ buffering to maintain ionic balance 
(Holthoff and Witte, 2000), formation and maintenance of the blood-brain 
barrier (Sobue et al., 1999) and provision of metabolic support (Wender et 
al., 2000). 
Oligodendrocytes are highly branched cells that act to facilitate the 
conduction of action potentials in the CNS by attaching to axons and 
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insulating them with layers of myelin. This allows electrical signals to travel at 
speed over great distances without decreasing in strength via saltatory 
propagation (Figure 1.2). Due to the electrical insulating properties of myelin, 
action potentials are able to effectively “leap” from one region of 
unmyelinated axon (known as a Node of Ranvier) to the next (Figure 1.2 B), 
increasing speeds of conduction up to 10-fold (Purves et al., 2001). One 
oligodendrocyte cell can attach to and myelinate multiple axons within its 
vicinity (Lubetzki et al., 1993). Mature oligodendrocytes are typically 
identified by the expression of myelin-associated proteins such as myelin 
basic protein (MBP), myelin/oligodendrocyte specific protein (MOSP) or 
galactocerebroside (GalC) (reviewed by Buchet and Baron Van-Evercooren, 
2009). 
 Figure 1.2 – Facilitation of neuronal signalling by oligodendrocytes  
The propagation of action potentials over long distances at speed is aided by the actions 
of oligodendrocyte cells. A) Oligodendrocytes extend a network of processes which attach 
to nearby neuronal axons. The oligodendrocytes ensheath axons with multiple layers of 
myelin, providing electrical insulation. Action potentials “skip” between Nodes of Ranvier 
(regions of unmyelinated axon) by the process of saltatory conduction (B). Following 
excitation, opening of voltage-gated Na+ channels results in a region of localised 
depolarisation. Due to the insulation provided by myelin, the charge cannot leak out in 
immediately adjacent regions of membrane and, instead, travels further along the axon to 
the next Node of Ranvier. This localised depolarisation results in the activation of voltage-
gated Na+ channels to trigger an action potential which, in turn, depolarises the 
membrane at the subsequent Node of Ranvier and so on down the length of the axon. In 
this manner, action potentials can travel along myelinated axons up to 10 times faster 
than unmyelinated equivalents (Purves et al., 2001).  
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Schwann cells are the myelinating cell of the PNS. In contrast to 
oligodendrocytes, each Schwann cell is typically associated with, and 
myelinates, only a single axon. As a result they demonstrate much less 
complex branching and are more bipolar in morphology (Corfas et al., 2004). 
S100 calcium-binding proteins are the most commonly used marker to 
identify Schwann cells (Gonzalez-Martinez et al., 2003), although, as with 
oligodendrocytes, they also express myelin-associated proteins including 
MBP. 
Myelin sheets consist primarily of lipids with structural stability provided by 
cross-linking proteins. Although slight differences in the lipid compositions of 
CNS and PNS myelin are evident, it is in the protein fraction where 
significant variations are observed. Proteolipid protein (PLP) is the main 
structural protein found in CNS myelin, constituting 30 – 50% of the total 
protein content. Very little PLP is found in PNS myelin, where its crosslinking 
function is compensated for by P0 glycoprotein to provide stabilisation of lipid 
layers (Quarles et al., 2005). Similarly MBP accounts for approximately 30% 
of the protein content of CNS myelin, but only 5 – 18% of PNS myelin. 
Despite the differences in myelin composition within the central and 
peripheral nervous systems, the functionality is largely unaffected. 
1.2.2 Neurotrophic and growth factors 
A number of growth factor molecules help to maintain nervous system 
functionality by supporting cell survival. Members of the neurotrophin family: 
nerve growth factor (NGF), neurotrophin-3 (NT-3) and brain-derived 
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neurotrophic factor (BDNF) help to differentially maintain survival of neuronal 
subtypes under normal physiological conditions (reviewed by Skaper, 2012). 
Other growth factors, such as basic fibroblast growth factor (bFGF) and 
platelet-derived growth factor-a (PDGF-a) act as potent mitogens for early 
stage neuronal and oligodendrocyte cells. (Engel and Wolswijk, 1996; Gritti 
et al., 1996). Transforming growth factor β-1 (TGFβ-1) and the closely-
related glial cell line-derived neurotrophic factor (GDNF) may afford 
protection to neuronal cells against excitotoxicity as a result of elevated 
glutamate levels (Ho et al., 2000). Insulin-like growth factor-1 (IGF-1) has 
been demonstrated to possess anti-apoptotic properties for oligodendrocytes 
(Ness and Wood, 2002) and can encourage their maturation (Hsieh et al., 
2004). 
1.3 Spinal cord injury 
Spinal cord injury (SCI) is a major cause of paralysis worldwide. Often fatal, 
due to paralysis of the intercostal and other muscles essential for 
maintenance of breathing, there is an estimated global incidence rate of 15 – 
40 non-lethal cases per million people per year (Lee et al., 2013). The 
causes of injury are wide and varied, although, perhaps unsurprisingly, motor 
vehicle accidents, trips/falls, sports injuries and violence all feature 
prominently (Figure 1.3). 
 Figure 1.3 – Major causes of SCI resulting in paralysis 
Worldwide, motor vehicle accidents and falls are among the major causes of paralysis 
(statistics taken from Lee et al., 2013).  
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There are four main types of damage that can be inflicted upon the cord. 
Contusion injuries are the most commonly observed and occur as the result 
of a sudden impact bruising the cord. Increased pressure placed upon the 
spinal cord, by a developing tumour for example, may cause a compression 
injury. Laceration injuries occur where fragments of shattered bones sever 
the neural tissue. Finally, the spinal cord is susceptible to concussion 
injuries, where the effects may only be temporary and recovery is usually 
seen within 24 – 48 hours (Zwimpfer and Bernstein, 1990). Most SCIs 
usually involve a combination of the above mechanisms (Sekhon and 
Fehlings, 2001). 
In addition to the physical consequences of SCI, which vary in severity 
depending upon the location and type of injury, significant psychological and 
social burdens are inflicted on both patients and their families. In the most 
severe of non-fatal cases, there is a complete loss of all motor and sensory 
functions, as well as reflexes, at spinal levels below the site of injury 
(Thumbikat et al., 2009). An injury affecting only one side of the spinal cord 
may result in unilateral paralysis. It is estimated that lifetime care costs for a 
25 year old who suffers a complete injury in the upper cervical region, 
resulting in quadriplegia, may be as high as $3million and so there is also a 
considerable financial impact (Priebe et al., 2007). 
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1.3.1 Pathophysiology 
The pathophysiology of SCI can be divided into two separate phases. The 
primary phase involves the physical insult to the spinal cord itself disrupting 
blood vessels, axons and cell membranes. The secondary phase includes 
multiple events that subsequently occur at the cellular level. 
The initial damage compromises the blood-brain barrier integrity allowing the 
infiltration of leukocytes and other inflammatory cells into the neural tissue 
(Fleming et al., 2006). The resulting inflammatory response triggers 
activation of microglia and astrocytes which, in turn, release further pro-
inflammatory factors attracting more white blood cells and exacerbating the 
inflammation (Babcock et al., 2003). The release of proteolytic and oxidative 
enzymes by activated microglia enlarges the injury area and contributes to 
neurological dysfunction (Fleming et al., 2006). 
The neurological deficits that occur as a result of SCI are primarily attributed 
directly to cellular loss, and the resultant disruption of neuronal signalling. 
Various factors induce cellular death additional to the initial physical trauma. 
Activated microglia express Fas ligand to induce glial and neuronal apoptosis 
(Casha et al., 2001). Disruption of the vascular supply results in extensive 
haemorrhaging at the injury site (Tator and Koyanagi, 1997) and the 
subsequent ischaemia can contribute to cell death via mitochondrial 
dysfunction (Sullivan et al., 2007). Loss of ionic homeostasis leads to the 
accumulation of neurotransmitters, including glutamate, which can induce 
neuronal cell death via excitotoxic mechanisms (Yanase et al., 1995; 
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Wrathall et al., 1996). Oxidative radicals are released in the immediate 
aftermath of SCI and are responsible for membrane peroxidation and DNA 
and protein damage. Activated leukocytes and macrophages release 
superoxide as part of the inflammatory response, and ischaemia-reperfusion 
events increase free radical generation, contributing to cell death (reviewed 
by Genovese and Cuzzocrea, 2006). 
The degradation of normal axonal signalling pathways is also heavily 
involved in functional impairment. Wallerian degeneration, a process 
whereby the section of a severed axon distal to the cell body progressively 
disintegrates, is observed extensively following injury (Guth et al., 1999). 
Also of key importance is the delayed chronic demyelination that presents as 
a result of oligodendrocyte death (Totoui and Keirstead, 2005). 
1.3.2 Repair and regeneration following SCI 
The CNS lacks capacity for endogenous repair, unlike the PNS where a 
degree of natural regeneration is observed to restore functionality (reviewed 
by Navarro, 2009). Overcoming the numerous factors that prevent CNS 
regeneration is a key goal for research into treatments for various conditions 
including SCI, stroke and Parkinsons disease. 
Astrocytes are heavily involved in the pathological events inhibiting CNS 
regeneration. Over a number of days following injury, astrocytes proliferate at 
the site of injury and bind tightly together through numerous interwoven 
extracellular processes to form the glial scar (Wilhelmsson et al., 2006; Sun 
et al., 2010). This is primarily a protective mechanism as the scar is largely 
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impenetrable, providing a physical barrier to prevent the infiltration of 
inflammatory leukocytes and to restrict damaging factors to the injury site. 
However, access of endogenous oligodendrocyte precursor cells (OPCs) to 
demyelinated axons is also blocked, preventing remyelination. Additionally, 
the scar is inhibitive to axonal regrowth and regeneration due to the 
expression of inhibitory molecules including chondroitin sulphate 
proteoglycans and cytotactin/tenascins (McKeon et al., 1991). Furthermore, 
axonal growth inhibitory molecules – myelin-associated glycoprotein and 
NoGo – may be released as by-products from the breakdown of myelin 
(reviewed by Sandvig et al., 2004). As a consequence, the injured spinal 
cord presents an extremely hostile environment to cell growth. 
1.3.3 Roles of neurotrophic and growth factors 
A recent study has suggested that, following a spinal cord injury, only minor 
changes in the mRNA expression profile of neurotrophin and growth factors 
are observed. Excepting increases in expression of IGF-1 and TGFβ-1 and 
downregulation of PDGF-a, the endogenous growth factor profile remains 
largely unchanged (Hawryluk et al., 2012a). Modulating the injured spinal 
cord environment by administering exogenous neurotrophins and/or growth 
factors can help to create more supportive conditions for regrowth and 
regeneration. Such strategies have proven effective in promoting locomotor 
recovery in a number of experimental models of SCI (Bregman et al., 1997; 
McTigue et al., 1998; Rabchevsky et al., 2000; Koda et al., 2002; Widenfalk 
et al., 2003; Iannotti et al., 2004; Zhang et al., 2013). The precise 
mechanisms resulting in functional recovery are varied and help to highlight 
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the significance of each growth factor in the regenerative process. BDNF and 
NT-3 can each promote axonal regrowth (Bregman et al., 1997; McTigue et 
al., 1998), with BDNF also observed to inhibit oligodendrocyte apoptosis 
resulting in increased axonal remyelination (Koda et al., 2002). 
Administration of GDNF has been associated with increased neuronal 
survival and decreased cavity size (Iannotti et al., 2004). Similarly, bFGF 
may help protect against apoptosis of neuronal cells (Rabchevsky et al., 
2000; Zhang et al., 2013). Administration of vascular endothelial growth 
factor-A (VEGF-A) results in improved locomotor function through an 
alternative mechanism associated with the maintenance/repair of spinal cord 
blood vessel architecture (Widenfalk et al., 2003). The reported lack of 
upregulation of neurotrophic and growth factor expression (Hawryluk et al., 
2012a) will certainly contribute to the limited regenerative ability of the injured 
spinal cord. 
1.3.4 Current clinical treatment 
Using treatments currently available, it is impossible to completely reverse 
the effects of spinal cord injury. Instead, short-term emphasis is placed on 
minimising the extent of further damage after the initial injury, and longer 
term rehabilitation and symptom management through physiotherapy. An 
immediate focus is placed on immobilising and stabilising the injury site to 
prevent any further damage caused by the movement of shattered vertebrae, 
as well as maintaining blood pressure and clear airways (Bernhard et al., 
2005). The steroidal anti-inflammatory Methylprednisolone is commonly 
administered in the weeks following SCI and may prove useful in reducing 
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secondary inflammatory damage. However, its actual beneficial value still 
remains a matter of some controversy (Sayer et al., 2006; Suberviola et al., 
2008). Decompression surgery, the removal of various tissues or bone 
fragments that may exert pressure on the cord, can be carefully performed 
with benefit in some patients (Papadopoulos et al., 2002). Physiotherapy can 
assist with physical rehabilitation, allowing patients to maximise their 
capabilities (Jacobs and Nash, 2004). 
1.3.5 Clinical treatments in development 
A number of emerging treatments that may help to improve recovery after 
SCI are currently in early stage clinical trials. A number of these developing 
therapeutics focus on neuroprotection strategies to reduce the extent of 
damage in the early stages of SCI. Following systemic hypothermia 
treatment, where the vascular system is cooled to 33°C to reduce secondary 
inflammation, increased numbers of patients show improved physical 
recovery, in comparison to control subjects, without adverse effects (Levi et 
al., 2010). Riluzole, a Na+ channel blocker known to reduce excitotoxic cell 
death and already approved for the treatment of amyotrophic lateral 
sclerosis, is currently undergoing phase I trials for SCI (Fehlings et al., 2012). 
Minocycline acts against a number of the secondary mechanisms of injury by 
inhibiting microglia activation, stabilising mitochondrial activity and 
neutralising oxidative radicals. Improved motor recovery over one year of 
minocycline treatment was observed in a randomised placebo-controlled 
phase II clinical trial (Casha et al., 2012).  
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Alternative approaches act to reverse the inhibition of endogenous CNS 
regeneration by myelin-breakdown products. Monoclonal antibodies against 
NoGo protein are currently in phase II clinical trials (Zörner and Schwab, 
2010). The inhibition of Rho signalling, normally activated by myelin-
breakdown products resulting in axonal growth cone collapse, using Cethrin, 
has proven effective in early-stage clinical trials of injuries at the cervical 
level (Fehlings et al., 2011). 
Due to the complexity of the pathological events following spinal cord injury, 
it is improbable that one single treatment will act as a “magic bullet” to 
promote complete recovery. Rather, a combination of therapies will likely 
prove more effective by targeting multiple mechanisms to reduce damage 
and promote recovery. A great focus of research emphasis over recent years 
has been placed on cell replacement strategies using stem cells which can 
promote recovery through multiple mechanisms (Figure 1.4). The ideal 
treatment would help to recover normal neural function by replacing lost 
neuronal and glial cells, promoting the remyelination of demyelinated axons 
and assisting the formation of neural connections to bridge the lesion site, 
thereby, allowing efficient signal transduction. 
 Figure 1.4 – Targets for therapeutic intervention in SCI 
The complex multifaceted nature of spinal cord injury provides a range of potential 
targets for therapeutic intervention to reduce damage and promote repair. Stem cell 
transplantation strategies could prove particularly effective due to their potential to act 
through multiple mechanisms.  
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1.4 Stem cells 
Stem cells, undifferentiated cells with enhanced renewal capacity and the 
potential to differentiate into multiple lineages, offer great promise for the 
treatment of a multitude of medical conditions. Stem cells can be generally 
classified under one of two categories depending upon their tissue of origin: 
embryonic stem cells (ESCs) derived from a developing embryo and adult 
stem cells which may be found in a number of tissues within fully developed 
organisms. For the treatment of spinal cord injury, research has focused 
primarily on ESCs, neural stem cells (NSCs) and, more recently, 
mesenchymal stem cells (MSCs). 
1.4.1 Embryonic stem cells 
Embryonic stem cells are isolated from the inner cell mass of a developing 
embryo during blastomere formation. These cells possess unlimited self-
renewal capabilities and can be maintained in culture indefinitely (Suda et al., 
1987). ESCs are described as pluripotent cells due to their potential to 
differentiate into cell types from all three primary germ layers: the endoderm, 
ectoderm and mesoderm (Thomson et al., 1998). Included among the many 
specific cell types that ESCs have been demonstrated to differentiate into in 
vitro are neural cell types including astrocytes, neurons and oligodendrocytes 
(Reubinoff et al., 2001)  
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1.4.2 Stem cells of the CNS 
A diverse range of multipotent stem cells give rise to the glial and neuronal 
cells of the CNS in regionally and temporally specified patterns via a series 
of intermediate lineage-restricted precursors,. The NSCs commonly 
investigated in vitro are multipotent and can be isolated from embryonic 
tissue or from a number of regions of the adult CNS including: the 
subventricular zone (Doetsch et al., 1999), cortex (Arsenijevic et al., 2001), 
hippocampus (Kukekov et al., 1999) and the spinal cord (Weiss et al., 1996). 
NSCs are typically characterised by the expression of nestin, an intermediate 
filament protein (Lendahl et al., 1990). Under appropriate culture conditions, 
with the addition of bFGF and epidermal growth factor (EGF), NSCs 
proliferate as floating bodies of cells known as neurospheres (Wachs et al., 
2003). NSCs within neurospheres maintain multipotency and demonstrate 
the ability to differentiate into astrocytes, neurons and oligodendrocytes 
(Arsenijevich et al., 2001). 
Over recent years there has been a shift in the perception of what constitutes 
the true neural stem cell in vivo. Traditionally, neuroepithelial cells residing in 
neurogenic regions of the embryonic CNS, such as the subventricular zone, 
were believed to give rise directly to neuronal and glial cells (Figure 1.5). 
Increasing evidence, however, now points to the common precursor being 
more glial in nature (reviewed by Malatesta and Götz, 2013). Radial glia 
arise from dividing neuroepithelial cells and are typically identified by the 
expression of brain lipid binding protein (BLBP) and glutamate aspartate 
transporter (GLAST) (Anthony et al., 2004). Radial glia possess the ability to 
24 
 
divide asymmetrically: self-renewing while also giving rise to daughter post-
mitotic neurons or intermediate precursor cells (Noctor et al., 2004) (Figure 
1.5). Evidence suggests that radial glial cells give rise to the vast majority of 
neurons in the adult CNS (Anthony et al., 2004; Merckle et al., 2004). 
However, the line between neuroepithelial and radial glial cells remains 
blurred and, as such, the term NSC is often used interchangeably to apply to 
either phenotype. 
Bipotential cell types with the ability to differentiate into oligodendrocytes and 
astrocytes, via intermediate precursors, are known as glial restricted 
precursors (GRPs) (Gregori et al., 2002). These arise from both 
neuroepithelial stem cells and radial glia, and are identified by expression of 
A2B5 antigen (Rao and Mayer-Proschel, 1997; Kessaris et al., 2008). 
A further restriction in differentiation potential results in the derivation of 
oligodendrocyte precursor cells (OPCs). These are found throughout the 
developing CNS and diminish in number post-natally. It is believed that 
populations of OPCs arise from radial glial cells via GRPs (Merkle et al., 
2004; Fogarty et al., 2005) although regionally specified oligodendrocytes of 
the spinal cord have been observed to derive from a shared motorneuron 
progenitor (Lu et al., 2002; Zhou and Anderson, 2002). 
 Figure 1.5 – Stem cells of the central nervous system 
The concept of a neural stem cell is fluid and constantly evolving. Candidates for NSCs 
include neuroepithelial cells and radial glial cells, which can both give rise to daughter 
neuronal cells via asymmetric cell division. Glial cells typically derive from glial restricted 
precursor cells, themselves differentiated from radial glia and/or neuroepithelial cells.  
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1.4.3 Mesenchymal stem cells 
MSCs represent a source of adult stem cells that can be isolated from a 
number of different tissues. MSCs are identified by the expression of cell 
surface antigens, such as CD73, CD90 and C105, together with the absence 
of markers for cells of haematopoetic origin, such as CD11b, CD33 and 
CD45 (Dominici et al., 2006). MSCs are typically multipotent and possess the 
ability to differentiate into osteoblasts, chondrocytes and adipocytes. Human 
MSCs have been isolated from a diverse range of sources including: bone 
marrow (Pittenger et al., 1999), known as bone marrow stromal cells 
(BMSCs), adipose tissue (Zuk et al., 2002) and umbilical cord blood (Kern et 
al., 2006). 
MSCs possess an advantage over ESCs and NSCs in that their isolation 
does not require the destruction of brain or foetal tissue. However, MSCs 
may be considered less versatile due to their more restricted differentiation 
potential. Nevertheless, limited evidence demonstrates the in vitro 
differentiation of neuronal-like (Tropel et al., 2006; Anghileri et al., 2009) and 
glial-like (Kennea et al., 2009; Radtke et al., 2009; Park et al., 2010a) 
phenotypes from MSCs. 
1.4.4 Stem cell therapeutics for SCI 
Because the loss and/or death of cells is a significant contributing factor to 
the complications observed following a spinal cord injury, replacement of 
these cells proves an appealing therapeutic strategy. If transplanted stem 
cells can survive and integrate into the neural environment then recovery 
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may be observed (Kim and de Vellis, 2009). A number of different stem cell 
populations have been investigated in animal models and have 
demonstrated promise, justifying stem cell transplantation as a potential 
treatment for SCI. 
1.4.4.1 Embryonic stem cell transplantation 
A degree of functional recovery following the transplantation of 
undifferentiated ESCs into rodent models of SCI has been established by a 
number of studies. Murine ESCs transplanted into the spinal cords of rats 9 
days after the induction of a weight drop injury can still be identified 33 days 
post-transplantation, demonstrating their ability to survive within the sub-
acute injury environment. Markers for differentiated oligodendrocytes, 
astrocytes and neurons can be detected within the transplanted cell 
population. Improved hindlimb motor function in the transplant group is 
observed when compared to controls, suggesting this recovery is mediated 
through the spontaneous differentiation of neural cell types (McDonald et al., 
1999). 
Improved recovery following ESC transplantation, however, may not be 
solely mediated through direct cell replacement. Transplantation of mouse 
ESCs two hours following contusion injury in a mouse SCI model results in a 
quicker and more extensive recovery of motor function in comparison to 
control treated groups. Reduced levels of macrophages and neutrophils are 
found at the transplantation site (Bottai et al., 2010). As such, embryonic 
stem cell transplantation therapies may also help to minimise damage and 
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functional loss by inhibiting the inflammatory response, if applied within an 
acute timeframe. 
1.4.4.2  Transplantation of ESC-derived neural precursors 
Two cell types, in particular are thought to be essential for the restoration of 
normal neuronal function following a spinal cord injury. Functionally active 
neurons are required to reform the disrupted neural connections and 
oligodendrocytes are needed to myelinate demyelinated and/or newly formed 
axons, thereby, facilitating electrical conduction of nerve impulses. With the 
transplantation of undifferentiated stem cells, cell fate is entirely determined 
by the environment of the injured spinal cord, which is naturally inhibitive to 
neuronal growth and regeneration. Undesirable cell types which may hinder 
repair, particularly astrocytes, are often the predominant phenotype identified 
within grafted ESC populations (Sykova and Jendelova, 2005). One strategy 
to circumvent this is to pre-differentiate cells prior to transplantation, thereby 
restricting the potential for undesirable differentiation and improving 
functional outcome (Marques et al., 2010). The ability of ESCs to differentiate 
in vitro into precursors for oligodendrocytes and motorneurons, therefore, 
demonstrates promise for recovery and regeneration following SCI (Zhang et 
al., 2001; Nistor et al., 2005). 
Using a 42 day differentiation protocol it is possible to derive a highly purified 
population of OPCs from human ESCs. These cells survive within spinal cord 
white matter and differentiate into mature oligodendrocytes. Furthermore, 
transplantation of these precursors is associated with elevated levels of 
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multilayered myelination in a mouse model of demyelination (Nistor et al., 
2005). Following transplantation of human ESC-derived OPCs into a sub-
acute model of rat SCI, increased remyelination of demyelinated axons was 
observed. Animals in the transplant groups showed improved hindlimb 
functional recovery, as assessed by behavioural and kinetic analyses. In a 
chronic SCI model however, although transplanted cells could still be 
identified within the spinal cord, there was no associated change in 
myelination levels or locomotion recovery. Interestingly, only around 55% of 
oligodendrocyte-remyelinated axons were physically associated with 
transplanted cells, suggesting that native oligodendrocytes may have been 
recruited to the site of injury (Keirstead et al., 2005). ESC-derived OPCs 
express multiple neurotrophic factors including BDNF and transforming 
growth factor β-2 which could be responsible for the recruitment of 
endogenous cells (Faulkner and Keirstead, 2005). ESC-derived OPCs have 
also demonstrated neuroprotective functions. Increased white and grey 
matter sparing is observed at OPC transplantation sites suggesting a 
possible inhibitory effect on factors influencing cell death following injury 
(Sharp et al., 2010). Similarly, sensory signalling pathways are preserved 
when OPCs are transplanted 2 hours following the induction of a contusion 
injury in rats (All et al., 2012).  
Motorneuron progenitor cells derived from human ESCs and injected into the 
developing chick embryo survive, adopt appropriate mature morphology, 
projecting long range axons. Similarly, in the adult rat spinal cord, a large 
outgrowth of cholinergic axons can be identified (Lee et al., 2007). Following 
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a viral-induced spinal cord injury, ESC-derived motorneuron progenitor cells 
extend axons forming physiologically active neuromuscular junctions and are 
associated with an increased recovery of hindlimb grip strength (Deshpande 
et al., 2006). 
The transplantation of ESC-derived oligodendrocyte and motorneuron 
precursor cells simultaneously may work synergistically to provide an even 
more effective therapeutic strategy. Following complete spinal transection, a 
greater extent of motor function recovery has been observed in dual 
transplant groups compared with transplantation of either progenitor 
individually (Erceg et al., 2010). 
1.4.4.3 Transplantation of CNS stem cells 
The most obvious stem cell candidates for transplantation into the injured 
spinal cord would be those that are resident within the CNS itself and give 
rise to mature neuronal and glial cells. Human foetal NSCs expanded in vitro 
as neurospheres, survive and express markers for mature neurons and 
oligodendrocytes following transplantation into the injured murine thoracic 
spinal cord. This is associated with improved locomotion recovery and, 
furthermore, the formation of synapses between host neurons and 
transplanted cells can be identified, indicating possible functional integration 
into neuronal signalling pathways (Cummings et al., 2005). Similarly, in a 
primate contusion injury model, mature neurons, astrocytes and 
oligodendrocytes can be identified as having differentiated from a population 
of transplanted foetal human NSCs. Animals in the transplant group 
31 
 
demonstrated increased spontaneous electrical activity and grip strength 
(Iwanami et al., 2005).  
In addition to apparent direct cellular replacement, NSCs have also been 
demonstrated to promote functional recovery through neurotrophic effects. 
NSCs produce and secrete a range of neurotrophic factors that can promote 
endogenous axonal regrowth and sprouting into spinal cord lesions (Lu et al., 
2003; Amemori et al., 2013). In fact, recovery may be a combination of both 
cellular replacement and neurotrophic effects working simultaneously. NSCs 
transplanted 9 days after induction of a rat SCI differentiate mainly into 
astrocytes and oligodendrocytes. Increased host oligodendrocyte survival 
can be observed together with axonal remyelination by transplanted cells 
(Parr et al., 2008) 
As with embryonic stem cells, the transplantation of restricted lineage 
precursor cells may provide a more effective therapeutic strategy by 
preventing the differentiation of unwanted cell types. GRPs can be isolated 
from the embryonic spinal cord through fluorescence activated sorting based 
on expression of A2B5. These cells survive following transplantation into the 
injured spinal cord, migrating out from sites of injection and maturing into 
astrocytes and oligodendrocytes (Han et al., 2004). Transplantation of GRPs 
in combination with a similarly isolated population of neuronal-restricted 
progenitors into the rat spinal cord has resulted in improved locomotor 
activity and recovery of bladder control reflexes (Mitsui et al., 2005). 
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1.4.4.4 Transplantation of cells derived from other tissues 
In addition to embryonic and CNS-derived stem cells, cells isolated from 
adult tissues have also demonstrated promise in experimental SCI models. 
BMSCs represent one such adult stem cell. Although expression of neuronal 
and astrocytic markers by BMSCs has been associated with functional 
recovery following transplantation into the spinal cord (Chiba et al., 2009), 
the regenerative effects are most likely mediated through growth factor 
production. BMSCs show the ability to express a range of neurotrophic 
factors in vitro (Hawryluk et al., 2012b) and can promote spinal cord recovery 
when not transplanted directly into the cord itself. Recovery has been 
observed following the administration of BMSCs systemically through tail 
vein injection (Quertainmont et al., 2012). Alternatively, BMSCs pre-
differentiated into neuronal-like cells (Nagdhi et al., 2009) or Schwann cells 
(Someya et al., 2008; Kamada et al., 2011; Novikova et al., 2011) have also 
been shown to promote sparing of spinal cord tissue and been associated 
with improved functional recovery following SCI. 
As an alternative to stem/progenitor cells, the transplantation of post-mitotic 
somatic cells can promote recovery after SCI. Increased remyelination can 
be observed after the transplantation of Schwann cells either alone, or in 
combination with olfactory ensheathing cells, a similar glial cell type found 
specifically in the olfactory bulb (Takami et al., 2002). The ability of olfactory 
ensheathing cells to promote this type of recovery remains a matter of 
debate due to a number of conflicting studies (Ramón-Cueto et al., 2000; 
Takami et al., 2002; Pearse et al., 2007). 
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1.4.4.5 Alternative mechanisms and approaches for stem cell therapy 
A number of studies have investigated methods for enhancing stem cell-
mediated functional recovery. Promising approaches include: augmentation 
of growth factor production, improving transplanted cell survival through the 
use of extracellular scaffolds or transplanting a combination of different cell 
types. 
Genetically engineering stem cells to overexpress neurotrophic factors may 
provide a method for enhancing the regenerative effects mediated through 
growth factor release. This approach has demonstrated promise with NSCs 
(Lu et al., 2003), GRPs (Cao et al., 2005) and BMSCs (Lu et al., 2005). 
Transplanted scaffolds or hydrogels can provide a means of bridging the 
cavity that arises following SCI.  The injury site is inhospitable to neuronal 
growth but the provision of a suitable substrate by itself may be sufficient to 
aid and guide the growth and regeneration of cells and/or axons within this 
environment (Stokols and Tuszynski., 2006; Tysseling et al., 2010). 
Alternatively, they can be seeded with stem cells, improving transplanted cell 
survival and attracting axonal outgrowth (Hatami et al., 2009; Gros et al., 
2010; Liu et al., 2013). 
A synergistic effect may be achieved when transplanting more than one cell 
type simultaneously by targeting repair through complimentary mechanisms. 
Co-transplantation with Schwann cells (Olson et al., 2009), olfactory 
ensheathing cells (Luo et al., 2013) or BMSCs (Parr et al., 2008) can 
improve grafted NSC survival and functional outcomes.  
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A further alternative approach could involve the recruitment of endogenous 
progenitor cells to repair the damaged tissue. .Progenitors within the spinal 
cord are naturally recruited to differentiate and proliferate following injury 
(Barnabe-Heider et al., 2010). However, the proliferating population consists 
primarily of astrocyte and ependymal precursors as opposed to the more 
desirable oligodendrocytes and neuronal cells which could help in the 
recovery of neuronal function. For the greatest efficacy, any treatment to 
attract endogenous precursors would need to utilise a mechanism that 
facilitates navigation past the glial scar which would block the access of cells 
to the injury site. 
1.4.4.6 Clinical trials 
At this moment in time it remains unclear which source of stem/progenitor 
cells represents the most effective for use in SCI treatment. Despite the 
promise shown by stem cells of various origins in animal models, only a 
handful of treatments have progressed sufficiently to be entered into early 
stage clinical trials for human SCI. 
The most high profile trial in recent years was run by California-based Geron 
pharmaceuticals investigating the use of human ESC-derived OPCs (as 
described by Keirstead et al., 2005 and Nistor et al., 2005). This trial was the 
focus of much media attention as it was the first approval for the clinical use 
of human ESCs. After only a year, the trial was abruptly discontinued. 
Despite the official line that this decision was taken on financial grounds, 
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whispers of safety concerns abound suggesting that even lineage-restricted 
ESCs may not be the best candidate for SCI stem cell therapy. 
Elsewhere, no adverse effects have been reported following the 
transplantation of autologous BMSCs (Pal et al., 2009), which may even be 
associated with an improved quality of life for some patients (Park et al., 
2012). The use of adipose tissue-derived MSCs has similarly demonstrated 
short-term safety (Ra et al., 2011). Human NSCs derived from 8-9 week 
gestational foetuses have already demonstrated promise in phase I trials for 
treatment of the myelin-associated disorder Pelizaeus-Merzbacher disease 
(Gupta et al., 2012) and are currently being tested for SCI.  
Such early clinical trials are primarily focused on assessing safety and 
tolerance of transplanted cells. It is a few more years yet before any 
improvements, as a result of cell therapy for human SCI, can be confirmed. 
1.4.4.7  Issues 
The therapeutic use of stem cells remains a controversial topic, particularly 
with those isolated from embryonic tissues, and faces intense opposition. 
Isolating ESCs and NSCs involves the destruction of foetal and/or brain 
tissue, potentially placing limits upon their applications despite the recent 
advancements into clinical trials. Cells with similar properties derived from 
more easily accessible sources can provide a means of circumventing such 
ethical concerns. However, the isolation of BMSCs, the leading candidate in 
this field, is an extremely invasive procedure. This study aims to assess the 
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potential of progenitor cells residing in the dental pulp for use in SCI 
treatment. 
1.5 The dental pulp 
The dental pulp harbours the living components found within the core of the 
tooth. The pulp is comprised primarily of connective tissue but also contains 
an extensive blood capillary system and is highly innervated. A diverse range 
of cell types are found within the pulp including fibroblasts, odontoblasts and 
immune cells. 
1.5.1 Function 
The dental pulp has a number of physiological roles including: immune 
defence responses to oral pathogen invasion (reviewed by Goldberg et al., 
2009), sensory functions (Holland, 1994; El Karim et al., 2011) and the 
production of dentine through the actions of odontoblast cells (Arana-Chavez 
and Massa, 2004). Dentine, an organic mineralised matrix similar in 
composition to bone, provides mechanical support for the brittle tooth enamel 
and physical protection from oral pathogen invasion. During tooth 
development, primary dentine, of a regular tubular structure, is secreted by 
odontoblasts to form a solid mass encasing the pulpal cavity. After the 
completion of root development, production is switched to secondary 
dentine, of a similar structure but at a much slower rate, through life. In 
response to mild pulpal injury, such as early caries, surviving odontoblasts at 
the pulp-dentine interface produce reactionary dentine. More severe 
damage, however, results in the death of odontoblasts and new odontoblast-
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like cells are recruited to the injury site to produce atubular reparative 
dentine, protecting the vital pulp tissue (reviewed by Smith et al., 1995). The 
source of these new cells are thought to be dental pulp progenitor cells 
(DPPCs) which respond to extracellular signals and exogenous growth 
factors by migrating to the site of injury and differentiating into new dentine-
forming odontoblasts (Tecles et al., 2005). 
1.5.2 Progenitor cells 
Cells with progenitor characteristics isolated from the dental pulp were first 
described by Gronthos et al. (2000). The authors isolated clonogenic 
populations of cells with fibroblast-like morphology from the dental pulp of 
human impacted molars. These cells possessed a stem cell marker profile 
similar to BMSCs with higher proliferative and colony-forming properties. The 
isolated DPPCs demonstrated the ability to produce mineralised dentine-like 
tissue both in vitro and in vivo. A similar population of cells, with even higher 
proliferation properties, were subsequently isolated from deciduous teeth and 
named stem cells from human exfoliated deciduous teeth (SHEDs) (Miura et 
al., 2003). Since these early reports, numerous investigations have been 
undertaken characterising the functions, properties, and potential uses of 
DPPCs and SHEDs in tissue engineering. 
DPPCs represent a highly heterogeneous population of cells. Large 
differences are observed in the proliferation and mineralisation potential of 
single cell-derived clones, suggesting the existence of multiple progenitor 
populations within the pulp (Gronthos et al., 2002). One such population is 
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thought to be associated with perivascular region where rapid cellular 
proliferation is seen in response to odontoblastic injury (Shi and Gronthos, 
2003; Tecles et al., 2005). Activation of notch signalling following pulp-
capping suggests that further populations reside in the cell-rich region close 
to the odontoblast layer and within the pulpal stroma (Lovschall et al., 2005).  
1.5.2.1 Properties 
DPPCs are generally classified as mesenchymal stem cells due to their 
expression of markers such as CD44, CD73, CD90, CD105, stem cell 
antigen 1 (SCA1) and stro-1 (Patel et al., 2009; Govindasamy et al., 2010; 
Guimaraes et al., 2011). In vitro, DPPCs can be readily induced to 
differentiate into the classic MSC lineage cell types of 
osteoblasts/odontoblasts, chondrocytes and adipocytes using established 
protocols (Gronthos et al., 2002; Balic et al., 2010; Govindasamy et al., 
2010). 
The differentiation potential of DPPCs may not be strictly limited to 
mesenchymal cell types, however. Expression of pluripotency markers, such 
as nanog, Oct-4, SOX2 and SSEA4 can be found in cultured cells 
(Guimaraes et al., 2011; Osathanon et al., 2011; Karaöz et al., 2011). 
Additionally, DPPCs already express markers associated with more mature 
phenotypes, such as muscle (α-smooth muscle actin and myosin II (Patel et 
al., 2009)) and neurons (βIII-tubulin and  Map2 (Karaöz et al., 2011)). A 
number of studies have demonstrated the potential for endothelial (Iohara et 
al., 2008 and 2013) myogenic (Kerkis et al., 2008; Nakatsuka et al., 2010), 
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hepatocytic (Ishkitiev et al., 2012) and melanocytic (Stevens et al., 2008; 
Paino et al., 2010) differentiation. Due to this potential versatility, a varied 
range of therapeutic applications have been proposed for DPPCs (Figure 
1.6). 
1.5.2.2 Advantages of DPPCs 
The dental pulp has a distinct advantage over other adult sources of MSC-
like cells in that it can be accessed through entirely non-invasive procedures. 
Healthy adult teeth, particularly impacted molars, are often extracted during 
orthodontic treatment, while deciduous teeth are naturally shed in childhood. 
Rather than simply discarding the teeth, pulpal tissue can be excavated and 
cryogenically preserved. DPPCs or SHEDs can subsequently be isolated 
from such tissue, following thawing, with no detrimental effects in viability, 
proliferation or differentiation (Woods et al., 2009; Ma et al., 2012). This has 
led to the founding of tissue banks which serve as stores of patient-matched 
progenitor cell samples ready to be accessed if and when required in the 
future.  
A number of studies have demonstrated potent immunomodulatory 
properties of DPPCs. Immunogenic reactions to DPPCs may be suppressed 
by the inhibited activation and induced apoptosis of T-cells (Pierdomenico et 
al., 2005; Demircan et al., 2011; Zhao et al., 2012). This suggests that in 
addition to patient-matched autologous applications, DPPCs may be 
tolerated as an allogeneic cell transplant without the need for 
immunosuppression (Kerkis et al., 2008). 
 Figure 1.6 – Proposed therapeutic applications of DPPCs 
Dental pulp progenitor cells demonstrate promise for the repair and regeneration for 
varied tissue types including neural, muscular, corneal and mineralised tissue. 
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1.5.2.3 DPPCs and the CNS 
DPPCs possess a number of characteristics that suggest they may provide a 
suitable and effective alternative to embryonic or neural stem cells for cell 
replacement therapies in the CNS. A number of markers commonly used to 
identify the stem and progenitor cells of the CNS are expressed by DPPCs. 
Nestin (Gronthos et al., 2002; Király et al., 2009; Patel et al., 2009), musashi 
(Karbanová et al., 2011), SOX2 (Karaöz et al., 2011) and A2B5 (Sakai et al., 
2012) have all been found to be expressed by cultured DPPCs indicating that 
they might have an inherent capacity to differentiate into neuronal and glial 
cell types. In fact, undifferentiated DPPCs often demonstrate low basal 
expression levels of more mature neuronal markers, such as Map2, NF and 
βIII-tubulin (Osathanon et al., 2011; Sakai et al., 2012). Similarly, expression 
of the astrocytic marker GFAP (Gronthos et al., 2002; Sakai et al., 2012) and 
oligodendrocyte-associated 2',3'-cyclic-nucleotide 3'-phosphodiesterase 
(CNPase) (Sakai et al., 2012) has also been reported. 
1.5.2.3.1 Neuronal differentiation 
Various protocols have been devised for the in vitro differentiation of 
neuronal-like cells from DPPCs (reviewed by Young et al., 2013). The most 
commonly adopted method involves the generation of floating neurosphere-
like bodies by culturing in media containing bFGF and EGF on low-
attachment culture surfaces (Table 1.1). When cells are dissociated from 
neurospheres and allowed to attach to coated plastics, they adopt 
appropriate neuronal morphology and express the early stage neuronal 
markers Map2 and βIII-tubulin (Sasaki et al., 2008). A further maturation 
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step, with the addition of neurotrophic factors to culture media, may result in 
a more complex morphology and the expression of later stage markers such 
as NF or neuromodulin (Iohara et al., 2006; Govindasamy et al., 2010). 
Patch clamp recordings, to assess electrophysiological functionality of 
neuronal-like cells, have been reported for two further differentiation 
protocols (Arthur et al., 2008; Király et al., 2009) (Table 1.2). Arthur et al. 
devised two separate differentiation protocols resulting in the differentiation 
of βIII-tubulin, NF and neural cell adhesion molecule (NCAM)-positive 
sensory and motor neuron-like cells. Cells differentiated using this protocol 
display voltage-gated Na+ currents consistent in properties with neuronal 
cells. The protocol developed by Király et al. involves stimulation of cAMP 
and protein kinase C signalling to induce expression of neurogenin-2 (Ngn2), 
NF and neuron-specific enolase. In addition to Na+ currents, cells 
differentiated using this protocol also possess voltage-activated K+ currents. 
However, no action potentials or spontaneous activity are demonstrated by 
these cells (Aanismaa et al., 2012). The generation of an action potential by 
neuronally-differentiated DPPCs has yet to be observed. This is a key 
requirement for proving that DPPCs truly can differentiate into functionally 
active neurons, providing evidence of their potential to promote CNS repair 
through direct cellular replacement.  
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1.5.2.3.2 Production of neurotrophic and growth factors in vitro 
In vitro, DPPCs can produce and release a wide range of neurotrophic 
factors including BDNF, NGF, NT-3 and GDNF (Nosrat et al., 2001 and 
2004; Soria et al., 2010; Nesti et al., 2011). Furthermore, DPPCs express 
VEGF-A (Iohara et al., 2008) and have comparable mRNA expression levels 
to BMSCs for other growth factors including IGF-1, bFGF, TGFβ-1 and 
PDGF (Shi et al., 2001).  
Through the release of such soluble growth factors DPPCs have been 
demonstrated to promote the growth and survival of primary cultured 
neurons. Co-cultured DPPCs support trigeminal ganglion neuron survival, 
without a requirement for exogenous growth factors (Nosrat et al., 2001). 
Similarly, increased survival of primary cultured dopaminergic neurons is 
observed in DPPC co-cultures, which also offer a degree of protection from 
specific neurotoxins (Nosrat et al., 2004; Nesti et al., 2011). The neuronal 
differentiation of NSCs on three dimensional poly(ethyl acrylate-co-
hydroxyethyl acrylate) scaffolds is enhanced when pre-seeded with DPPCs 
(Soria et al., 2010). DPPC-conditioned medium, alone, is sufficient to exert 
such neurotrophic effects, promoting survival, proliferation and neurite 
outgrowth of neuroblastoma cell lines (Sugiyama et al., 2011; Ishikaza et al., 
2013), confirming actions through the release of soluble factors. 
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1.5.2.3.3 DPPCs and the uninjured nervous system 
Such in vitro observations suggest the potential of DPPCs to promote 
neuronal survival and recruit endogenous NSCs in vivo. Similar neurotrophic 
effects have been observed following DPPC transplantation into the 
developing and/or healthy peripheral and central nervous systems. 
Regenerating endogenous axons can be identified growing through pulp 
explants enclosed within chitosan mesh tubes 32 weeks following grafting 
into the transected rat sciatic nerve (Matsushita et al., 2012). A similar 
innervation, accompanied with vascularisation, is observed following the 
grafting of pulpal tissue intraocularly (Nosrat et al., 2001). An increase in 
proliferation of endogenous neural cells is observed following DPPC 
transplantation into murine hippocampus. Increased expression of nestin and 
βIII-tubulin suggests that the implanted DPPCs are inducing endogenous 
progenitor cells to differentiate. Elevated production of NGF, VEGF and 
BDNF is the proposed mechanism for this NSC recruitment (Huang et al., 
2008). During avian embryogenesis, transplantated DPPCs are seen to 
attract axonal growth cones, disrupting normal neural development (Arthur et 
al., 2009). 
1.5.2.3.4 DPPCs and in vivo models of stroke 
Most of our knowledge regarding the transplantation of DPPCs into the 
injured CNS is obtained from in vivo models of stroke. DPPCs injected into 
the cerebrospinal fluid of newborn rats localise in regions adjacent to cold-
induced lesions (Király et al., 2011) as well as neurogenic regions (the 
subventricular, subgranular and subcallosal zones). In a model of cerebral 
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ischaemia DPPCs are similarly identified settling within NSC niches (Fang et 
al., 2013). The localisation of transplanted DPPCs in regions of active 
neurogenesis suggests their potential for contributing to the regeneration of 
neural tissue. 
Reduced functional deficits have been observed following the transplantation 
of DPPCs (Yang et al., 2009; Sugiyama et al., 2011; Fang et al., 2013; 
Ishikaza et al., 2013) or SHEDs (Yamagata et al., 2013) into rodent models 
of cerebral ischaemia. The transplantation of dental pulp-derived progenitor 
cells reduces tissue loss by increasing survival of endogenous neuronal cells 
(Yang et al., 2009; Yamagata et al., 2013) and promoting revascularisation 
(Sugiyama et al., 2011; Ishikaza et al., 2013). Although, limited expression of 
neuronal, astrocytic and oligodendrocytic markers has been identified among 
transplanted cells in one study (Fang et al., 2013), overwhelming evidence 
suggests the protective/regenerative effects are mediated through trophic 
actions. Comparable outcomes are seen following the injection of SHED-
conditioned medium, alone, suggesting a paracrine mechanism (Yamagata 
et al., 2013). In situ expression of VEGF, BDNF, NGF and GDNF has been 
identified by transplanted cells and is likely responsible for these effects 
(Sugiyama et al., 2011; Ishikaza et al., 2013). Although models of stroke at 
first glance may appear to be removed from a spinal cord injury, pathological 
events at the cellular level and the obstructions to regeneration are similar 
and as such these results may be transferrable to SCI. 
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1.5.2.3.5 DPPCs and in vivo models of SCI 
Less information is available regarding the transplantation of DPPCs into the 
injured spinal cord. Dental pulp tissue explants grafted into the rat lumbar 
spinal cord, immediately following a hemisection injury, express GDNF and 
more than double the survival rate of endogenous motor neurons (Nosrat et 
al., 2001). Improved functional outcome has been observed following DPPC 
transplantation into the injured spinal cord in two separate studies. 
The transplantation of DPPCs directly into the injury epicentre at either 7 or 
28 days after generation of a compressive SCI in mice is associated with 
improved recovery of hindlimb function (de Almeida et al., 2011). Increased 
expression of BDNF, NGF, NT-3 and NT-4 is observed, accompanied with 
greater preservation of white matter tissue. Expression of GFAP and S100 
by transplanted cells suggests astrocytic/Schwann cell differentiation. 
In a rat model, involving complete transection of the spinal cord, 
transplantation of DPPCs or SHEDs immediately following injury results in 
improved hindlimb functional outcome (Sakai et al., 2012). Given the timing 
of cellular transplantation it would appear the effects were likely mediated 
through neuroprotective actions attenuating secondary mechanisms of injury. 
Increased axonal sparing, preservation of myelin and decreased apoptosis of 
of resident neuronal and glial cells support this theory. Approximately 90% of 
transplanted cells were reported to express oligodendrocytic markers while 
the remaining 10% could not be identified. The differentiation of neuronal 
cells following DPPC transplantation into the injured spinal cord has yet to be 
reported.  
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1.6 Aims and outlines 
Dental pulp progenitor cells have been demonstrated to promote functional 
improvements following spinal cord injury primarily through paracrine 
neuroprotective mechanisms. The overall objective of this study is to 
investigate the ability of DPPCs to promote spinal regeneration and repair 
through the direct replacement of neuronal and glial cells. This specific 
research question will be answered by dividing the work into three major 
aspects, beginning with the isolation of purified DPPC cultures with 
enhanced neural potential, determining their ability to differentiate into 
neuronal and glial cell types and, finally, the translation of these findings into 
spinal cord tissue.  
The specific aims of this thesis are summarised as follows: 
1) The isolation and characterisation of progenitor cells from murine 
dental pulp and assessment of neural potential based upon 
expression of Nestin and neurotrophic/growth factors 
2) Development of protocols demonstrating the ability of DPPCs to 
differentiate in vitro into: 
a. Functionally active neurons 
b. Oligodendrocytes 
3) Using these protocols to investigate the transplantation of pre-
differentiated DPPCs into ex vivo and in vivo spinal cord tissue.
  
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2: Materials and Methods
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2.1 Materials 
2.1.1 Animals 
All procedures were approved by the Cardiff University Biological Standards 
Office and performed in accordance with UK Home Office guidelines under 
the Animals (Scientific Procedures) Act 1986 (Project licence no: 30/2816, 
Personal licence no: 30/9506). 
21-28 day old C57/Bl6 mice were used for tissue harvest and obtained from 
the University Animal House colonies at the JBIOS Heath Hospital site. Mice 
were sacrificed by CO2 asphyxiation in accordance with Schedule 1 of the 
Animals (Scientific Procedures) Act 1986. 
2.1.2 Tissue culture  
To maintain sterility, all tissue culture procedures were performed in a 
Microflow Peroxide Class II advanced biological safety cabinet (Bioquell, 
UK). Unless otherwise specified, cells were cultured on Cell+ treated culture 
plastics (Sarstedt, Germany) and maintained at 37°C and 5% CO2 in a tissue 
culture incubator (Binder, Germany). 
2.1.3 Cellular imaging 
2.1.3.1 Phase contrast imaging 
Phase contrast images of cells in culture were captured using an Eclipse 
TS100 inverted phase contrast light microscope (Nikon, Japan) with a 
camera attachment (Canon, Japan). 
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2.1.3.2 Fluorescent imaging 
Fixed and fluorescent antibody-stained cells were viewed and images 
acquired using an AX7 microscope (Olympus, Japan) connected to a DXM-
1000 camera with ACT-1 imaging software (both Nikon, Japan). 
2.1.3.3 Image processing 
Acquired images were processed and overlapping images merged using 
freely available ImageJ software. 
2.2 Methods 
2.2.1 Tissue Culture 
2.2.1.1 Dental pulp progenitor cell culture 
Murine dental pulp cells (isolated as described in Chapter 3) were cultured in 
α-modification Minimum Essential Medium (αMEM) containing 2mM 
glutamine, ribonucleosides and deoxyribonucleosides (Life Technologies, 
UK). The medium was supplemented with 1% (v/v) penicillin/streptomycin, 
20% (v/v) heat-inactivated foetal bovine serum (FBS) (Life Technologies, 
UK) and 100µM l-ascorbic acid 2-phosphate (Sigma-Aldrich, UK). Medium 
was changed every 2-3 days until cells reached 80-90% confluence. 
2.2.1.2 Passaging DPPC Cultures 
Upon reaching confluence, culture medium was removed by aspiration and 
the cells washed with phosphate buffered saline (PBS) (Sigma-Aldrich, UK). 
Cells were dissociated by adding Accutase (Sigma-Aldrich, UK) and returned 
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to the incubator for 10 minutes until they became rounded and detached. 
Culture medium was then added to neutralise the Accutase. The resultant 
solutions of medium plus cells were transferred to 15ml falcon tubes and 
centrifuged at 400G for 5 minutes. After discarding the supernatant, pellets 
were resuspended in medium and cell counts performed using a 
haemocytometer with trypan blue exclusion adopted to assess cell viability. 
Cells were reseeded on new culture plastics at a density of 4000 viable 
cells/cm2 for continuous culture, or as per experimental requirements. 
2.2.1.3 Cryopreservation and re-establishment of DPPCs 
To maintain a stock of readily available cells, DPPCs were cryopreserved at 
regular intervals during culture. Following passaging, a minimum of 1 x 106 
cells were resuspended at 1 x 106 cells/ml in heat inactivated FBS + 20% 
(w/v) dimethyl sulphoxide (DMSO) (Fisher Scientific, UK) and transferred to 
2ml cryovials (Greiner Bio-one, Germany).  Cryovials were slowly cooled to -
80°C in propan-2-ol filled Mr Frostys (Nalgene, USA). After being stored for 
24hours at -80°C, cryopreserved cells were transferred to liquid nitrogen 
storage. 
As required, DPPCs were re-established from frozen stock by thawing in a 
37°C water bath with gentle agitation. Thawed cell suspensions were 
transferred to 15ml conical tubes containing culture medium and centrifuged 
at 400G for 5 minutes. Following centrifugation, traces of DMSO were 
removed by discarding the supernatant and resuspending the cell pellets in 
culture medium for a further 5 minute centrifugation. Cell counts with trypan 
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blue exclusion were performed and the cells reseeded in culture plastics at 
4000 cells/cm2. 
2.2.1.4 Embryonic neural stem cell culture 
Neural stem cells isolated from the cortex of E14.5 C57Bl/6 mice by post-
doctoral researcher colleagues were maintained in Dulbecco’s Modified 
Eagles Medium (DMEM)/Ham’s F12 (1:1) containing L-glutamine and 
HEPES buffer and 1% (v/v) penicillin/streptomycin (Life Technologies, UK). 
This was supplemented with 1x Non-Essential Amino Acids (NEAA (Sigma-
Aldrich, UK)), 20ng/ml basic fibroblast growth factor (bFGF), 20ng/ml 
epidermal growth factor (EGF) (both Peprotech, UK) and 1x N2 supplement 
(Life Technologies, UK). 
2.2.1.5 Subculturing NSC cultures 
NSCs were cultured as floating neurospheres at 37°C with 5% CO2 and half 
medium changes performed every 2 days. As neurospheres expanded and 
increased in size, the centre of the spheres began to turn dark as cells 
became deprived of nutrients. Before reaching this stage, spheres were 
subcultured. The medium and floating spheres were aspirated and 
centrifuged at 100G for 5 minutes. 1ml of Accutase was used to dissociate 
the pellet and left to incubate at room temperature for 10 minutes, 
dissociating spheres to a single cell suspension. The actions of Accutase 
were then stopped by the addition of culture medium. Following a further 
centrifugation at 100G for 5 minutes, the supernatant was discarded and the 
cells resuspended in medium. Cell counts were performed and the cells 
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resuspended at a density of 100,000 cells/ml for continuous culture or 
seeded on poly-l-lysine/laminin coated plates for experiments. 
2.2.2 Characterisation Techniques 
For characterisation of marker expression reverse-transcription polymerase 
chain reaction (rt-PCR), quantitative polymerase chain reaction (qPCR) and 
immunocytochemistry (ICC) methods were used. 
2.2.2.1 Extraction of total RNA from cells 
Approximately 5 x 105 cells were used per RNA extraction. Total RNA was 
extracted using an RNeasy Mini Kit with on-column DNase digestion 
(QIAGEN, UK) according to manufacturer’s directions. All procedures were 
performed using certified RNase and DNase-free pipette tips (Fisher 
Scientific, UK). Briefly, cells were washed with PBS then lysed in Buffer RLT, 
to which 1% (v/v) β-mercaptoethanol (Sigma-Aldrich, UK) had been added. 
Lysates were then transferred to QIAshredder™ spin columns and 
homogenised by 2 minutes centrifucation at 13,600G. An equal volume of 
70% (v/v) ethanol (Sigma-Aldrich, UK) was added to the filtrates and the 
samples then transferred to RNeasy™ spin columns. A further centrifugation 
for 20 seconds at 10,000G resulted in the binding of RNA to the spin column 
membranes. Following a wash-through, by the addition of 350μl Buffer RW1 
to spin columns and 20 seconds centrifugation at 10,000G, genomic DNA 
contamination was eliminated by adding 80μl RNase-free DNase (QIAGEN, 
UK) to the membrane and incubating at room temperature for 15 minutes. A 
further wash-through with Buffer RW1 was then performed before two 20 
56 
 
second 10,000G centrifugation washes with 500μl Buffer RPE. Spin column 
membranes were then dried out by centrifuging at 13,600G for one minute 
and, finally, RNA was eluted by adding 30-50μl of nuclease-free water 
(Promega, UK) to the spin column and centrifuging for one minute at 
10,000G. The total yield of RNA per extraction was measured using a 
Nanovue spectrophotometer (GE Healthcare, UK) to measure the 
absorbance at 260nm. A260/A280 ratios of 1.9-2.1 indicated extraction of 
good quality RNA. RNA samples were stored at -80°C until required for 
reverse transcription. 
2.2.2.2 Extraction of total RNA from tissues 
RNA samples extracted from murine spleen and corpus callosum tissue were 
used as positive controls for PCR experiments. These tissues were carefully 
dissected from adult C57Bl/6 mice and immediately frozen in sterile 1.5ml 
microcentrifuge tubes on dry ice, to prevent RNA degradation. Frozen 
tissues were then lysed by adding 700μl Buffer RLT + 1% β-mercaptoethanol 
and repeatedly triturating with progressively smaller pipette tips and sterile 
needles until the lysed tissues could pass through 25 gauge needles. Tissue 
lysates were then transferred to QIAshredder™ spin columns and RNA 
purified as described previously (section 2.2.2.1). 
2.2.2.3 Reverse transcription 
Reverse transcription reactions were performed using sterile autoclaved 
tubes and tips. 500/1000ng of extracted total RNA was mixed with 1µl of 
random primer (Promega, UK) and then made up to 15µl total volume with 
57 
 
nuclease-free water before heating at 70°C for 5 minutes in a thermocycler 
(VWR, UK). 10µl of reaction mastermix (1x MMLV buffer, 0.5mM dNTPs, 
24units RNasin RNase inhibitor and 200units MMLV reverse transcriptase in 
nuclease-free water (all Promega, UK)) was added to the RNA/primer mix 
and incubated at 37°C for one hour. Following the reverse transcription 
reaction cDNA was used immediately for end point (section 2.2.2.4) or 
quantitative (section 2.2.2.5) PCR reactions or stored at -20°C. Matching RT-
ve controls were produced for each reverse transcription reaction by 
substituting total RNA with nuclease-free water. 
2.2.2.4 End-point polymerase chain reaction 
1µl of cDNA was used per PCR reaction. Reaction mixtures were composed 
of cDNA, 1x reaction buffer, 200µM dNTPs, 0.5µM each of the appropriate 
forward and reverse primers, 1mM MgCl2 and 1.25 units taq DNA 
polymerase and made up to 25µl total volume with nuclease-free water (all 
Promega, UK). 30-40 cycles of a 1 minute denaturation step at 95°C, 
followed by 1 minutes annealing at 60°C and 1.5 minutes elongation at 72°C 
were performed. A matching PCR-ve control was produced for each product 
of interest by substituting cDNA with 1µl nuclease-free water. 
2.2.2.5 Agarose gel electrophoresis and PCR product visualisation 
PCR products were visualised following electrophoresing in 1.4% (w/v) 
agarose/TAE gel. 1.4g of agarose powder was added to 100ml of TAE buffer 
(40mM Tris base, 20mM acetic acid and 1mM EDTA (all Fisher Scientific, 
UK) and heated in a microwave until fully dissolved. 5µl of ethidium bromide 
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(Promega, UK) was added to the mixture which was then poured into a gel 
cast and left in a fume hood until set. Up to 10µl of each PCR product was 
added into separate wells on the gel submerged in an electrophoresis tank 
filled with TAE buffer. After electrophoresing at 90V for 45 minutes, DNA was 
visualised under U.V. light and images acquired. 
2.2.2.6 Real-time quantitative PCR 
Following reverse transcription of 500ng or 1000ng RNA, the resultant cDNA 
was diluted with nuclease-free water 1:5 or 1:10, respectively. 5µl of diluted 
cDNA was added to wells of Bright White 96-well PCR plates (PrimerDesign, 
UK). To each well, a 15µl reaction/primer mix (10µl Precision MasterMix with 
ROX and SYBRgreen (PrimerDesign, UK), 300nM each of the appropriate 
forward and reverse primers and made up to 15µl with nuclease-free water) 
was added. Each reaction was performed in triplicate. Plates were sealed 
with a clear optical adhesive seal (PrimerDesign, UK) and centrifuged at 
3000G for 5 minutes to ensure adequate mixing of reaction components. 
Plates were loaded into the ABI Prism 7000 qPCR machine (Advanced 
Biosystems, UK) and the following cycling conditions used: an initial 
denaturation step of 95°C for 10 minutes followed by 40 cycles of 15 
seconds denaturation (95°C) and 1 minute annealing/elongation at 60°C. 
Dissociation curves starting from 60°C were recorded to check for specificity 
of the reactions and products were electrophoresed on 1.4% agarose gels 
(section 2.2.2.5) in order to confirm product size. Dissociation curves and 
confirmed sizes for each product are displayed in Appendices I and II, 
respectively. The threshold for Ct values was set at a stage where all 
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reactions were in the linear amplification stage using ABI Prism 7000 SDS 
software. Ct values were exported to Microsoft Excel and relative changes in 
expression calculated using the 2-∆∆CT method (Livak and Schmittgen, 2001). 
Statistical analyses were performed using Graphpad Prism Software. 
2.2.2.7 rt-PCR and qPCR primers 
Unless previously published (denoted by *), primers were designed using 
Primer-BLAST software (NCBI, USA). Individual primers were designed to 
span exon-exon junctions and products to span at least one genomic intron 
wherever possible. Primer pairs were selected that matched only the desired 
product on the organism genome. Primer sequences are found in individual 
experimental chapters, with the exception of those used for the detection of 
neurotrophic and growth factor expression which are displayed below in 
Table 2.1.  
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BDNF* 
NM_00754
0.4 
f:  TGGCAGTGCAGGAGGAATTTCTGA 
r:  GCAGAAGGCCTAAGCAACTTGACA 
148 60 
bFGF* 
NM_00800
6.2 
f: TTCAAGGATCCCAAGCGGCTCTA 
r: TGTGGGTCGCTCTTCTCCC 
101 60 
GDNF* 
NM_01027
5.2 
f: AGAATTCCAGAGGGAAAGGTCGCA 
r: TCCTCCTTGGTTTCGTAGCCCAAA 
115 60 
IGF-1* 
NM_01051
2.4 
f:  TGGCACTCTGCTTGCTCACCTTTA 
r: TTGGTCCACACACGAACTGAAGAG 
102 60 
NGF* 
NM_01360
9.2 
f: ACTTCCAGGCCCATGGTACAATCT 
r: TTGATGTCCGTGGCTGTGGTCTTA 
148 60 
NT-3* 
NM_00116
4034.1 
f: ACTACGGCAACAGAGACGCTACAA 
r: ATAGCGTTTCCTCCGTGGTGATGT 
145 60 
PDGF-a* 
NM_00880
8.3 
f: ATTCCCGCAGTTTGCAAGACCA 
r: CCAGATCAAGAAGTTGGCCGATGT 
87 60 
TGFβ-1* 
NM_01157
7.1 
f: GTGGCCAGATCCTGTCCAAACTAA 
r: CATTAGCACGCGGGTGACTTCTTT 
191 60 
VEGF-A* 
NM_00102
5250.3 
f: TATTGCCGTCCAATTGAGACCCTG 
r: GCACACAGGACGGCTTGAAGATATAC 
85 60 
Table 4.2  – qPCR primer sequences 
* Primer sequence described by Hawryluk et al., 2012b. 
Table 2.1 – Neurotrophic and growth factor primer sequences 
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2.2.2.8 Immunocytochemistry staining  
Following removal of medium, cells were washed with PBS for 3 minutes 
before being fixed with 4% (w/v) paraformaldehyde (PFA) for 20 minutes at 
room temperature. A further 3 minute wash with PBS was performed and the 
cells then permeabilised with 0.1% (v/v in PBS) Triton X-100 for 10 minutes 
at room temperature. After a 3 minute PBS wash, 2% (w/v) bovine serum 
albumin fraction V (BSA) (Fisher Scientific, UK) in PBS was applied for 30 
minutes in order to block non-specific binding. This was removed and 
replaced with appropriate primary antibody(s) (Tables 2.2 and 2.3) diluted in 
2% BSA and incubated overnight in a dark humid chamber at 4°C. The 
following day, 3 PBS washes lasting 5 minutes were performed. Slides were 
then incubated in 2% BSA with complementary fluorophore-conjugated 
secondary antibodies (Table 2.4.) in the dark at room temperature for 1 hour. 
Four further 5 minute washes with PBS were performed before the cells were 
mounted onto glass cover slips using mounting media supplemented with 
DAPI stain (VectorLabs, UK). Slides were stored at 4°C in the dark, to 
prevent bleaching, until required for imaging (section 2.1.3.2). 
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2.2.2.9 Tables of antibodies 
The following antibodies were used for immunocytochemistry and/or 
immunohistochemistry staining. 
 
Antibody Manufacturer Cat. No. Host Species Isotype Dilution 
A2B5 Millipore MAB312R Mouse IgM 1:500 
β-actin Cell Signalling 8H10D10 Mouse IgG2b 1:600 
βIII-tubulin Cell Signalling D71G9 Rabbit IgG 1:200 
GFAP Millipore 041062 Rabbit IgG 1:500 
Map2 Millipore AB5622 Rabbit Polyclonal 1:250 
MBP Millipore 05-675 Mouse IgG1 1:200 
MOSP Millipore MAB328 Mouse IgM 1:1000 
Musashi 
Life 
Technologies 
710237 Rabbit Polyclonal 1:500 
Nestin Santa Cruz SC-33677 Mouse IgG1 1:100 
NF-l Abcam ab78159 Mouse IgG2b 1:100 
Olig1 Millipore AB15620 Rabbit Polyclonal 1:1000 
Olig2 Millipore AB9610 Rabbit Polyclonal 1:500 
S-100 Abcam A4066 Mouse IgG2a 1:100 
SOX10 Abcam ab27655 Rabbit Polyclonal 1:1000 
Synaptophysin Abcam AB8049 Mouse IgG1 1:15 
 
 
 
 
 
Table 2.2 – Primary antibodies used 
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Antibody Manufacturer Cat. No. Concentration 
Normal mouse IgG Santa Cruz sc-2025 Assay dependent 
Normal mouse IgM Santa Cruz sc-3881 Assay dependent 
Normal rabbit IgG Santa Cruz sc-2027 Assay dependent 
Antibody Manufacturer Cat. No. Host Species Fluorophore Dilution 
Anti-mouse 
IgG (H+L) 
Life 
Technologies 
A11001 Goat 
Alexa Fluor 
488 
1:500 
Anti-mouse 
IgM (µ 
chain) 
Life 
Technologies 
A21042 Goat 
Alexa Fluor 
488 
1:500 
Anti-mouse 
IgG (H+L) 
Life 
Technologies 
A11005 Goat 
Alexa Fluor 
594 
1:500 
Anti-rabbit 
IgG (H+L) 
Life 
Technologies 
A11012 Goat 
Alexa Fluor 
594 
1:500 
Table 2.4– Secondary antibodies used 
Table 2.3 – Isotype control antibodies used 
  
 
 
 
 
 
 
 
 
 
Chapter 3: Isolation and characterisation 
of murine dental pulp progenitor cells with 
neural potential 
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3.1 Introduction 
The dental pulp and the CNS share similar developmental origins, deriving 
from the embryonic ectoderm layer. Following neurulation, migrating cranial 
neural crest cells give rise to the cellular components of the dental pulp (Chai 
et al., 2000) while the neural tube develops into the brain and spinal cord. 
Due to these developmental similarities, the dental pulp could represent a 
source of cells with enhanced potential for neural repair. 
DPPCs possess a number of desirable characteristics that may be used to 
provide an indication of their potential for neural repair, through direct cell 
replacement or trophic effects. The expression of nestin, an early marker of 
neuronal lineage cells, is well established for both rat (Sasaki et al., 2008) 
and human (Gronthos et al., 2002) DPPCs, and could provide a potential 
marker for identifying cells with the ability for neuronal and glial 
differentiation. DPPCs have demonstrated potent in vitro neurotrophic effects 
in co-culture studies (Nosrat et al., 2001, 2004; Nesti et al., 2011) or through 
the use of DPPC-conditioned media (Sugiyama et al., 2011; Ishikaza et al., 
2013). Expression of transcripts for neurotrophic and growth factors could be 
used to identify DPPC cultures with a similar potential to promote CNS repair 
through the release of paracrine soluble factors. 
Many techniques have been described for the derivation and culture of 
DPPCs, with the methods adopted depending largely upon the intended 
purpose of the study. Following extirpation from the tooth, a cellular 
suspension is often produced from the pulp by treatment with digestive 
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enzymes such as a collagenase/dispase mixture (Gronthos et al., 2000, 
2002) or trypsin (Balic and Mina 2005). Alternatives to this approach include 
mechanical vortexing to release cells from the root of the tooth (Yang et al., 
2009) or explant cultures (Spath et al., 2010; Lizier et al., 2012).  
Largely, no purification method is used, resulting in mixed cultures where 
progenitor cells make up only a small fraction. For most purposes, it is 
beneficial to selectively isolate purified populations of progenitor cells. The 
simplest method is to clonally isolate single cell-derived populations 
(Gronthos et al., 2002), although time is required for expansion to provide 
suitable cell numbers for experimental procedures. Alternatively, a number of 
specific sorting techniques are available, and have been successfully used to 
isolate enriched cultures of mixed cells. Neural crest-derived progenitor cells 
can be specifically selected using antibodies to low-affinity nerve growth 
factor receptor (LANGFR/P75) in magnetic activated cell sorting 
(Waddington et al., 2009). Similarly, Stro-1 immunoreactive mesenchymal 
progenitor cells can be selectively sorted either magnetically (Yu et al., 2010) 
or fluorescently (Yang et al., 2007). Side population progenitor cells have 
been selected from porcine pulp using fluorescent-activated cell sorting 
techniques to purify cells with the ability to exclude Hoescht 33342 DNA dye, 
due to expression of breast cancer resistance protein (Iohara et al., 2008; 
Sugiyama et al., 2011; Ishikaza et al., 2013). As yet, however, there is no 
suitable protocol reported for the specific isolation of DPPCs with enhanced 
neural potential, as indicated by nestin expression and the ability to produce 
neurotrophic factors. 
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In this study, following collagenase/dispase digestion to a cellular 
suspension, the preferential adherence to fibronectin selection method was 
used to select for progenitor cells from the dental pulp of mouse incisors. 
This technique provides a simple method of isolating cells of more immature 
phenotypes, without the same requirement for specialist equipment as 
traditional fluorescence/magnetic sorting techniques. As cells differentiate, 
functionality of β1 integrin decreases. The limited amount of time allowed for 
attachment to fibronectin-coated surfaces results in adherence of only the 
most primitive cell types, separating them from transit amplifying and other 
terminally differentiated cell types which remain suspended in the culture 
medium (Jones and Watt, 1993; Dowthwaite et al., 2004). This method has 
already proven successful for the specific isolation of progenitor cells from 
oral tissues including the oral mucosa lamina propria (Davies et al., 2010) 
and the dental pulp (Waddington et al., 2009). Following isolation using this 
method, murine dental pulp cells were expanded as either clonal or 
heterogeneous populations. Each cell culture was then screened for neural 
potential by investigating the expression of nestin and transcripts for a 
selection of soluble neurotrophic and growth factors. 
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3.2 Objectives 
 To isolate and expand clonal and heterogeneous populations of murine 
dental pulp cells 
 To confirm progenitor status of cell cultures by determining the 
expression of mesenchymal markers 
 To identify cultures with enhanced potential for neuronal and glial 
differentiation based on nestin expression 
 To examine the expression of a range of neurotrophic and growth 
factors, identifying those DPPC cultures with the potential for promoting 
CNS repair through trophic mechanisms.  
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3.3 Materials and methods 
3.3.1 Dental pulp extraction from murine incisors and cell 
isolation 
The outer coats of CO2-asphyxiated mice were sterilised by immersing in 
70% (v/v) ethanol prior to dissection. Lateral incisions were made in each 
cheek using sterile surgical scissors to make for easier access to teeth. The 
soft tissue surrounding both the upper and lower incisors was carefully 
detached using a sterile scalpel and individual teeth extracted with a pair of 
sterile forceps. Once removed, teeth were kept hydrated by immersing in 
culture medium until ready for pulp removal. Under a dissecting microscope, 
a longitudinal incision was carefully made along the length of each incisor, 
exposing the pulpal cavity, and the pulp gently excavated. 
Harvested pulp was minced in media on a sterile glass slide before being 
transferred to a 4mg/ml solution of collagenase/dispase (Roche Diagnostics, 
Germany) for enzymatic digestion at 37°C for 1 hour with regular agitation. 
Following digestion, a single-cell suspension was obtained by passing 
through a 70µm-pore mesh cell strainer (BD Biosciences, USA). The cell 
suspension was then spun at 400G in a centrifuge and the supernatant 
discarded. A cell count was performed using a haemocytometer before 
seeding cells for the fibronectin adhesion assay. 
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3.3.2 Fibronectin adhesion assay 
6-well culture plates were coated with 10µg/ml fibronectin from human 
plasma (Sigma Aldrich, UK), diluted in PBS, overnight at 4°C. The following 
day, fibronectin solution was aspirated and the wells washed with PBS 
before seeding with cells. Cells were seeded at a density of 4000/cm2 
(40,000 per well) in DPPC medium (section 2.2.1.1). Plates were placed in 
the tissue culture incubator for 20 minutes to allow for the adhesion of cells 
with high integrin functionality, before the medium containing unattached, 
non-adherent, cells was transferred to separate wells and the initial wells 
filled with fresh DPPC medium. Following the fibronectin selection assay, 
cells were incubated at 37°C with 5% CO2 and expanded for up to 12 days 
with medium changes performed every 2-3 days. 
3.3.3 Colony forming efficiency (CFE) 
24 hours after fibronectin selection, the total number of attached and spread-
out cells was manually counted for each individual well by viewing under a 
microscope (section 2.1.3.1). The plates were then observed every other day 
and the number of colonies derived from a single cell, defined as a cluster of 
at least 32 cells, counted per well. Colony forming efficiencies were 
calculated by expressing the number of colonies counted in one well, on a 
given day, as a percentage of the total cell count of the same well 24 hours 
after fibronectin adhesion: 
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3.3.4 Isolation of single cell-derived clones and 
heterogeneous populations 
At the end of the 12-day period a number of colonies were selected for 
isolation and expansion as single cell-derived clones from each well, based 
on cell number and a visual assessment of health. Medium was removed 
from wells before performing a PBS wash. Clonal rings, made by removing 
the ends of 1ml pipette tips and autoclaving, were used to isolate individual 
colonies by attaching to the base of the well with High Vacuum Grease (Dow 
Corning, UK) to form a water-tight seal. The cells within each colony were 
detached from the culture plate by addition of Accutase, pre-warmed to 
37°C, for 10 minutes to the clonal ring. The subsequent detached cells were 
seeded into individual wells of 96-well plates, one clone per well, for 
expansion culture (section 3.3.6). 
A number of isolated cells were expanded as heterogeneous populations by 
pooling together all colonies from one or more wells. To produce these mixed 
cultures, no clones were selected from the wells and the colonies allowed to 
expand and merge until the entire well reached 80-90% confluence. At this 
stage the cells were passaged and expanded as normal (section 3.3.6).  
3.3.5 Nomenclature for isolated dental pulp cells 
To identify each isolated clone/heterogeneous population the following 
nomenclature system was devised. The cultures were named starting with 
the date of isolation, followed by their fibronectin adhesion status (A = 
fibronectin-adherent, NA = fibronectin non-adherent), followed by the well 
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number from which they were isolated, and finishing with a clonal letter 
identification (if applicable). Thus, 19_8A2A represents a clonal population 
isolated on the 19th August that is fibronectin-adherent, was selected from 
well 2 and designated as clone A. Similarly, 9_7NA1 identifies a mixed 
population of cells isolated on the 9th July that was non-adherent and 
expanded from well 1. 
3.3.6 Dental pulp cell expansion culture and population 
doublings 
FDental pulp cells were expanded in culture, with a medium change every 2-
3 days, until nearing confluence. At ~80% confluence, cells were passaged 
and counted as described previously (sections 2.2.1.1 and 2.2.1.2). Cells 
were reseeded at a density of 4000 viable cells/cm2 on plastic dishes of 
increasing surface area and expanded until sufficient numbers were 
available for use in further experiments. Fibronectin-coated culture surfaces 
were not used beyond passage 0. The level of population doublings (PD) 
during expansion culture was monitored and calculated using the following 
formula:     
   
                  –                            
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3.3.7 Identification of progenitor cells 
In order to confirm the cells as progenitor cells they were screened for the 
expression of a panel of stem cell markers including CD90, CD45, nestin and 
SCA1 (for primers see Tables 3.1 and 3.2). Total RNA was extracted from 
each clone/heterogeneous culture at the earliest possible opportunity, once 
sufficient cell numbers were reached, and used for rt-PCR and qPCR 
characterisation methods (sections 2.2.2.1 – 2.2.2.7). This same RNA was 
used to screen for the expression of transcripts for TGFβ-1, IGF-1, PDGF-a, 
bFGF, VEGF-A, NT-3, NGF, BDNF and GDNF (for primers see Table 2.1).  
Positive control samples were provided by RNA extracted from cultured 
NSCs (sections 2.2.1.4 and 2.2.1.5), as well as spleen and corpus callosum 
tissue (section 2.2.2.2). 
Expression of nestin was confirmed at the protein level using 
immunocytochemistry (section 2.2.2.8). Following passaging, pulp cells were 
seeded at 4,000/cm2 on 8-chamber culture slides (BD Biosciences, USA). 
After 24 hours these were fixed and stained immunocytochemically with 
antibodies against nestin and an appropriate isotype control (Tables 2.2 – 
2.4). To quantify the number of nestin-expressing cells in heterogeneous 
cultures, low magnification images were acquired (section 2.1.3.2) and the 
number of Alexa-fluor-488-positive cells expressed as a percentage of DAPI-
labelled cells. Counts were performed for at least ten separate visual fields 
per population and a mean percentage calculated ± standard deviation.  
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3.3.8 Tables of Primers  
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CD90 
NM_00938
2.3 
f: GCCTGACAGCCTGCCTGGTGAACCAAA 
r: TGCCGCCACACTTGACCAGCTTGTCTCT 
330 60 
CD45 
NM_00111
1316.1 
f: CCCATCAAAGATGCCCGAAAGCCCCACA 
r: CCGTCGAAGTTTGAGGAGCAGGTGAGGGT 
507 60 
Nestin 
NM_01670
1.3 
f: AACAGAGATTGGAAGGCCGCTGGCAGGAC 
r: GGGTTCTGGCCTTAAGGAATTCCTGTGTC 
420 60 
SCA1 
NM_01073
8.2 
f: ACCTGCCCCTACCCTGATGGAGTCTGT 
r: TGTGTGCCTCCAGGGTCATGAGCAGCA 
522 60 
GAPDH 
NM_00808
4.2 
f: AGACGGCCGCATCTTCTTGTGCAGTGC 
r: ACATACTCAGCACCGGCCTCACCCCAT 
326 60 
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Nestin 
NM_01670
1.3 
f: CCAAAGAGGTGTCCGATCATC 
r: CTCCCTTCTTCTTCATCAGCATCT 
147 60 
β-actin 
NM_00739
3.3 
f: TCTTTGCAGCTCCTTCGTTGCCG   
r: GTCCTTCTGACCCATTCCCACCA 
200 60 
Table 3.1 – Primer sequences for identification of progenitor cells 
Table 3.2 – Primer sequences for qPCR 
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3.4 Results 
3.4.1 Colony formation following dental pulp cell isolation 
Dental pulp cells were successfully isolated and cultured from murine 
incisors. The fibronectin preferential adhesion assay resulted in the 
separation of isolated cells into two distinct populations: those that 
successfully attached to fibronectin-coated plates within 20 minutes, termed 
the adherent population, and those that did not, termed the non-adherent 
cells. 24 hours following selection, both fibronectin-adherent and fibronectin-
non-adherent wells were sparsely populated with small fibroblastic-like cells 
(Figure 3.1 A). Over the first 12 days of primary culture, a number of these 
fibroblastic-like cells in both fibronectin-adherent and non-adherent wells 
were found to rapidly clonally expand and form discrete individual colonies 
(Figure 3.1 B and C). At day 12 no difference was observed between the 
ability of adherent and non-adherent cells to form colonies as demonstrated 
by colony forming efficiencies of 0.0049 ± 0.0011 and 0.0050 ± 0.0003, 
respectively (Figure 3.1 E). 
 Figure 3.1 – Colony formation by primary cultured dental pulp cells. 
Dental pulp cells proliferate rapidly over 12 days of primary culture and form distinct 
colonies. A) Individual cells growing on fibronectin 24 hours after isolation. B) A small 
clonally-derived cluster of cells after 3 days culture. C) A large colony before clonal 
isolation on day 12. D) During expansion culture single-cell derived clones adopt bipolar 
fibroblastic-like morphology typical of dental pulp cells (bars = 100µm). E) No difference 
in colony forming efficiency was observed between fibronectin-adherent and 
fibronectin-non-adherent cells at day 12 (n=7±SEM).  
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3.4.2 Expansion of clonal and heterogeneous populations 
After 12 days individual colonies were selected for expansion as single cell-
derived clones or allowed to merge together forming a heterogeneous 
population. Throughout expansion culture dental pulp cells remained typically 
bipolar and fibroblastic-like in morphology (Figure 3.1 D) with heterogeneity 
observed in mixed populations.  
Single cell-derived clones demonstrated rapid initial proliferation, as 
measured by cumulative population doublings, in comparison to 
heterogeneous populations (Figure 3.2). Initial proliferation rates for 
heterogeneous populations of pulp cells remained lower than clonal rates for 
a sustained period. However, over longer-term culture, a sharp increase in 
proliferation was observed between 80-100 days. The rate of clonal 
expansion remained more stable throughout in comparison to mixed 
populations, although differences in the rates of doubling between clones 
were evident. Several clones (7_10BA1B, 7_10BA2C and 10_11BNA3A) 
were seen to expand for at least 40 population doublings without senescing 
(Figure 3.2 B).  
  
 
 
 
A 
B 
Figure 3.2 – Population doublings of dental pulp cells during expansion culture 
Cumulative population doublings of both heterogeneous (A) and clonal (B) populations 
were recorded during expansion culture. A) In mixed populations a pronounced lag 
phase was seen over the first 80-90 days, after which the rate of population doubling 
sharply increases. B) A number of single cell-derived clones of dental pulp cells 
proliferate steadily for up to 240 days of culture reaching 50+ population doublings. 
Clonal differences in the rate of doubling were apparent  
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3.4.3 Characterisation of murine dental pulp cells 
Total RNA was extracted from each clone or mixed population at as early a 
stage as was practicable (between 15 and 25 population doublings (PDs)). 
Rt-PCR was used to screen for mRNA expression of markers associated 
with mesenchymal (CD90 and SCA1), haematopoetic (CD45) and neural 
(nestin) progenitor cells (Figure 3.3). SCA1 was found to ubiquitously 
expressed, regardless of fibronectin adhesion properties or 
clonal/heterogeneous status. No expression of CD45 was detected in any 
culture. Expression of CD90 and nestin was found to vary between 
populations, being expressed either separately or together. No pattern of 
CD90/nestin expression was observed with respect to the fibronectin 
adhesion or clonal/heterogeneous properties of the cultures. 
   CD90 CD45 Nestin SCA1 GAPDH 
Non –
adherent 
mixed 
populations 
9_7NA1 
     
9_7NA3 
     
19_8NA1-3 
     
7_10BNA1-3 
     
Total 
population 
14_9TP 
     
Adherent 
Clones 
19_8A2A 
     
7_10BA1B 
     
7_10BA2C 
     
7_10BA2B 
     
Non-
adherent 
clones 
10_11BNA2B 
     
10_11BNA3A 
     
Controls 
RT-ve 
     
PCR -ve 
     
+ve control 
     
Figure 3.3 – mRNA expression of progenitor cell markers  
Rt-PCR was used to detect the expression of CD90, CD45, Nestin,SCA1 and GAPDH in isolated 
dental pulp cells. SCA1 expression was identified in all isolates whereas CD90 and Nestin 
expression was found to be more variable. CD45 expression was not detected in any 
population. RNA extracted from NSCs was used as a positive control for CD90, Nestin, SCA1 
and GAPDH whereas a CD45 positive control was provided by murine spleen tissue.  
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3.4.4 Nestin expression 
As nestin is a key marker identifying early stage neural cells, its expression 
by murine dental pulp cells was explored in further detail using 
immunocytochemistry and qPCR.  
The percentage nestin expression was calculated for three heterogeneous 
populations, 9_7NA1, 19_8NA1-3 and 14_9TP (15 – 20 PDs). Percentage 
expression was found to be 83.61% ± 7.37, 86.48% ± 5.84 and 79.04% ± 
11.29, respectively (Figure 3.4).  
Four clones, 19_8A2A, 7_10BA1B, 7_10BA2C and 10_11BNA3A (20 – 25 
PDs), were immunostained for nestin expression (Figure 3.5). In contrast to 
rt-PCR results (Figure 3.3), positive staining of all four clones was observed 
with weaker staining of clones 19_8A2A and 10_11BNA3A. qPCR was used 
to quantify mRNA expression in each of these clones relative to β-actin 
(Figure 3.6). 19_8A2A (0.21% ± 0.05) and 10_11BNA3A (0.017% ± 0.005%) 
express significantly reduced (p<0.01) levels of nestin mRNA compared to 
both 7_10BA1B (5.56% ± 2.26) and 7_10BA2C (4.35% ± 0.076). 
   
Figure 3.4 – Immunocytochemistry of nestin in mixed populations 
Three heterogeneous cultures were stained for nestin expression: 9_7NA1 (A & B), 
19_8NA1-3 (C & D) and 14_9TP (E & F). Alexa-fluor 488 counterstained cells (B, D & F) 
were counted and expressed as a percentage ± SD of DAPI-stained nuclei (G). 
Respective mouse IgG isotype controls for each population are also displayed (A, C & E) 
(scale bars = 100µm).  
 
   
Figure 3.5 – Immunocytochemistry of nestin in single cell-derived clones 
Four clonal cultures were stained for nestin expression: 19_8A2A (A & B), 
10_11BNA3A (C & D), 7_10BA1B (E & F) and 7_10BA2C (G & H). Cultures 
were stained with anti-nestin (B, D, F & H) and normal mouse IgG antibodies 
(A, C, E & G) as an isotype control. Anti-mouse IgG alexa fluor 488 secondary 
antibody was used (scale bars = 100µm). 
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3.4.5 Neurotrophic and growth factor expression 
Total RNA extracted from murine dental pulp clones/heterogeneous cultures 
was also screened for the presence of RNA transcripts for a range of growth 
factors associated with promoting neuronal survival and repair: TGFβ-1, IGF-
1, PDGF-a, bFGF, VEGF-A, NT-3, NGF, BDNF and GDNF (Figures 3.6 and 
3.7). All cultures were found to express TGFβ-1, VEGF-A, NGF, BDNF and 
GDNF. Clonal differences were observed in the expression of IGF-1, PDGF-
a and bFGF, whereas NT-3 was not found to be expressed by any mDPPC 
culture. 
   TGFβ-
1
 
 
IGF-1  
PDGF-
a  
bFGF  
VEGF-
A  
GAPDH 
Non –
adherent 
mixed 
populations 
9_7NA1 
     
 
9_7NA3 
     
 
19_8NA1-3 
     
 
7_10BNA1-3 
     
 
Total 
population 
14_9TP 
     
 
Adherent 
Clones 
19_8A2A 
     
 
7_10BA1B 
     
 
7_10BA2C 
     
 
7_10BA2B 
     
 
Non-
adherent 
clones 
10_11BNA2B 
     
 
10_11BNA3A 
     
 
Controls 
RT-ve 
     
 
PCR -ve 
     
 
+ve control 
     
 
  Figure 3.7 – mRNA expression of growth factors  
Rt-PCR was used to detect the expression of TGFβ-1, IGF-1, PDGF-a, bFGF and VEGF-A by 
different populations of isolated dental pulp cells All populations were found to express 
TGFβ-1, IGF-1 and VEGF-A, whereas expression of bFGF and PDGF-a was more variable. RNA 
extracted from murine corpus callosum was used as a positive control.  
   BDNF GDNF NT-3 NGF GAPDH 
Non –
adherent 
mixed 
populations 
9_7NA1 
     
9_7NA3 
     
19_8NA1-3 
     
7_10BNA1-3 
     
Total 
population 
14_9TP 
     
Adherent 
Clones 
19_8A2A 
     
7_10BA1B 
     
7_10BA2C 
     
7_10BA2B 
     
Non-
adherent 
clones 
10_11BNA2B 
     
10_11BNA3A 
     
Controls 
RT-ve 
     
PCR -ve 
     
+ve control 
     
Figure 3.8 – mRNA expression of neurotrophic factors  
Rt-PCR was used to detect the expression of BDNF. GDNF, NT-3 and NGF by different 
populations of isolated dental pulp cells All populations were found to express BDNF, GDNF 
and NGF. NT-3 expression was not detected in any population. RNA extracted from murine 
corpus callosum was used as a positive control. 
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3.5 Discussion 
Preferential adherence to fibronectin separates cells based on the functional 
expression of the α5β1 integrin subunit (Jones and Watt, 1993). This method 
selects cells of more immature phenotypes, which display increased integrin 
functionality and, therefore, adhere to fibronectin-coated culture surface in a 
shorter timeframe, from mixed populations. Variations of this method have 
been used to successfully isolate purified populations of human epidermal 
stem cells (Jones and Watt, 1993), articular cartilage progenitor cells 
(Dowthwaite et al., 2004), oral mucosa lamina propria progenitor cells 
(Davies et al., 2010), cord blood mesenchymal progenitor cells (Maurice et 
al., 2007) and dental pulp progenitor cells (Waddington et al., 2009).  
One measure for the effectiveness of this selection technique is the 
calculation of colony forming efficiencies. Cells that adhere to fibronectin 
within 20 minutes typically possess a greater CFE than non-adherent cells 
(Jones and Watt, 1993; Dowthwaite et al., 2004). The ability of individual 
cells to form colonies greater than 32 cells in number is thought to provide a 
reliable means of identifying progenitor cells. Five population doublings are 
required to reach this stage and adopting this definition eliminates colonies 
derived from transit amplifying cells with reduced self-renewal properties 
(Jones and Watt, 1993). Thus, isolated cultures with higher CFEs should 
contain a greater proportion of progenitor cells. However, this does not 
necessarily equate to differentiation potential. No difference was observed in 
the proportion of epidermal stem cells able to undergo terminal differentiation 
in cultures of adherent cells with high CFEs, compared to cells that 
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underwent no selection procedure (Jones and Watt, 1993). In most reports, 
non-adherent cells are simply disregarded and, as such, these populations of 
cells remain largely uncharacterised (Maurice et al., 2007; Waddington et al., 
2009; Davies et al., 2010). 
In this study, no difference in the CFEs of adherent and non-adherent murine 
dental pulp cells was found, suggesting that not all progenitor cells may have 
been separated from the initial population (Figure 3.1). Expression of mRNA 
transcripts for CD90, SCA1 and nestin were detected in both non-adherent 
clonal and non-adherent heterogeneous cultures (Figure 3.3) confirming that 
a population of progenitor cells remain unattached at the end of the 20 
minute adhesion. The duration of time initially allowed for adherence to 
fibronectin can prove critical. For the isolation of epidermal stem cells, 5 
minutes was identified as an optimal length of time. The CFE ratio between 
adherent and non-adherent cells began to equalise at longer durations, as 
transit amplifying cells attached to the fibronectin (Jones and Watt, 1993). 
This observation may not be applicable to all cell types however. Additional 
40 minute steps, after an initial 20 minute adhesion, have proven effective in 
the further purification of remaining non-adherent progenitor cells from 
cartilage (Dowthwaite et al., 2004) and oral mucosal lamina propria (Davies 
et al., 2010) tissues. Despite their non-adherent properties, clonal and mixed 
DPPC cultures not attaching to fibronectin within 20 minutes retained 
expression of the key marker desired for this study, nestin (Figures 3.3 – 
3.6), and so were deemed suitable for further investigation. 
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Single cell-derived clones typically demonstrated an initial rapid rate of 
population doubling, followed by a short lag phase, before increasing and 
remaining at a steady rate (Figure 3.2 B). Heterogeneous cultures, however, 
tended to proliferate slowly over the first 80-90 days of culture before a sharp 
increase in doubling rate was observed (Figure 3.2 A). Clonal cultures 
expressing progenitor markers (Figure 3.3) may possess enhanced self-
renewal properties and so maintain a steady rate of doublings over long 
periods (Gronthos et al., 2002; Waddington et al., 2009). In heterogeneous 
cultures, it is likely that only a small number of cells capable of self-renewal 
are initially present. Other contaminating cell types, capable of only limited 
renewal, proliferate very slowly, if at all. As an example, primary cultured 
murine fibroblasts divide approximately 10 times before senescing in serum-
containing media at normal oxygen levels (Rohme, 1981; Loo et al., 1987; 
Parrinello et al., 2003). Gronthos et al., (2002) report that 80% of single cell-
derived DPPC clonal cultures fail to proliferate beyond 20 population 
doublings.  During the early stages of culture, the presence of such cells 
within mixed population masks the higher proliferation of cells with progenitor 
characteristics. Over the long term, non-proliferating cells may drop out of 
culture as a result of senescence and/or post-mitotic differentiation and 
eventually progenitors begin to predominate.  This could, perhaps, explain 
the sharp increase in proliferation rate that can be seen in heterogeneous 
cultures (Figure 3.2 A), which will eventually consist entirely of progenitor 
cells. 
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It is now widely accepted that there may in fact be multiple populations of 
progenitor cells residing in different locations of the pulp. Different niches 
have been proposed to exist in situ associated with the vasculature, within 
the pulpal stroma and in the sub-odontoblast layer (Shi and Gronthos, 2003; 
Lovschall et al., 2005; Téclès et al., 2005). Depending upon their resident 
niche, progenitor cells may possess different proliferative and differentiation 
capababilities. The methods used to isolate cells in this study do not select 
for cells associated with any specific niche and mixed cultures will likely 
comprise of progenitor cells from all niches. The clonal differences observed 
in proliferative abilities (Figure 3.3) and marker expression (Figure 3.4 – 3.8) 
may be associated with the original niche from which each cell was derived. 
Without using specific sorting techniques from the very start, it remains a 
challenge to identify from which niche an in vitro cell culture may have 
originated. 
In order to identify the isolated murine pulp cells as progenitor cells, the 
mRNA expression of different progenitor cell markers was examined (Figure 
3.3). Four markers were chosen for investigation. CD90 is an essential 
marker required for the identification of mesenchymal progenitor cells 
(Dominici et al., 2006). Similarly, no expression of CD45 should be found 
within mesenchymal cultures as this is indicative of contamination with cells 
of haematopoietic origin. Together, the expression of CD90 and absence of 
CD45 indicates that the majority of the isolated populations contained 
mesenchymal progenitor cells (Figure 3.3). SCA1 represents a more general 
stem cell marker and has been used to identify haematopoietic cells 
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(Spangrude et al., 1988), as well as progenitor cells found in mammary 
(Welm et al., 2002), prostate (Burger et al., 2005), cardiac (Matsuura et al., 
2004) and dental pulp (Patel et al., 2009) tissue. Its expression by every 
DPPC culture (Figure 3.3) suggests that the isolated cells may have the 
potential for differentiation into cell types additional to those traditionally 
associated with mesenchymal cells: osteoblasts, chondrocytes and 
adipocytes (Dominici et al., 2006). The final marker investigated, and key for 
this study to give an indication of potential for neuronal and glial 
differentiation, was the early stage neural marker nestin. 
The intermediate filament nestin was first used to distinguish neural stem 
cells from more differentiated cells in the neural tube (Lendahl et al., 1990). 
Although its precise functions are as yet unidentified, knockdown 
experiments suggest that, rather than a structural role, it is involved in NSC 
survival and self-renewal (Park et al., 2010b). Nestin expression has been 
identified in progenitor cells from many other ectodermal and mesenchymal 
tissues including the dermis, bone marrow and dental pulp (Toma et al., 
2001; Gronthos et al., 2002) and its presence may give a reliable indication 
of neural potential. Nestin expression was examined in isolated murine 
dental pulp cells in more detail using immunocytochemistry and qPCR. 
Between 75-90% of cells within heterogeneous cultures were identified as 
nestin-positive (Figure 3.4), a significantly higher proportion than the 3.5% 
reported in cultures of total populations from rat incisors (Takeyasu et al., 
2006). In a differentiation experiment, Takeyasu’s mixed population of cells 
tended towards a more astrocytic than neuronal phenotype, demonstrated by 
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upregulation of GFAP and unchanged levels of βIII-tubulin and Map2. It is 
believed the higher percentage of nestin-expressing cells found using the 
isolation and culture methods described in this chapter may result in a 
greater tendency towards a neuronal phenotype using similar differentiation 
conditions. Other studies have reported the isolation of dental pulp progenitor 
cells with enhanced neural potential based upon the formation of 
neurosphere-like structures. Rat incisor dental pulp cells can be encouraged 
to initially grow as enriched nestin-expressing suspended bodies on 
superhydrophobic plates in a medium containing bFGF and EGF (Sasaki et 
al., 2008). Although neuronal-like differentiation of cells dissociated from the 
neuropheres was observed, the scalability of this approach is questionable 
as spheres can only be successfully maintained for one subculture in vitro. 
Mixed and clonal populations of nestin-expressing DPPCs isolated using the 
methods described in this study, however, have demonstrated the ability to 
proliferate beyond 40 population doublings (Figure 3.2). Thus, expansion of 
these DPPCs with neural potential will not suffer from the same scalability 
issues associated with culture as nestin-expressing neurosphere-like bodies 
(Sasaki et al., 2008). 
Two clones, 19_8A2A and 10_11BNA3A, that did not express mRNA 
transcripts for nestin, as detected by rt-PCR (Figure 3.3), showed weak 
immunocytochemistry staining compared to the background set using 
matching isotype controls (Figure 3.5 A – D). qPCR confirmed the presence 
of nestin mRNA in these clones, but at very low levels in comparison with 
two other clones, 7_10BA1B and 7_10BA2C (Figure 3.6). The lack of 
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expression of nestin mRNA detected by rt-PCR may have been due to 
cycling conditions that, perhaps, weren’t fully optimised for the primer pair. 
These clonal differences in expression levels will allow comparisons to be 
made between weakly and strongly nestin-positive cells in subsequent 
differentiation chapters, confirming whether nestin is potentially a useful 
marker for identifying DPPCs with increased neuronal and glial differentiation 
capabilities. 
The ability of the isolated murine dental pulp progenitor cells to produce a 
range of growth factors and neurotrophic factors thought to modulate a 
number of mechanisms involved in neural repair and regeneration was 
investigated (Figures 3.7 and 3.8). At the mRNA level, DPPCs were found to 
express TGFβ-1, IGF-1, PDGF-a, bFGF and VEGF-A. Similarly, cells were 
found to also express NGF, BDNF and GDNF, but not NT-3, matching 
previous studies demonstrating expression of neurotrophic factors excluding 
NT-3 by cultured DPPCs (Nosrat et al., 2001, 2004; Nesti et al., 2011).  
The release of NGF, BDNF and GDNF by DPPCs has been measured at the 
protein level using ELISA techniques (Nesti et al., 2011; Soria et al., 2011). 
Similar quantitative measures are required to demonstrate that cultured 
mDPPCs can produce and release the factors investigated in this study 
(Figures 3.7 and 3.8). However, their expression at the mRNA level does 
provide a strong indication of the cells ability to secrete the related growth 
factors. The release of growth factors by cells of the dental pulp plays 
important roles in vivo to promote trigeminal ganglion innervation of the tooth 
during development (Luukko et al., 1997a, 1997b) and to promote 
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revascularisation following injury (Tran-Hung et al., 2008). Whether these 
effects are mediated by progenitor cells or other cells resident in the pulp is 
unclear.  The expression of mRNA for these growth factors by mDPPCs 
suggests that progenitor cells could be responsible, in part, for this. Similar 
innervation and revascularisation effects would prove instrumental in growth 
factor-mediated repair of the damaged CNS by transplanted DPPCs.  Such 
trophic effects have been observed in vivo following grafting into neural 
tissue. Chitosan mesh tubes enclosing human pulp explants grafted into the 
transected sciatic nerve of SD rats act as a conduit for regenerating 
endogenous axons which can be identified growing through the grafts 
(Matsushita et al., 2012). Porcine side population DPPCs have also 
demonstrated the potential to promote revascularisation in models of 
hindlimb and cerebral ischaemia (Iohara et al., 2008; Sugiyama et al., 2011; 
Ishikaza et al., 2013). These studies demonstrate the ability of DPPCs to 
exert influences upon endogenous cells of the CNS and PNS following 
transplantation. Expression of mRNA for a wide range of neurotrophic and 
growth factors (Figures 3.7 and 3.8), suggests that the isolation and culture 
methods used in this study are suitable for the derivation of cells with 
potential to promote repair/regeneration of the injured spinal cord through 
similar paracrine mechanisms. 
Stem cells isolated from the murine dental pulp possess very similar 
properties to those isolated from human molars, expressing mesenchymal 
markers (CD73, CD90, CD117, SCA1 and Stro-1) and embryonic markers 
(SSEA-1 and OCT-4) (Guimarães et al., 2011). They also possess 
96 
 
adipogenic, chondrogenic, myogenic and osteogenic differentiation 
capabilities (Balic and Mina., 2010; Nakatsuka et al., 2010; Zainal Ariffin et 
al., 2012). As such, murine DPPCs do not represent an inferior source of 
cells for laboratory investigations. However, they may be partially removed in 
some properties from human DPPCs as a result of differences in tooth 
development between species. Murine incisors continually erupt throughout 
life due to the abrasive gnawing nature of their eating habits producing 
significant wear and tear. This necessitates a more active population of 
resident stem cells in comparison with the human pulp, whose stem cells are 
more quiescent and reactive in nature. An additional mesenchymal stem cell 
niche is proposed to exist between the labial and lingual cervical loops of the 
proximal root of the mouse incisor pulp (Harada et al., 1999; Seidel et al., 
2010; Lapthanasupkul et al., 2012). These cells give rise to transit amplifying 
progeny which further differentiate into dentine-forming odontoblasts and 
enamel-forming ameloblasts, and migrate distally to sustain continual tooth 
growth at the root (Harada et al., 1999). The continuous turnover of 
progenitor cells within this location is evidenced by extensive BrdU uptake in 
the region (Harada et al., 1999; Seidel et al., 2010). In contrast, in the pulp of 
the human molar, BrdU labelling is observed only following pulpal exposure 
and damage, and is restricted to the perivascular niche (Téclès et al., 2005). 
This suggests the existence of a small population of slowly proliferating stem 
cells that remain at rest until activated by suitable stimuli (Shi and Gronthos, 
2003). Despite the in situ differences in turnover rates and niche location, 
human and murine DPPCs retain similar mesenchymal characteristics in 
vitro. Expression of CD90, SCA1 and nestin by mDPPCs in this study (Figure 
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3.3) is sufficient to confirm that these cells provide a suitable means of 
investigating the behaviours of dental pulp-derived mesenchymal progenitor 
cells. 
3.6 Summary 
 Clonal and heterogeneous populations of cells were isolated from the 
dental pulp of murine incisors using the selective adhesion to fibronectin 
method. 
 20 minutes fibronectin adhesion is insufficient to select for all pulpal 
progenitor cells evidenced by similar CFEs and the expression of 
progenitor markers in both adherent and non-adherent cultures. 
 Clonal differences were observed in the expression of RNA transcripts for 
progenitor markers and neurotrophic factors. Clones have been 
separated into those that express nestin at low (19_8A2A and 
10_11BNA3A) and high levels (7_10BA1B and 7_10BA2C) allowing for 
comparisons in subsequent neuronal and glial differentiation studies. 
 Isolated DPPC cultures were found to express mRNA transcripts for a 
range of neurotrophic and growth factors indicating their potential to 
promote repair/regeneration of the CNS through the release of soluble 
factors. 
  
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4: Development of a protocol for 
the differentiation of neuronal-like cells 
from dental pulp progenitor cells
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4.1 Introduction 
A major goal of any cellular transplantation therapy for SCI is the 
replacement of dead neurons to reform functional neuronal pathways. In vitro 
differentiation protocols provide a valuable tool to determine the optimal 
conditions for the derivation of such neuronal-like cells from progenitor cells. 
Although such protocols may not be directly applicable in vivo, they present 
confirmation of the potential for neuronal differentiation and supply a means 
of investigating further mechanisms through which transplanted cells could 
promote spinal regeneration.   
As yet, there is no definitive method for the in vitro differentiation of neuronal-
like cells from DPPCs, although a number of protocols have been published 
(reviewed by Young et al., 2013). Different approaches include the 
generation of floating neurosphere-like bodies (Iohara et al., 2006; Takeyasu 
et al., 2006; Sasaki et al., 2008; Govindasamay et al., 2010; Osathanon et 
al., 2011; Osathanon et al., 2013), stimulation of cAMP and protein kinase C 
signalling to induce the onset of functional properties (Király et al. 2009), and 
the addition of retinoic acid (Arthur et al., 2008) or β-mercaptoethanol and 
butylated hydroxyanisole (Zhang et al., 2006a; Osathanon et al., 2013) to 
culture media. 
One issue associated with these reported methods is that, prior to 
differentiation, DPPCs typically already express a number of the markers 
used to identify them as neuronal-like cells including: βIII-tubulin, Map2, NF 
and NeuN (Karaöz et al., 2011; Osathanon et al., 2011; Sakai et al., 2012). 
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Although the presence of such markers provides strong evidence of the 
potential for DPPCs to differentiate into neurons, it also necessitates the use 
of quantitative methods, such as qPCR, to confirm changes in neuronal 
marker expression. In the literature, such quantitative methods are often not 
used (Iohara et al., 2006; Zhang et al., 2006a; Sasaki et al., 2008; Karaöz et 
al., 2011; Osathanon et al., 2011). Of those studies using appropriate 
methods, the induction and/or upregulation of glial markers, such as GFAP, 
is often reported indicating that the differentiated cells may be of a potentially 
more astrocytic phenotype, rather than true neuronal cells (Takeyasu et al., 
2006; Király et al. 2009; Govindasamy et al., 2010; Karaöz et al., 2011). As 
such, these published methods may not be the most suitable, and there 
remains a requirement for a protocol to definitively derive neuronal-like cells 
from DPPCs. 
In order to act as a direct cell replacement, transplanted cells must be 
capable of functionally compensating for neurons lost following SCI. Patch 
clamp techniques can be used to record and assess the functionality of 
neuronal-like cells by measuring electrical currents under defined conditions. 
Two leading studies report on the electrophysiological properties of 
neuronally differentiated DPPCs (Arthur et al., 2008; Király et al. 2009). Each 
differentiation protocol derives cells with neuronal-like morphology 
expressing late stage neuronal markers. In one study, Arthur et al. recorded 
inward-directed voltage-activated Na+ currents in DPPCs differentiated using 
their protocol. Király et al. identified not only Na+, but also outward voltage-
propagated K+ currents, albeit only present in a small proportion of 
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differentiated cells. A follow-up study using Király’s protocol reported that 
DPPCs from only one out of four patient samples were capable of 
differentiation into neuronal-like cells (Aanismaa et al., 2012). No voltage-
activated Ca2+ currents have been detected in DPPCs differentiated using 
these protocols and, crucially with regards to neuronal signalling, no signs of 
spontaneous activity or action potentials evoked using standard voltage ramp 
protocols have been recorded. The ability to generate a full action potential is 
a key requirement, which has not yet been achieved, to demonstrate that 
DPPCs truly can differentiate into functionally active neurons. The 
development of a protocol to reproducibly derive functional neuronal-like 
cells from DPPCs would be a significant development. 
CNS development and the subsequent onset of neuronal functional 
properties fall under complex genetic control. Transcription factors, such as 
SOX1, SOX2, Pax6 and Myelin transcription factor 1-like (Myt1l), in addition 
to the RNA binding protein Musashi and nestin, are important in regulating 
self-renewal and regional differentiation of NSCs (Kim et al., 1997; Imai et 
al., 2001; Takahashi and Osumi. 2002; Graham et al., 2003; Park et al., 
2010b). Indentifying the expression of such developmental markers by 
DPPCs could provide a means of determining the most appropriate methods 
to promote their neuronal-like differentiation. In developing a differentiation 
protocol it may also be of importance to identify whether DPPCs are closer in 
phenotype to radial glial or neuroepithelial NSCs. BLBP and GLAST are 
typically used to identify radial glial cells (Anthony et al., 2005), whereas 
CD133 expression is more indicative of a neuroepithelial phenotype (Corbeil 
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et al., 2010). A comprehensive comparison of the expression of such 
developmental markers between DPPCs and NSCs will serve as a 
foundation for the rational development of a neuronal differentiation protocol 
underpinned by logic and reasoning.  
4.2 Objectives 
 To provide a comprehensive characterisation of the expression of 
developmental and late stage neuronal markers by mDPPCs and 
compare this with NSCs.  
 To develop a definitive protocol for the differentiation of functional 
neuronal-like cells from DPPCs and confirm phenotype using appropriate 
quantitative methods. 
 To investigate how neuronal differentiation may affect the ability of 
DPPCs to promote neural repair via trophic mechanisms. 
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4.3 Materials and methods 
4.3.1 Characterisation of neural marker expression 
RNA extracted from low-passage DPPC cultures at between 15-25 
population doublings was used with rt-PCR (see sections 2.2.2.1 – 2.2.2.5) 
to identify undifferentiated DPPC expression of developmental neural 
markers (SOX1, SOX2, Pax6, Myt1l and P75), neural stem cell markers 
(BLBP, GLAST, Musashi, CD133) and mature neuronal markers (NF-l). RNA 
extracted from cultured murine NSCs (sections 2.2.1.4 and 2.2.1.5) was 
used as a positive control. Primer sequences and targets are shown in Table 
4.1. 
Four single cell-derived clones (19_8A2A, 10_11BNA3A, 7_10BA1B and 
7_10BA2C (20-25 PDs)) in culture were further fixed with 4% PFA and 
immunocytochemically stained (section 2.2.2.7) with antibodies against 
nestin and Musashi, together with appropriate isotype controls (Tables 2.2 – 
2.4).  
4.3.2 DPPC differentiation in NSC medium  
Culture surfaces were coated with 0.01% poly-l-lysine (Sigma-Aldrich, UK) 
for 5 minutes at room temperature. This was removed and the surfaces 
allowed to completely air dry for a minimum of one hour before rinsing with 
PBS. Laminin (Sigma-Aldrich, UK), diluted to 20µg/ml in PBS, was then used 
to coat the culture plastics overnight at room temperature. Laminin solution 
was removed the day after and, following a wash with PBS, the surfaces 
were ready for seeding with cells.  
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Four DPPC clones (19_8A2A, 10_11BNA3A, 7_10BA1B and 7_10BA2C (20-
30 PDs)) were passaged (sections 2.2.1.1. and 2.2.1.2) and seeded at 4,000 
cells/cm2 on poly-l-lysine/laminin-coated dishes in NSC medium (section 
2.2.1.4). Cells seeded in DPPC medium were used as an undifferentiated 
control. Photos were acquired of the differentiating cells every day to record 
changes in morphology. After 7 days of differentiation, RNA was extracted 
(section 2.2.2.1) from each culture, reverse transcribed (section 2.2.2.3) and 
the resultant cDNA used for qPCR (section 2.2.2.5). Fold change in 
expression was calculated for the general stem cell marker SCA1 and the 
neural markers nestin, Map2 and NF-l (Table 4.2). 
4.3.3 Maturation in neurotrophin-containing medium 
In order to encourage the development of functional properties, a further 
maturation step was added to the protocol. 7_10BA2C was differentiated in 
NSC medium on poly-l-lysine/laminin-coated dishes and slides, as described 
above, for 5 days. After 5 days differentiation, the cells were rinsed with PBS 
and the medium replaced with a neurotrophin-containing medium: 
Neurobasal medium supplemented with 1% (v/v) penicillin/streptomycin, 
2mM L-glutamine (all Life Technologies, UK), 1x NEAA (Sigma-Aldrich, UK), 
10ng/ml BDNF, 10ng/ml NGF and 10ng/ml NT-3 (all Peprotech, UK). 
Differentiating DPPCs were allowed to mature in neurotrophin-containing 
medium for up to 15 days (Figure 4.1). qPCR was used to quantify fold 
changes of expression of SCA1, nestin, Map2, NF-l, SOX2, Pax6, BLBP, 
Ncam and neurogenic marker Ngn2 (Table 4.2), in addition to neurotrophic 
and growth factors (Table 2.1), from RNA extracted on days 0, 5, 10 and 15 
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of differentiation (Figure 4.1). Cells were fixed on day 15 and 
immunocytochemically stained with antibodies against Map2 and NF-l, 
together with appropriate isotype controls (Tables 2.2 – 2.4). Cells 
differentiated for 15-19 days were used for patch clamp functional testing. 
As a positive control for ICC staining, NSCs (sections 2.2.1.4 and 2.2.1.5) 
were seeded on poly-l-lysine/laminin coated chamber slides and 
differentiated in neurotrophin-containing medium for 10 days before antibody 
staining.  
 
 
4.3.4 Patch clamp recordings 
Transmembrane currents were recorded in conventional whole-cell 
configuration from DPPCs after 15-19 days of differentiation. Cells 
differentiated on poly-l-lysine/laminin-coated glass cover slips were bathed in 
a continuous wash-through of extracellular solution designed to resemble in 
vivo extracellular fluid, containing: 135mM NaCl, 5mM KCl, 1.2mM MgCl2, 
1.25mM CaCl2, 10mM d-glucose, and 5mM N-2-hydroxyethylpiperazine-N′-2-
ethanesulfonic acid (HEPES); adjusted to a pH of 7.4 using NaOH. The 
pipette solution was designed to match intracellular ionic concentrations and 
Figure 4.1 – DPPC differentiation experimental design 
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contained: 117mM KCl, 10mM NaCl, 2mM MgCl2, 1mM CaCl2, 2mM 
Na2ATP, 1mM Na2GTP, 11mM HEPES, and 11mM ethylene glycol 
tetraacetic acid; free [Ca2+]i was adjusted to 100 nM; pH was adjusted to 7.2 
with KOH. A micromanipulator control system was used to manoeuvre fire-
polished glass pipettes until contact was made with the cellular membrane 
and suction applied to form a high resistance seal. Further suction resulted in 
patch rupture and entrance into whole cell recording mode. All recordings 
were performed at room temperature (22 ± 0.5 °C) using an Axopatch 200B 
amplifier and Digidata 1320 A/D interface (Axon Instruments, Forster City, 
CA, USA). Holding voltage was set to -70 mV and transmembrane currents 
recorded using a voltage step protocol of 80 ms duration of voltages ranging 
from -120 to +80 mV. Series resistance and membrane capacitance were 
compensated ≈ 90 % (11.6 ± 1.5 MΩ and 29.9 ± 3.1 pF, respectively (n = 6)). 
Pipette resistances were ≈ 5 – 10 MΩ when filled with the pipette solution. All 
recordings were filtered with an 8-pole Bessel filter at 5 kHz and digitized at 
10 kHz. Half-activation voltage (V50 = 75.7 ± 3.1 mV) and slope coefficient (h 
= 23.1 ± 0.8) were obtained from the current-voltage curve.  
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4.3.5 Tables of primers 
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BLBP 
NM_02127
2.3 
f: GGACACAATGCACATTCAAGAA 
r: CCGAACCACAGACTTACAGTTT 
101 60 
CD133 
NM_00893
5.2 
f: GAATGCGCCATGCAGGAGGAAGTGCTT 
r: GGCTGCTCCCCAGACTGCTTAGGCTTG 
542 60 
GAPDH 
NM_00808
4.2 
f: AGACGGCCGCATCTTCTTGTGCAGTGC 
r: ACATACTCAGCACCGGCCTCACCCCA 
326 60 
GLAST 
NM_14893
8.3 
f: ACCAAAAGCAACGGAGAAGAG 
r: GGCATTCCGAAACAGGTAACTC 
144 60 
Musashi 
NM_00862
9.1 
f: GGGGTGGATAAAGTGCTGGCGCAATCG 
r: CGCTCTACACGGAATTCGGGGAACTGGT 
533 60 
Myt1l 
NM_00109
3775.1 
f: TGGTCACGTCAGTGGCAAATA 
r: TGCAAATGGTTTTCGCTTGGG 
121 60 
NF-l 
NM_01091
0.1 
f: CAAGAGCCGCTTCACCGTGCTAACCGA 
r: CGCTGGTTATGCTACCCACGCTGGTGA 
392 60 
P75 
NM_03321
7.3 
f: CTCAGATGAAGCCAACCACG 
r: CCTTGTGATCCATCGGCCA 
133 60 
Pax6 
NM_00124
4198.1 
f: TACCAGTGTCTACCAGCCAAT 
r: TGCACGAGTATGAGGAGGTCT 
194 60 
SOX1 
NM_00923
3.3 
f: CCTTGCTAGAAGTTGCGGTCCCAGA r: 
CCTCCTCTTGTCGGCTCGAAGTCTC 
84 60 
SOX2 
NM_01144
3.3 
f: GCGGAGTGGAAACTTTTGTCC 
r: CGGGAAGCGTGTACTTATCCTT 
157 60 
 
 
 
  
Table 4.1  – rt-PCR primer sequences 
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BLBP 
NM_02127
2.3 
f: GGACACAATGCACATTCAAGAA 
r: CCGAACCACAGACTTACAGTTT 
101 60 
GAPDH 
NM_00808
4.2 
f: AGGTCGGTGTGAACGGATTTG 
r: TGTAGACCATGTAGTTGAGGTCA 
123 60 
Map2 
NM_00103
9934.1 
f: TGACACTTGGGACCTGGACGAGTAT 
r: ACACCACTTCTTCAACCAACGCTCA 
105 60 
Ncam 
NM_00108
1445.1 
f: CAGTGAAGAAAAGACTCTGGATG 
r: TTCCCTTCCCAAGTGTACACA 
213 60 
Nestin 
NM_01670
1.3 
f: CCAAAGAGGTGTCCGATCATC 
r: CTCCCTTCTTCTTCATCAGCATCT 
147 60 
NF-l 
NM_01091
0.1 
f: TGAGAAGCACGAAGAGCGAGATGG 
r: TGAAACTGAGCCTGGTCTCTTCGC 
135 60 
Ngn2 
NM_00971
8.2 
f: AACTCCACGTCCCCATACAG 
r: GAGGCGCATAACGATGCTTCT 
103 60 
Pax6 
NM_00124
4198.1 
f: TACCAGTGTCTACCAGCCAAT 
r: TGCACGAGTATGAGGAGGTCT 
194 60 
SCA1 
NM_00127
1416.1 
f: GAGGCAGCAGTTATTGTGGAT 
r: ACCCAGGATCTCCATACTTTCA 
99 60 
SOX2 
NM_01144
3.3 
f: GCGGAGTGGAAACTTTTGTCC 
r: CGGGAAGCGTGTACTTATCCTT 
157 60 
 
  
Table 4.2  – qPCR primer sequences 
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4.4 Results 
4.4.1 Expression of neural markers by DPPCs 
Prior to differentiation, RNA was extracted from each isolated dental pulp 
progenitor cell clone and mixed population at the earliest possible population 
doubling level. This was used to screen for the mRNA expression of a 
selection of neural stem cell and mature neural markers (Figures 4.2 and 
4.3). All isolated DPPC cultures were found to express SOX2, P75, BLBP 
and Musashi. No clones or mixed populations expressed SOX1 or CD133. 
Expressions of Pax6, Myt1l, GLAST and NF-l were heterogeneous with 
differences evident between different cultures. No pattern of marker 
expression was apparent with regards to adhesion to fibronectin properties. 
Individual clones with low (19_8A2A and 10_11BNA3A) and high (7_10BA1B 
and 7_10BA2C) levels of nestin mRNA expression were immunostained with 
antibodies against the neural progenitor markers nestin and Musashi 
(Figures 4.4 and 4.5). All four clones were found to double-stain for both 
early stage neural markers, at the protein level, with weaker nestin staining 
observed in 19_8A2A and 10_11BNA3A. 
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Figure 4.2 – mRNA expression of developmental neural markers 
Rt-PCR was used to detect the expression of SOX1, SOX2, Pax6, Myt1l and P75 in 
undifferentiated DPPCs. SOX2 and P75 expression was identified in all cell populations, 
whereas Pax6 and Myt1l expression was found to differ between cultures. SOX1 was 
not expressed by any of the DPPC populations. RNA extracted from primary cultured 
neural stem cells was used as a positive control. 
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Figure 4.3 – mRNA expression of NSC and mature neural markers  
Rt-PCR was used to detect the expression of BLBP, GLAST, Musashi, CD133 and NF-l in 
undifferentiated DPPCs. BLBP and Musashi expression was identified in all cell 
populations, whereas GLAST and NF-l expression was found to differ between cultures. 
CD133 was not expressed by any of the DPPC populations. RNA extracted from primary 
cultured neural stem cells was used as a positive control. 
 
   
Figure 4.4 – Presence of nestin and Musashi in weakly nestin-expressing clones 
Clones with low levels of nestin mRNA expression, 19_8A2A (A) and 10_11BNA3A (B), 
were fixed and stained with antibodies against the neural stem cell markers nestin 
(green) and Musashi (red). Nuclei were counterstained with DAPI. Merged images of 
the respective isotype controls are shown (C & D). Scale bars = 100μm.   
 
 Figure 4.5 – Presence of nestin and Musashi in strongly nestin-expressing clones 
Clones with high levels of nestin mRNA expression, 7_10BA1B (A) and 7_10BA2C (B) 
were fixed and stained with antibodies against the neural stem cell markers nestin 
(green) and Musashi (red). Nuclei were counterstained with DAPI. Merged images of 
the respective isotype controls are shown (C & D). Scale bars = 100μm.   
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4.4.2 DPPC clones cultured in NSC medium 
Due to the similarities in marker expression with NSCs, initial attempts to 
differentiate DPPCs down a neural lineage were based on NSC culture 
protocols. The four clones (19_8A2A, 10_11BNA3A, 7_10BA1B and 
7_10BA2C) were passaged and seeded afresh, in NSC medium, on poly-l-
lysine and laminin-coated culture surfaces. Changes in morphology were 
observed over 7 days culture. mRNA extracted on day 7 was compared with 
mRNA extracted prior to differentiation to analyse changes in gene 
expression using qPCR techniques. 
Low nestin-expressing clone 19_8A2A appeared morphologically unchanged 
following culture in NSC medium, remaining bipolar and fibroblastic-like 
(Figure 4.6 A and B). 10_11BNA3A, also with low levels of nestin mRNA, 
was similarly unchanged although some cells appeared to show stress fibre 
formation (Figure 4.6 C and D). Clones with high nestin mRNA levels, 
7_10BA1B and 7_10BA2C, appeared similarly fibroblastic-like in DPPC 
medium (Figure 4.6 E and G, respectively). However, these clones were 
found to adopt a more neuronal-like morphology in NSC medium, with 
rounded cell bodies extending multiple long and branched processes (Figure 
4.6 F and H). No obvious proliferation in NSC culture medium was observed 
in any of the four clones tested. 
At the end of 7 days culture in NSC medium, changes in expression of 
SCA1, nestin, Map2 and NF-l were investigated (Figure 4.7). The general 
stem cell marker SCA1 was downregulated by all four clones. Nestin 
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expression was downregulated by 19_8A2A, upregulated by 10_11BNA3A 
and 7_10BA2C but unchanged in 7_10BA2C. Map2 expression increased in 
19_8A2A, 7_10BA1B and 7_10BA2C but was unaffected in 10_11BNA3A. 
Expression of NF-l was found to be unchanged in 19_A2A cells, decreased 
in 10_11BNA3A but increased in both strong nestin-expressing clones, 
7_10BA1B, 7_10BA2C. 
   
Figure 4.6 – Morphology changes following culture in NSC medium 
In DPPC medium 19_8A2A (A), 10_11BNA3A (B), 7_10BA1B (E) and 7_10BA2C (G) 
displayed bi/tripolar fibroblastic-like morphology, typical of DPPCs. After 7 days culture 
in NSC medium no significant changes in morphology were observed in 19_8A2A (B), 
while 10_11BNA3A showed signs of stress (D). Small numbers of cells adopted a more 
neuronal like phenotype, with small round bodies extending multiple processes in 
7_10BA1B (F) and 7_10BA2C (H). Scale bars = 100μm  
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4.4.3 Maturation with neurotrophins 
As the clone with the most neuronal-like appearance and mature marker 
expression profile, 7_10BA2C was used for further analysis to investigate the 
addition of an extra differentiation step to the protocol. Following 5 days 
culture in NSC medium, cells were exposed to a maturation medium 
containing the neurotrophic factors NT-3, NGF and BDNF. RNA was 
extracted from the cells on days 0, 5, 10 and 15 for qPCR to analyse 
changes in gene expression. Cells were fixed on day 15 and stained with 
antibodies against Map2 and NF-l. 
In DPPC medium, prior to differentiation, the cells were typically fibroblastic-
like in appearance (Figure 4.8 A). After 5 days culture in NSC medium, cell 
bodies appeared rounder and long processes could be seen branching from 
the cells (Figure 4.8 B). On day 10, 5 days after switching to the 
neurotrophin-containing medium, process extensions were longer and 
appeared to make intercellular connections (Figure 4.8 C). By day 15, the 
differentiating cells had formed a highly interconnected network of neuronal-
like cells (Figure 4.8 D). 
By day 5 of differentiation, mRNA expression of SCA1 was strongly 
downregulated (Figure 4.9). During the same time-period, expression of 
nestin and NF-l were seen to increase before plateauing. Expression of the 
intermediate neuronal marker Map2 continued to increase over the 15 day 
differentiation protocol indicating a more mature neuronal phenotype. 
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On day 15, presence of Map2 and NF-l proteins were identified in the 
differentiating DPPCs by immunocytochemical staining (Figure 4.10 A). 
Neural stem cells, similarly differentiated in neurotrophin-containing medium 
for 10 days, also stained positively for both markers and showed a 
comparable morphology, albeit smaller in size (Figure 4.10 B). 
   
Figure 4.8 – Morphology changes during differentiation in NSC medium followed by 
neurotrophin-containing medium  
7_10BA2C were cultured for 5 days in NSC medium before being transferred to a NGF, NT-
3 and BDNF-containing medium for 10 further days. A) In DPPC medium, before 
differentiation, cells were typically bi/tripolar and fibroblastic-like. B) After 5 days in NSC 
medium, cell bodies appeared rounder and sprouting of multiple long processes was 
evident. C) 5 days after transfer to a neurotrophin-containing medium, long processes 
extended by neuronal-like cells appear to form network like connections. D) Intercellular 
connections are maintained after 10 days culture in neurotrophin-containing medium, on 
day 15 of differentiation. Scale bars = 100µm.  
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 Figure 4.10 – DPPCs show similar morphology to NSCs differentiated in neurotrophin-
containing medium  
7_10BA2C after 15 days differentiation (A) and NSCs after 10 days culture in 
neurotrophin-containing medium (B) were fixed and double-stained with antibodies 
against Map2 (red) and NF-l (green). Cells of both types showed similar morphology and 
stained positive for both neuronal markers. Appropriate isotype controls are shown for 
DPPCs (C) and NSCs (D). Scale bars = 100μm.   
 
123 
 
4.4.4 Functional testing 
Patch clamp recording techniques were used to assess the functionality of 
the neuronal-like cells differentiated from DPPCs using this protocol. 
Recordings were taken from 6 cells of the clonal population 7_10BA2C after 
15 days differentiation. High resting membrane potentials ranging between -6 
and -10mV were recorded for the differentiated DPPCs (Figure 4.11 A). 
Action potentials could not be evoked by 80 ms voltage steps from -120 to 
+80 mV in incremental steps of 10 mV from a holding potential of -70 mV 
(Figure 4.11 B). Outward K+ currents but no inward Na+ currents were 
identified in whole cell measurements (Figure 4.11 C and D). 
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4.4.5 Changes in expression of neural markers during 
differentiation 
Following identification of the non-functional characteristics of differentiated 
7_10BA2C, a more detailed analysis was performed on the changes in 
mRNA expression on days 0, 5, 10 and 15. Expression of SOX2 was 
continuously upregulated over 15 days differentiation while Pax6 remained 
unchanged (Figure 4.12 A). BLBP expression decreased over the first 5 days 
of differentiation, at which point expression of Ncam began to increase. 
Expression of the neurogenic marker Ngn2 remained constant over 15 days 
(Figure 4.12 B). 
 Figure 4.12 – Changes in expression of NSC renewal and neurogenic genes during 
differentiation 
RNA extracted from 7_10BA2C cells on days 0, 5, 10 and 15 of the differentiation 
protocol was used for quantifying changes in expression of mRNA transcripts (±SD) for 
genes involved in NSC self-renewal (A) and neurogenesis (B) using the 2-ΔΔct method for 
qPCR analysis. A) Expression of SOX2 increased over 15 days differentiation, whereas 
Pax6 remained unchanged. B) Ngn2 expression was unchanged over 15 days, BLBP 
decreased over the first 5 days of differentiation and Ncam expression increased from 
day 5 onwards.  
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4.4.6 Changes in neurotrophin and growth factor expression 
during differentiation 
The changes in expression of neurotrophins and growth factors at days 0, 5 
10 and 15 was also investigated using qPCR. At the end of 15 days 
differentiation, expression of NT-3, NGF and BDNF were unchanged 
although increased expression of both NT-3 and BDNF was identified on day 
10. Expression of GDNF decreased over 15 days (Figure 4.13 A). bFGF 
expression was strongly upregulated by day 5 of differentiation and remained 
so until day 15. TGFβ-1 was unchanged over the first 5 days of differentiation 
before increasing over the next 10 days. A relatively smaller increase was 
observed in expression of VEGF-A. Expression of PDGF-a and IGF-1 was 
unchanged at the end of 15 days (Figure 4.13 B). 
 Figure 4.13 – Changes in expression of neurotrophic and growth factors during 
differentiation 
RNA extracted from 7_10BA2C cells on days 0, 5, 10 and 15 of the differentiation 
protocol was used for quantifying changes in expression of mRNA transcripts (±SD) for 
neurotrophins (A) and growth factors (B) using the 2-ΔΔct method for qPCR analysis. A) 
Expression of NT-3, BDNF and GDNF was much unchanged on day 15 although a small 
increase was seen between days 5 and 10, GDNF slowly decreased over 15 days. B) 
Expression of TGFβ-1, bFGF and VEGF-A increased during the differentiation protocol, 
PDGF-a and IGF-1 remained unchanged at the end of 15 days.  
.  
  
 
129 
 
4.5 Discussion 
Previous studies have identified expression of a handful of NSC markers, 
such as Musashi and SOX2, in cultured DPPCs (Govindasamy et al., 2010; 
Karaöz et al., 2011; Karbanová et al. 2011; Aanismaa et al., 2012). In fact, 
DPPCs often express mature neuronal markers, such as Map2, NF and βIII-
tubulin, at a basal level (Karaöz et al., 2011; Osathanon et al., 2011; Sakai et 
al., 2012). This chapter provides a comprehensive characterisation of the 
expression of further neural lineage markers, demonstrating a degree of 
heterogeneity between different cell cultures and clones. Prior to 
differentiation, DPPCs were found to express both developmental and later 
stage neural markers, with a profile similar to NSCs (Figures 4.2 – 4.5). 
The transcription factors SOX1 and SOX2 are important for maintenance of 
NSC identity and self-renewal properties (Bylund et al., 2003; Graham et al., 
2003; Kan et al., 2004). Expression of SOX2 was identified in all mDPPC 
cultures tested, but not the closely-related SOX1 (Figure 4.2). There is a 
degree of functional overlap between the two transcription factors and 
deficiencies in one can often be compensated for by the other (Graham et 
al., 2003). Thus, the absence of SOX1 in DPPCs does not necessarily imply 
a less NSC-like phenotype. 
During development, Pax6 expression gradients are essential for the 
regional specification of ventral progenitor cells of the spinal cord and 
hindbrain (Ericson et al., 1997; Takahashi and Osumi, 2002). Pax6 
expression is important in regulating the self-renewal and differentiation of 
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NSCs with transcriptional targets including cell cycle regulators and initiators 
of neurogenesis (Sansom et al., 2009). Pax6 expression in DPPCs was 
found to be heterogeneous, ranging from complete absence to high levels in 
different cell cultures (Figure 4.2). With regards to NSCs, increased Pax6 
expression drives neuronal differentiation and inhibits self-renewal, whereas 
reduced Pax6 levels also result in reduced self-renewal (Sansom et al., 
2009). It is possible that, in this manner, the precise level of Pax6 expression 
may be a factor determining the neuronal differentiation potential of each 
individual DPPC culture. Cells with mid to high levels of Pax6 may represent 
those with a greater propensity for neuronal differentiation. Only four DPPC 
cultures were found to express the transcription factor Myt1l which is 
associated with developing neurons of the CNS (Kim et al., 1997). 
All DPPC cultures showed positive expression of the neural crest-associated 
marker P75 (Figure 4.2). The dental pulp arises from the neural crest during 
tooth development (Chai et al., 2000) and this observation confirms the cells 
used in this study are of neural crest origin, similar to those previously 
described (Waddington et al., 2009; Janebodin et al., 2011).  
BLBP, a marker for radial glial NSCs and a transcriptional target of Notch1 
and Notch3 signalling (Anthony et al., 2005), was found to be expressed by 
all DPPCs. Another radial glia marker, GLAST, was found to be more 
variable in expression (Figure 4.3). The expression of both BLBP and 
GLAST, together with the absence of CD133, suggests that DPPCs may be 
closer in characteristics to radial glial NSCs than neuroepithelial NSCs. 
Given that radial glia are the source of the majority of neurons in the brain 
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(Anthony et al., 2004; Merkle et al., 2004), this provides strong indication of a 
neuronal potential for DPPCs. 
Expression of mRNA transcripts for Musashi were identified in all mDPPC 
cultures and protein was present, together with nestin, in four different single 
cell-derived DPPC clones (Figures 4.3 – 4.5). Musashi helps to maintain 
NSC self-renewal properties by binding m-Numb RNA to suppress its 
translation and subsequent inhibition of Notch1 signalling (Imai et al., 2001). 
Notch1 signalling is one of the key pathways involved in NSC self-renewal 
(Hitoshi et al., 2002) and has similarly been implicated in maintaining dental 
pulp cell progenitor properties  (Zhang et al., 2008; He et al., 2009; Wang et 
al., 2011). Notch1 signalling is induced in the sub-odontoblast layer and 
perivascular regions of the pulp following capping of rat adult molars, both of 
which are believed to harbour niches of DPPCs (Lovschall et al., 2005). In 
vitro, over-expression of constitutively activated Notch1 intracellular domain 
or jagged1 ligand inhibits DPPC odontoblastic differentiation, but does not 
affect proliferation (Zhang et al., 2008). Similarly, inhibition of notch signalling 
by RNA interference of delta-1 ligand promotes differentiation and inhibits the 
proliferation of DPPCs (Wang et al., 2011). Embryonic knockout of Notch1 
results in depletion of NSCs, and their in vitro differentiation is enhanced 
following attenuation of notch signalling (Hitoshi et al., 2002). The importance 
of this signalling pathway in maintaining progenitor/stem cell identity of both 
NSCs and DPPCs suggests that Musashi may perform a similar function in 
DPPCs by binding RNA transcripts to prevent the translation of Notch 
inhibitory factors. Immunocytochemical staining of Musashi in DPPCs 
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indicated a primarily cytoplasmic localisation (Figures 4.4 and 4.5), allowing it 
to function in mRNA binding. In differentiating NSCs, unbound Musashi tends 
to translocate to the nucleus (MacNicol et al., 2008; Nickerson et al., 2011). 
This cytoplasmic localisation in DPPCs is consistent with early stage 
proliferating neural cells. 
Based upon this initial characterisation data, it is clear that DPPCs share a 
number of characteristics with NSCs. As such, a differentiation protocol was 
developed based on procedures used in NSC culture. Four DPPC clones 
demonstrating low or high levels of nestin mRNA expression were grown in 
NSC culture medium on poly-l-lysine/laminin coated plates for 7 days. After 7 
days differentiation, no significant alterations were observed in the 
morphology of the weaker nestin mRNA-expressing clones, although 
10_11BNA3A showed signs of stress (Figure 4.6 B and D). Stronger nestin-
expressing clones, on the other hand, adopted a more neuronal-like 
phenotype extending a number of long processes (Figure 4.6 F and H). This 
suggests that nestin expression may be indicative of neuronal differentiation 
potential using this protocol. In previously published neuronal differentiation 
studies, NSC culture media, similar to that utilised in this study, has been 
used to promote the generation of neurosphere-like structures from DPPCs 
on low attachment culture plates (Iohara et al., 2006; Takeyasu et al., 2006; 
Sasaki et al., 2008; Govindasamy et al., 2010; Osathanon et al., 2011). The 
formation of such spheres is associated with the expression of astrocytic 
markers, such as S100 (Sasaki et al., 2008), and upregulation of GFAP 
mRNA (Govindasamy et al., 2010). This approach, therefore, may not 
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represent the most effective method for deriving purified populations of 
neuronal-like cells from DPPCs. In order to minimise the adoption of 
astrocytic-like phenotypes occurring as a result of neurosphere formation, 
DPPCs differentiated using the protocol developed in this chapter were 
encouraged to adhere to poly-lysine/laminin-coated culture surfaces.  
qPCR analysis identified clonal differences in gene expression response to 
NSC medium (Figure 4.7). The general stem cell marker SCA1 was 
downregulated by all 4 clones, suggesting the neural inductive medium 
initiated a move away from the default mesenchymal progenitor phenotype. 
Those clones with stronger levels of nestin mRNA expression, 7_10BA1B 
and 7_10BA2C, adopted a more neuronal-like phenotype evidenced by the 
upregulation of neuronal markers Map2 and NF-l (Figure 4.7). On the other 
hand, in clones with initially lower levels of nestin mRNA expression, 
19_8A2A and 10_11BNA3A, expression of these markers was unchanged or 
downregulated, with only a small increase of Map2 observed in 19_8A2A. 
Together, these results suggest that mRNA expression levels of nestin may 
be an important factor in determining the potential of DPPCs for neuronal 
differentiation. Although the precise function of nestin is as yet unidentified, it 
is required for NSC self-renewal and survival. Knockdown of nestin in NSCs 
does not overtly affect their proliferation or differentiation, but does result in 
increased apoptosis (Park et al., 2010b). In contrast, the results presented in 
this chapter suggest a role for nestin in the differentiation of DPPCs. The 
formation of neurospheres from DPPCs using similar NSC media has been 
similarly associated with the upregulation of mRNA transcripts for NF (Iohara 
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et al., 2006; Govindasamy et al., 2010). In these reports, heterogeneous 
DPPC populations isolated with no selection step were used to generate 
neurospheres and, thus, it is likely that only a small proportion of cells were 
responding positively to the NSC medium. This report demonstrates changes 
in gene expression at a clonal level and suggests a possible means of 
identifying those cells with a greater potential for neuronal differentiation, 
based upon mRNA expression levels of nestin. This is a significant finding 
and may help explain why in previous studies only small numbers of DPPCs 
within mixed populations were found to adopt mature neuronal phenotypes 
(Király et al., 2009), and why different patient samples do not differentiate 
equally in the same inductive conditions (Aanismaa et al., 2012).  
The downregulation of mesenchymal markers and upregulation of neural 
markers, particularly by the stronger nestin-expressing clones 7_10BA1B 
and 7_10BA2C (Figure 4.7), suggests a “neuralisation” effect of NSC 
medium on mDPPCs. As these neuralised DPPCs appear to be more NSC-
like in marker expression, a further step was added to the differentiation 
protocol. 7_10BA2C was neuralised in NSC medium for 5 days, washed with 
PBS and then changed to a neurotrophin-containing medium for 10+ further 
days of maturation (Figure 4.1). Exposure of NSCs to BDNF, NGF or NT-3 
can promote their neuronal differentiation (Benoit et al., 2001; Ito et al., 2003; 
Chen et al., 2013). After switching from NSC medium to neurotrophin 
medium, 7_10BA2C cells became more neuronal-like in appearance with 
rounded cell bodies and projected multiple long range processes that 
extended towards other cells to form network-like connections (Figure 4.8). 
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This morphology was mirrored by NSCs seeded on poly-lysine/laminin-
coated dishes and differentiated in the same neurotrophin-containing 
medium for 10 days (Figure 4.10). 
Changes in the expression of SCA1, nestin, Map2 and NF-l were again 
analysed using quantitative PCR (Figure 4.9). Over the first five days of 
neuralisation, as seen before (Figure 4.7), levels of SCA1 reduced while the 
neural markers increased. Map2 continued to increase over the next 10 days 
differentiation. Expression of nestin and NF-l, increased over the first 5 days 
of maturation before plateuaing.  At the end of 10 days maturation, fixed cells 
stained positively for Map2 and NF-l demonstrating their presence in both 
7_10BA2C and NSCs (Figure 4.10). The presence of both late neuronal 
markers, at the protein level, confirmed that differentiating DPPCs were of a 
neuronal-like phenotype, similar to NSCs grown in the same medium. As 
such, approaches used to encourage the neuronal differentiation of NSCs 
may represent a simple method of promoting comparable DPPC neuronal-
like differentiation. This provides further evidence of the similarities between 
DPPCs and NSCs. 
In order to test the functionality of DPPC-derived neuronal-like cells, patch 
clamp techniques were used to provide electrophysiology readings for 
7_10BA2C cells after 5 days neuralisation followed by 10-15 days 
maturation. Previous studies have shown the passive membrane potential of 
NSCs typically ranges from -40 to -85mV, depending upon tissue of origin 
and developmental stage at the time of isolation, and is around -70mV in 
terminally differentiated neurons (Gritti et al., 1996; Yasuda and Adams, 
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2010). Neuronally differentiated DPPCs possessed highly depolarised 
membrane potentials ranging between -6 and -10mV (Figure 4.11 A). Such 
high resting potentials are typically associated with unexcitable cell types. No 
action potentials could be evoked using a voltage step protocol from a 
holding potential set to -70 mV (Figure 4.11 B). The influx of Na+ ions 
through voltage-gated channels is a key event in triggering action potentials. 
Outward voltage-activated K+ currents but not inward currents propagated 
through voltage-activated Na+ channels were identified in differentiated 
DPPCs (Figure 4.11 C and D). Previous studies using different approaches 
for the neuronal differentiation of DPPCs have recorded both Na+ and K+ 
currents, however, this is still insufficient for the generation of true action 
potentials (Arthur et al., 2008; Király et al., 2009; Aanismaa et al., 2012). 
Despite the presence of mature markers and appropriate morphology, the 
neuronal-like cells obtained using the protocol developed in this chapter are 
electrophysiologically unexcitable and, thus, unable to function like true 
neurons. This finding is similar to a previous report of skin-derived progenitor 
cells (Collo et al., 2006). Following neuronal differentiation, these cells 
adopted a neuronal-like morphology, comparable with that observed in 
DPPCs, and expressed both βIII-tubulin and Map2. As with DPPCs, voltage-
activated K+, but not Na+ currents were recorded to indicate a functionally 
immature neuronal phenotype. 
In order to ascertain why DPPC-derived neuronal-like cells were not 
functional, a more detailed qPCR analysis of the changes in gene expression 
during differentiation was performed. Throughout 15 days of differentiation, 
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expression of SOX2 was seen to steadily increase (Figure 4.12 A). SOX2 
actively inhibits NSC differentiation, helping to maintain pluripotency 
(Graham et al., 2003). It is only as SOX2 expression is downregulated during 
differentiation, that key transcription factors initiating the onset of neuronal 
functional properties, such as neurogenin-2 (Ngn2) and Mash1, become 
expressed (Bylund et al., 2003). Ngn2 was expressed at a low basal level by 
7_10BA2C, prior to differentiation, but its expression did not change during 
15 days differentiation (Figure 4.12 B). No expression of Mash1 was 
identified at any stage of differentiation. The induction of such proneural 
factors is unlikely while SOX2 remains expressed at high levels. Expression 
of Pax6 was largely unaltered during differentiation (Figure 4.12 A). 
Increased levels of Pax6 in NSCs are associated with neurogenesis 
(Sansom et al., 2009) and, as such, this provides further evidence that the 
onset of functional properties in DPPCs is unlikely at this stage of the 
protocol. Expression of neural cell adhesion molecule (Ncam) was found to 
increase sharply from day 5 of differentiation onwards, correlating with the 
transfer to neurotrophin-containing medium (Figure 4.12 B). Ncam is 
associated with neurite outgrowth and cell-cell interactions (Kolkova et al., 
2000; Kleene et al., 2010) and from day 5 of differentiation onwards, the 
extension of neuronal-like processes from DPPCs becomes more 
pronounced and synapse-like connections appear between cells (Figure 4.8). 
These process extensions are likely promoted by the addition of NGF, NT3 
and BDNF to the maturation medium which are known to induce expression 
of Ncam via binding to P75 (already expressed by DPPCs (Figure 4.2)) 
(Mirnics et al., 2005; Thornton et al., 2008). Despite the presence of more 
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mature neural markers, such as Ncam, Map2 and NF-l (Figure 4.10), the 
high levels of SOX2 expression and lack of proneural gene induction, in 
addition to electrophysiological readings, confirmed that the neuronal-like 
DPPCs were still of an immature phenotype. The protocol developed in this 
chapter, although simple and based upon the shared properties of NSCs and 
DPPCs, is insufficient to promote terminal functional differentiation of DPPCs 
and further steps will be required. 
More often thought of as a target for neurotrophic and growth factors to 
promote their proliferation and differentiation (Benoit et al., 2001; Chen et al., 
2013; Supeno et al., 2013), only limited information is available regarding the 
production and release of such factors by NSCs as they differentiate. In 
culture, NSCs express mRNA transcripts for a wide range of neurotrophic 
and growth factors, including NGF, NT-3, BDNF, GDNF, bFGF, PDGF-a, 
IGF-1, TGFβ-1 and VEGF-a (Hawryluk et al., 2012b). In the rat spinal cord, 
secretion of NGF, BDNF and GDNF by transplanted NSCs is associated with 
increased host axonal regrowth and myelination (Lu et al., 2003; Yan et al., 
2004). As NSCs differentiate in the presence of serum in vitro, transcripts for 
all the neurotrophic and growth factors investigated in this study, with the 
exception of PDGF-a and VEGF-A, are upregulated (Hawryluk et al., 2012b). 
Using the 15 day protocol developed in this chapter, only TGFβ-1, bFGF and 
VEGF-A increased in expression as DPPCs differentiated into neuronal-like 
cells (Figure 4.13). TGFβ-1 began to increase from day 5 onwards, at which 
point exogenous neurotrophic factors were added to the medium. Increased 
expression of VEGF-A, bFGF and TGFβ-1  by neuronally differentiated 
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DPPCs could potentially promote recovery from SCI by helping to maintain 
blood vessel architecture  (Widenfalk et al., 2003) and protect against death 
of endogenous neuronal cells (Ho et al., 2000; Zhang et al., 2013). 
Based on the results presented in this chapter, the production of 
neurotrophic and growth factors should be taken into account when 
considering DPPCs as a source of cells to directly replace endogenous 
neurons following SCI. Although neuronal differentiation is observed 
following NSC transplantation into in vivo models of SCI, increased 
expression of neurotrophic factors by grafted cells provides a secondary 
mechanism, through which recovery is promoted, by recruiting endogenous 
oligodendrocyte cells (Amemori et al., 2013). In fact, the regenerative effects 
of NSC transplantation can be enhanced using NSCs genetically engineered 
to overexpress NT-3 (Lu et al., 2003). At this current point in time, recovery 
following DPPC transplantation into in vivo SCI models is attributed to similar 
secondary neurotrophic mechanisms (de Almeida et al., 2011; Sakai et al., 
2012). This chapter has demonstrated that the expression of neurotrophic 
and growth factor mRNA transcripts changes during DPPC neuronal-like 
differentiation, potentially altering the mechanisms through which they can 
promote secondary regeneration. A similar neurotrophic and growth factor 
expression profile of DPPCs, following definitive differentiation into functional 
neuronal-like cells, would help to identify what further roles, in addition to 
direct cellular replacement, they can play in promoting spinal cord repair. 
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4.6 Summary 
 Undifferentiated DPPCs were found to express a range of developmental 
and mature neural markers demonstrating shared characteristics with 
NSCs. 
 Following culture in NSC medium, DPPCs become “neuralised”, as 
demonstrated by a more neuronal-like morphology, decreased 
expression of mesenchymal markers and increased expression of 
neuronal markers. The level of nestin expression, prior to differentiation, 
may be indicative of DPPCs ability to neuralise in NSC medium. 
 The addition of a further maturation stage, in the presence of 
neurotrophins, results in further increases of neural marker expression 
and morphology analagous to NSCs differentiated in the same medium. 
 DPPCs differentiated using this method show no indications of electrical 
functionality and are still of an immature neuronal-like phenotype. The 
differentiation protocol will require further development to promote 
functional maturation. 
 The expression of neurotrophic and growth factors by DPPCs is altered 
by differentiation into neuronal-like cells and this will prove important in 
considering the use of DPPCs to treat SCI. 
  
 
 
 
 
 
 
 
 
 
 
Chapter 5: Development of a protocol for 
the differentiation of oligodendrocyte-like 
cells from dental pulp progenitor cells 
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5.1 Introduction 
If cell replacement therapies are to result in complete functional recovery 
following SCI then, in addition to the replacement of neuronal cells, new 
sources of glial cells are also required. Oligodendrocytes are among the cell 
types most severely depleted following SCI, resulting in the chronic 
demyelination of axons to impair neuronal signalling (Li et al., 1999; 
Grossman et al., 2001; Totoiu and Keirstead, 2005). Replacement of 
oligodendrocytes with myelinating cells from alternative sources can help to 
improve recovery by restoring myelination and, thereby, facilitating axonal 
conduction. 
Transplantation of exogenous myelinating glial cells has proven successful in 
experimental models of SCI. Grafting of OPCs differentiated from human 
embryonic stem cells results in increased remyelination of endogenous 
axonal fibres accompanied with improved recovery of hindlimb function 
(Keirstead et al., 2005; Nistor et al., 2005). Alternatively, myelinating cells 
from other sources have demonstrated similar recovery and remyelination 
effects. Transplantation of PNS Schwann cells, either alone or in 
combination with olfactory ensheathing cells, a similar glial cell type found 
specifically in the olfactory bulb, has demonstrated efficacy at promoting 
functional recovery following SCI (Takami et al., 2002). The ability of 
olfactory ensheathing cells to promote this type of recovery remains 
controversial due to a number of contradicting studies (Ramón-Cueto et al., 
2000; Takami et al., 2002; Pearse et al., 2007). Schwann cells differentiated 
from BMSCs promote the sparing of spinal cord tissue and are associated 
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with improved functional recovery following SCI (Someya et al., 2008; 
Kamada et al., 2011). If DPPCs can similarly demonstrate the ability to 
differentiate into myelinating glial cells, their ease of isolation would endow 
them with a distinct advantage over other cell types for SCI transplantation. 
Cells of oligodendrocytic lineage are typically identified by the expression of 
the transcription factors Olig1 and Olig2 (Zhou et al., 2000). During 
development and differentiation from OPCs, the expression of 
oligodendrocyte markers follows a well-defined progression. At the earliest 
stages oligodendrocyte precursors can be identified by expression of the 
alpha subunit of platelet-derived growth factor receptor (PDGFR-α) (Pringle 
et al., 1992) and the neural crest glial-specific transcription factor SOX10 
(Kuhlbrodt et al., 1998). The cell surface ganglioside A2B5 is found on 
early/mid stage proliferative oligodendrocytes (Gard and Pfeiffer, 1990). As 
they continue to mature, expression of 2',3'-cyclic-nucleotide 3'-
phosphodiesterase (CNPase) develops (Yu et al., 1994). Expression of 
myelin-associated proteins, such as myelin basic protein (MBP), 
myelin/oligodendrocyte specific protein (MOSP) and galactocerebroside 
(GalC), indicates a terminal, functional myelinating phenotype (Dyer and 
Matthieu, 1994).  
Heterogeneous populations of dental pulp progenitor cells have been 
reported to express, at a basal level, various proteins associated with early 
stage glial cell types including A2B5, CNPase and GFAP (Gronthos et al., 
2002; Sakai et al., 2012) indicating potential for differentiation. As yet, 
however, no protocols have been developed for the specific differentiation of 
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glial cells from DPPCs. Expression of astrocytic markers, such as GFAP and 
S100 (Takeyasu et al., 2006; Sasaki et al., 2008; Janebodin et al., 2011; 
Karaöz et al., 2011), are often induced or found to increase during some 
neuronal differentiation protocols in vitro. Similarly, the unexpected 
differentiation of small numbers of GalC-positive, but Olig2-negative, 
oligodendrocyte-like cells has been reported as a side-product of a neuronal 
differentiation protocol (Aanismaa et al., 2012). The absence of Olig2 raises 
questions of whether these cells truly were of oligodendrocyte lineage.  In 
vivo, the spontaneous differentiation of MBP-positive mature 
oligodendrocytes has been reported following transplantation of SHEDS  into 
the injured rat spinal cord (Sakai et al., 2012) and GFAP/S100b-positive 
astrocytes derived from DPPCs transplanted into a mouse model of SCI (De 
Almeida et al., 2011). The development of a protocol for the specific 
differentiation of glial cells in vitro would provide a valuable model for 
investigating the roles that DPPCs have already demonstrated in promoting 
regeneration and repair in in vivo SCI studies. Furthermore, the DPPC-
derived oligodendrocytes, themselves, could provide a more suitable source 
of transplantable cells of a restricted lineage.  
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5.2 Objectives 
 To identify the expression of  a range of glial-associated markers by 
murine dental pulp progenitor cells 
 To develop a protocol demonstrating the ability of DPPCs to 
differentiate into oligodendrocyte-like cells in vitro and confirm 
phenotype using appropriate methods. 
 To investigate how oligodendrocyte differentiation may affect the 
ability of DPPCs to promote neural repair via trophic mechanisms  
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5.3 Materials and methods 
5.3.1 Characterisation of glial marker expression 
RNA extracted from low-passage DPPC cultures at between 15-25 
population doublings was used with rt-PCR (sections 2.2.2.1, 2.2.2.3 – 
2.2.2.5) to identify expression of range of glial markers by undifferentiated 
DPPCs, including those for early-mid stage oligodendrocytes (PDGFR-α and 
CNPase) and astrocytes/Schwann cells (GFAP and S100b). RNA extracted 
from murine corpus callosum tissue (section 2.2.2.2), a brain region enriched 
with glial cells, was used as a positive control. Primer sequences and targets 
are shown in Table 5.2 
Four single cell-derived clones (19_8A2A, 10_11BNA3A, 7_10BA1B and 
7_10BA2C (20-25 PDs)) were further fixed with 4% PFA and 
immunocytochemically stained (section 2.2.2.7) with antibodies against A2B5 
and SOX10, together with appropriate isotype controls (Tables 2.2 – 2.4).  
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5.3.2 Oligodendrocyte progenitor cell medium 
OPC medium was composed as outlined below in Table 5.1. 
Component Comments Supplier 
DMEM 
L-glutamine 
40mM Glucose 
Sigma-Aldrich, UK 
1 x SATO supplement 
16μg/ml putrescine 
62ng/ml progesterone 
5ng/ml sodium selenite 
100μg/ml BSA 
all Sigma-Aldrich, UK 
Holo-transferrin 50μg/ml Sigma-Aldrich, UK 
Insulin 5μg/ml Sigma-Aldrich, UK 
PDGFaa 10ng/ml Peprotech, UK 
bFGF 20ng/ml Peprotech, UK 
Penicillin/Streptomycin 1% (v/v) Life Technologies, UK 
 
5.3.3 DPPC differentiation in OPC medium 
8-well chamber slides (BD Biosciences, USA) were coated with 0.01% poly-l-
lysine (Sigma-Aldrich, UK) for 5 minutes at room temperature. This was 
removed and the surfaces allowed to completely air dry for a minimum of one 
hour before rinsing with PBS. During culture (sections 2.2.1.1 and 2.2.1.2), 
four DPPC clones (19_8A2A, 10_11BNA3A, 7_10BA1B and 7_10BA2C (20-
30 PDs)) were seeded at 10,000cells/cm2 in OPC medium. Cells seeded in 
DPPC medium were used as an undifferentiated control. Medium changes 
were performed every other day and phase contrast images acquired to 
record changes in cellular morphology. After 7 days differentiation, the 
Table 5.1 – OPC medium 
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chamber slides were fixed with 4% (w/v) PFA and immunocytyochemically 
stained (section 2.2.2.8) with primary antibodies against the oligodendrocyte-
associated markers Olig2, MBP and MOSP together with appropriate isotype 
controls (Tables 2.2 – 2.4). 
To keep consistent with the neuronal differentiation studies (see Chapter 4), 
7_10BA2C was selected for further analysis and a direct comparison made 
between glass and plastic surfaces for differentiation. Plastic tissue culture 
dishes and 8-chamber glass slides were coated with poly-l-lysine, as 
described above, and seeded with 7_10BA2C cells in OPC medium at 
10,000 cells/cm2. RNA was extracted (section 2.2.2.1) on days 0 (as an 
undifferentiated control), 5 and 10. qPCR measurements(section 2.2.2.5)  
were used to calculate the fold change in expression of oligodendrocyte-
associated CNPase and astrocyte/Schwann cell-associated S100b (for 
primers see Table 5.3), in addition to neurotrophins and growth factors (for 
primers see Table 2.1). Additionally, cells were fixed on differentiation days 0 
and 10 and immunostained with antibodies (Tables 2.2 – 2.4) against the 
oligodendrocyte markers Olig1 or Olig2, together with β-actin to demonstrate 
morphology, prior to, and after, 10 days of differentiation. Antibodies against 
GFAP and S100b were also used to investigate the expression of astrocytic 
and Schwann cell markers. Matching isotype control antibody (Table 2.3) 
stains were performed in parallel.  
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5.3.4 Tables of primers 
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CNPase 
NM_00114
6318.1 
f: TTTACCCGCAAAAGCCACACA 
r: CACCGTGTCCTCATCTTGAAG 
117 60 
GAPDH 
NM_00808
4.2 
f: AGACGGCCGCATCTTCTTGTGCAGTGC 
r: ACATACTCAGCACCGGCCTCACCCCAT 
326 60 
GFAP 
NM_00113
1020.1 
f: CAACTTTGCACAGGACCTCGGCACCCT 
r: GGCGGCGATAGTCGTTAGCTTCGTGCT 
437 60 
PDGFR-α 
NM_01105
8.2 
f: GGCCGCAGTGTTGGTGCTGTTGGTGAT 
r: TGGTGCAGGCTCCCAGCAAGTTCACAAT 
413 60 
S100b 
NM_00911
5.3 
f: TGGTTGCCCTCATTGATGTCT 
r: CCCATCCCCATCTTCGTCC 
179 60 
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NM_00114
6318.1 
f: TTTACCCGCAAAAGCCACACA 
r: CACCGTGTCCTCATCTTGAAG 
117 60 
GAPDH 
NM_00808
4.2 
f: AGGTCGGTGTGAACGGATTTG 
r: TGTAGACCATGTAGTTGAGGTCA 
123 60 
S100b 
NM_00911
5.3 
f: TGGTTGCCCTCATTGATGTCT 
r: CCCATCCCCATCTTCGTCC 
179 60 
 
  
Table 5.2 – rt-PCR primer sequences 
Table 5.3 – qPCR primer sequences 
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5.4 Results 
5.4.1 Expression of glial cell markers by DPPCs 
Prior to differentiation, RNA was extracted from each isolated DPPC clone 
and mixed population at the earliest possible population doubling level and 
used to screen for mRNA expression of a selection of glial cell markers 
(Figure 5.1). All isolated DPPC cultures were found to express markers 
associated with oligodendrocytes at progenitor (PDGFR-α) and later 
(CNPase) stages. Similarly, the astrocytic marker GFAP was also expressed 
by all cultures. S100b, associated with both astrocytes and Schwann cells, 
was found to be expressed in all cultures with the exception of one non-
adherent mixed population: 19_8NA1-3. 
Clones with low (19_8A2A and 10_11BNA3A) and high (7_10BA1B and 
7_10BA2C) levels of nestin expression were further immunostained with 
antibodies against the OPC cell surface marker A2B5 and SOX10, a glial-
associated transcription factor (Figures 5.2 and 5.3). All four clones were 
found to stain positive for both early stage oligodendrocyte markers A2B5 
and SOX10.
   PDGFR-
α 
CNPase GFAP S100b GAPDH 
Non –
adherent 
mixed 
populations 
9_7NA1 
     
9_7NA3 
     
19_8NA1-3 
     
7_10BNA1-3 
     
Total 
population 
14_9TP 
     
Adherent 
Clones 
19_8A2A 
     
7_10BA1B 
     
7_10BA2C 
     
7_10BA2B 
     
Non-
adherent 
clones 
10_11BNA2B 
     
10_11BNA3A 
     
Controls 
RT-ve 
     
PCR -ve 
     
+ve control 
     
  
Figure 5.1 – mRNA expression of glial cell markers. 
Rt-PCR was used to detect the expression of PDGFR-α, CNPase, GFAP and S100b in 
isolated dental pulp progenitor cells. PDGFR-α, CNPase and GFAP expression was 
identified in all cell populations, whereas S100b expression was found to be more 
variable. RNA extracted from mouse corpus callosum tissue was used as a positive 
control. 
 
   
Figure 5.2 – Presence of A2B5 and SOX10 in weakly nestin-expressing clones 
Clones with low levels of nestin mRNA expression, 19_8A2A (A) and 10_11BNA3A (B), 
were fixed and stained with antibodies against the early stage glial markers A2B5 
(green) and SOX10 (red). Nuclei were counterstained with DAPI. Merged images of the 
respective isotype controls are shown (C & D). Scale bars = 100μm. 
 
 Figure 5.3 – Presence of A2B5 and SOX10 in strongly nestin-expressing clones 
Clones with high levels of nestin mRNA expression, 7_10BA1B (A) and 7_10BA2C (B), 
were fixed and stained with antibodies against the early stage glial markers A2B5 
(green) and SOX10 (red). Nuclei were counterstained with DAPI. Merged images of the 
respective isotype controls are shown (C & D). Scale bars = 100μm.   
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5.4.2 DPPC clones cultured in OPC medium 
Due to the similarities in marker expression with OPCs, initial attempts to 
differentiate DPPCs down an oligodendrocyte lineage were based on media 
used in the culture of OPCs (O’Meara et al., 2011; Jagielska et al., 2012) 
The four clones (19_8A2A, 10_11BNA3A, 7_10BA1B and 7_10BA2C) were 
passaged and seeded afresh, at 10, 000 cells/cm2 in OPC medium, on poly-
l-lysine-coated chamber slides. Changes in morphology were observed over 
7 days culture before fixation for characterisation by immunocytochemistry. 
Low nestin-expressing clones 19_8A2A and 10_11BNA3A were observed to 
transform from their typical bi/tripolar fibroblastic-like morphology in DPPC 
culture medium (Figure 5.4 A and C, respectively) to a more branched 
phenotype in OPC medium (Figure 5.4 B and D). However, few cells were 
found to adhere and survive over the course of the 7 day culture period. 
Clones 7_10BA1B and 7_10BA2C appeared similarly fibroblastic in DPPC 
medium (Figure 5.4 E and G) but, on the other hand, were found to adopt a 
comparatively more highly branched glial-cell like morphology in OPC 
medium (Figure 5.4 F and H). No obvious proliferation was observed in any 
of the four clones tested. 
.
 Figure 5.4 – Morphology changes following culture in OPC medium 
In DPPC culture medium 19_8A2A (A), 10_11BNA3A (B), 7_10BA1B (E) and 7_10BA2C 
(G) displayed bi/tripolar fibroblastic-like morphology, typical of dental pulp progenitor 
cells. After 7 days culture in oligodendrocyte progenitor cell medium, however, all 4 
clones (B, D, F & H, respectively) adopted a highly branched, more glial-like, phenotype. 
Scale bars = 100μm  
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At the end of 7 days culture in OPC medium the presence of mature 
oligodendrocyte markers Olig2, MBP and MOSP was investigated. Olig2 was 
identified in all four clones following culture in OPC medium (Figure 5.5). 
MBP-positivity was not observed in either 19_8A2A or 10_11BNA3A (Figure 
5.6 B and D), but was identified in both 7_10BA1B and 7_10BA2C (Figure 
5.6 F and H, respectively). Presence of another myelin-associated protein, 
MOSP, was demonstrated in all cells of all four clones (Figure 5.7). The 
expression of mature oligodendrocyte markers strongly suggested that the 
differentiation of oligodendrocyte-like cells from DPPCs was induced using 
OPC medium. 
   
Figure 5.5 – Olig2-positivity following culture in OPC medium 
After 7 days culture in OPC medium, 19_8A2A (A & B), 10_11BNA3A (C & D), 7_10BA1B 
(E & F) and 7_10BA2C (G & H) were fixed with 4% paraformaldehyde. The fixed cells 
were subsequently stained with rabbit IgG antibodies as an isotype control (A, C, E & G) 
and antibodies against Olig2 (B, D, F & H). Presence of Olig2 was identified in all 4 
clones. Scale bars = 100μm  
  
 
   
Figure 5.6 – MBP-positivity following culture in OPC medium 
After 7 days culture in OPC medium, 19_8A2A (A & B), 10_11BNA3A (C & D), 7_10BA1B (E 
& F) and 7_10BA2C (G & H) were fixed with 4% paraformaldehyde. The fixed cells were 
subsequently stained with mouse IgG antibodies as an isotype control (A, C, E & G) and 
antibodies against MBP (B, D, F & H). Only the strongly nestin-expressing clones, 
7_10BA1B and 7_10BA2C, were identified as being MBP-positive. Scale bars = 100μm  
  
 
 Figure 5.7 – MOSP-positivity following culture in OPC medium 
After 7 days culture in OPC medium, 19_8A2A (A & B), 10_11BNA3A (C & D), 7_10BA1B 
(E & F) and 7_10BA2C (G & H) were fixed with 4% paraformaldehyde. The fixed cells 
were subsequently stained with mouse IgM antibodies as an isotype control (A, C, E & 
G) and antibodies against MOSP (B, D, F & H). Presence of MOSP was identified in all 4 
clones. Scale bars = 100μm  
 
 
160 
 
5.4.3 Optimisation of culture surface for differentiation 
Having demonstrated the greatest ability for oligodendrocyte differentiation 
based upon cell survival, morphology and specific marker positivity, 
7_10BA2C was selected for further analysis to investigate the effects of 
different culture surfaces and increased duration of differentiation. Cells were 
differentiated on poly-l-lysine-coated glass or plastic culture surfaces for 10 
days in OPC medium. Those cells grown on plastic for 10 days (Figure 5.8 C 
- G) displayed a demonstrably more highly branched oligodendrocyte-like 
morphology than those on glass chamber slides (Figure 5.8 A and B). 
 Figure 5.8 – Optimisation of culture surface for differentiation 
7_10BA2C was cultured in OPC medium for 10 days on poly-l-lysine-coated glass (A & B) 
and plastic (C – G) culture surfaces. Cells grown on plastic display a more highly 
branched morphology. Scale bars = 100μm  
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5.4.4 Changes in expression of glial markers during 
differentiation 
As dental pulp progenitor cells have been shown to express a number of 
markers associated with different developmental stages and types of glial 
cells prior to differentiation (Figure 5.1), the changes in expression of some 
of these during differentiation was investigated. 
7_10BA2C cells did not stain positive for the oligodendrocyte-specific 
transcription factor Olig1 before differentiation (Figure 5.9 A). After 10 days 
culture in OPC medium, however, Olig1 was identified both in the nucleus 
and the surrounding perinuclear cytoplasm (Figure 5.9 B). Nuclear staining of 
Olig2, on the other hand, was observed both prior to and following 
differentiation (Figures 5.10 A and B, respectively). Expression of GFAP, at 
the protein level, was not identified at either stage, whereas S100b was seen 
before, but not after, differentiation (Figure 5.11 A and B). Quantitative PCR 
demonstrated that, over 10 days differentiation, CNPase expression 
increased in conjunction with a downregulation of S100b (Figure 5.12). 
Together, these characterisation results confirm that OPC culture medium 
results in the upregulation/induction of oligodendrocyte-associated markers 
together with the downregulation of other glial cell markers in DPPCs. 
   
Figure 5.9 - Olig1 immunocytochemistry 
Undifferentiated 7_10BA2C cells cultured in standard DPPC medium (A & C) and after 10 
days differentiation in OPC medium (B & D) were fixed with 4% PFA before antibody 
staining. Olig1 positivity (red) was not found in undifferentiated cells (A) but was induced 
following differentiation (B). β-actin (green) was used to visualise cell morphology. 
Mouse IgG isotype controls for β-actin antibody are shown before (C) and after (D) 
differentiation. Rabbit IgG as an isotype control for Olig1 is shown in Figure 5.10 (C & D). 
Scale bars = 100μm.   
 
   
Figure 5.10 - Olig2 immunocytochemistry 
Undifferentiated 7_10BA2C cells cultured in standard DPPC medium (A & C) and after 10 
days differentiation in OPC medium (B & D) were fixed with 4% PFA before antibody 
staining. Olig2 positivity (red) was found at low levels in undifferentiated cells (A) and 
further induced following differentiation (B). β-actin (green) was used to visualise cell 
morphology. Rabbit IgG as an isotype control for Olig1 & Olig2 is shown before (C) and 
after (D) differentiation. Scale bars = 100μm.   
 
   
Figure 5.11 – GFAP and S100b immunocytochemistry 
Undifferentiated 7_10BA2C cells cultured in standard DPPC medium (A & C) and after 10 
days differentiation in OPC medium (B & D) were fixed with 4% PFA before antibody 
staining. S100b positivity (green) was found at low levels in undifferentiated cells (A) but 
reduced following differentiation (B) while GFAP staining was not observed at either 
stage. C & D) Differentiated neural progenitor cells provided a positive control for GFAP 
expression. Scale bars = 100μm.   
  
 
 Figure 5.12 – Changes in expression of CNPase and S100b during differentiation  
RNA extracted from 7_10BA2C cells on days 0, 5 and 10 of the differentiation protocol 
was used for quantifying changes in expression of mRNA transcripts for the 
oligodendrocyte marker CNPase and the astrocytic marker S100b using the 2-ΔΔct method 
for qPCR analysis. Expression of CNPase was found to increase during differentiation 
over 10 days accompanied by a concurrent decrease in S100b expression. 
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5.4.5 Changes in neurotrophin and growth factor expression 
during differentiation 
The changes in expression of neurotrophins and growth factors at days 0, 5 
and 10 were also investigated using qPCR. Both BDNF and GDNF were 
strongly downregulated over the first 5 days of differentiation before 
plateauing. Expression of NGF marginally decreased over 10 days while NT-
3 expression began to increase between day 5 and 10 (Figure 5.13 A). bFGF 
slowly decreased in expression over 10 days. TGFβ-1 was strongly induced 
over the first 5 days of differentiation, while relatively smaller increases were 
observed in expression of VEGF-A, IGF-1 and PDGF-a. Between days 5 and 
10 PDGF-a expression reduced to pre-differentiation levels and VEGF-A 
similarly decreased while TGFβ-1 and IGF-1 remained unchanged (Figure 
5.13 B). 
 Figure 5.13 – Changes in expression of neurotrophic and growth factors during 
differentiation 
RNA extracted from 7_10BA2C cells on days 0, 5 and 10 of the differentiation protocol 
was used for quantifying changes in expression of mRNA transcripts for neurotrophins 
(A) and growth factors (B) using the 2-ΔΔct method for qPCR analysis. A) Expression of 
neurotrophins tended to decrease with the exception of NT-3 which showed a marginal 
increase by day 10. B) Expression of TGFβ-1, IGF-1, VEGF-A increased during the 
differentiation protocol, PDGF-a remained unchanged and bFGF was downregulated.  
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5.5 Discussion 
This chapter provides the first in-depth characterisation of the expression of 
glial markers by DPPCs. Before differentiation, all isolated DPPCs 
populations were screened for the expression of glial cell markers by rt-PCR 
and immunocytochemistry. Undifferentiated DPPCs were found to express 
markers associated with glial-precursor cells, astrocytes, Schwann cells and 
early-mid stage oligodendrocytes (Figures 5.1 – 5.3). 
Glial-restricted precursors, with the potential for astrocytic or oligodendroytic 
differentiation, arise from neural stem cells during development and are 
neural crest in origin. Appearance of the A2B5 antigen, is believed to 
represent the transition from NSC to a glial-restricted phenotype (Rao and 
Mayer-Proschel, 1997). However, A2B5-positive cells may still retain the 
ability for multipotential neuronal differentiation (Nunes et al., 2003). A2B5 
expression was identified in all four clones used in this study together with 
SOX10 (Figures 5.2 and 5.3). SOX10 expression is associated with the 
neural crest during development and, as such, its appearance within DPPCs 
(Figures 5.2 and 5.3) is not unexpected given the developmental origins of 
the pulp (Chai et al., 2000). Multipotent neural crest cells migrate away from 
the neural tube into developing craniofacial tissues. At initiation of tooth 
morphogenesis these cells populate the underlying mesenchyme, eventually 
giving rise to the cellular components of pulpal tissue. Populations of 
progenitor cells retaining neural crest stem cell characteristics have been 
previously isolated from the pulp (Waddington et al. 2009; Janebodin et al., 
2011). These may represent a source of cells with greater potential for 
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neuronal and glial differentiation due to their neural tube origin, which gives 
rise to the adult CNS. Upon reaching adulthood, SOX10 expression is 
restricted to glial progenitor cells and mature oligodendrocytes in the CNS 
and Schwann cells in the PNS (Kuhlbrodt et al., 1998). Presence of A2B5 
and SOX10 together in DPPCs (Figures 5.2 and 5.3) suggests a possible 
glial precursor-like phenotype. 
Expression of GFAP by undifferentiated DPPCs has previously been 
reported at both the mRNA (Gronthos et al., 2002) and protein levels, as 
measured by fluorescence activated cell sorting and immunocytochemistry 
(Takeyasu et al., 2006; Sakai et al., 2012). In this study, the expression of 
mRNA transcripts for GFAP was detected (Figure 5.1) but no protein was 
identified by antibody-staining (Figure 5.11 A). Multiple isoforms of GFAP 
have been identified and many more may exist (Boyd et al., 2012). As such, 
this inconsistency between gene and protein expression may be due to 
differing specificities of the primer pair and antibody used in this study. The 
antibody has been demonstrated to work with differentiated NSCs (Figure 
5.11 D) and primary cultured astrocytes, but may not react with the specific 
isoform expressed by DPPCs. In addition to GFAP, DPPCs also expressed 
another astrocytic marker, S100b (Figures 5.1 and 5.11 A). S100 expression 
has been only previously been reported in DPPCs that have been induced to 
grow as neurospheres (Sasaki et al., 2008). Together, co-expression of both 
S100b and GFAP would appear to indicate a potential astrocytic phenotype 
of undifferentiated DPPCs. However, neither of these markers is entirely 
astrocyte-specific. GFAPs role is primarily structural in astrocytes and its 
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knockdown results in significant disruption of CNS extracellular architecture 
(Liedtke et al., 1996). The function of GFAP is less well defined for the many 
other cell types by which it is expressed including fibroblasts, chondrocytes, 
Schwann cells and BMSCs (Hainfellner et al., 2001). In addition to 
astrocytes, calcium-binding protein S100b expression is also strongly 
associated with Schwann cell identification. Furthermore, there is increasing 
evidence of S100b expression in subtypes of oligodendrocytes at both 
immature and mature stages of development (Hachem et al., 2005; Steiner 
et al., 2007 and 2008), bringing into question its suitability as a definitive 
marker for astrocytes/Schwann cells. Thus, the expression of S100b and 
GFAP mRNA by undifferentiated DPPCs (Figure 5.1) may not be indicative 
of a glial differentiation potential that is purely restricted to astrocytes or 
Schwann cells. 
Prior to differentiation, murine DPPCs were found to express a number of 
early-mid oligodendrocyte markers including PDGFR-α, CNPase, A2B5 and 
SOX10 (Figures 5.1 – 5.3). Within the CNS, expression of PDGFR-α 
subunits is restricted to cells of oligodendrocyte lineage (Pringle et al., 1992). 
CNPase forms a major constituent of CNS myelin, although its exact 
physiological role is unknown. It is implicated in the regulation of 
oligodendrocyte maturation and development of myelinating properties 
(Gravel et al., 1996). DPPC expression of CNPase and A2B5 has previously 
been reported for cells which were found to spontaneously differentiate into 
oligodendrocyte-like cells following transplantation into the injured spinal cord 
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(Sakai et al., 2012). As such, the presence of these markers in the DPPCs 
used in this study could provide evidence of oligodendrocytic potential. 
The glial marker expression profile of undifferentiated DPPCs gives a strong 
indication of their potential for glial differentiation (Figure 5.1). The in vivo 
differentiation of glial cells following transplantation of progenitor cells from 
the dental pulp into the injured spinal cord has been described in two 
contrasting studies, each reporting improvements in functional outcome. De 
Almeida et al. (2011) identified GFAP+/S100+ astrocytes derived from 
transplanted DPPCs, but no GalC+ oligodendrocytes, eight weeks after 
transplantation. Conversely, Sakai et al. (2012) report that eight weeks after 
grafting, 90% of surviving SHEDs had differentiated into MBP+ 
oligodendrocytes with no detectable GFAP expression among the remaining 
unidentified cells. These conflicting results may be explained due to the 
differences in the injury environment at the time of transplantation, 7 days 
after or immediately following injury, respectively. The cytokine and growth 
factor profile of the injured spinal cord will vary significantly at each time 
point. Transplantation in the sub-acute stages of injury, after 7 days, 
represents a more clinically relevant timeframe, but one that will be less 
conducive for growth and regeneration due to production of neuronal growth 
inhibitory molecules and the presence of myelin breakdown products 
(McKeon et al., 1991; Sandvig et al., 2004). It may be that this more hostile 
environment favours spontaneous differentiation towards an astrocytic 
phenotype. Alternatively, SHEDs are believed to represent a population of 
progenitor cells that are more immature in comparison to progenitor cells 
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isolated from the adult pulp based upon their odontogenic/osteogenic 
differentiation properties following transplantation into immunocomprimised 
mice (Miura et al., 2003). As with DPPCs (Gronthos et al., 2000), SHEDs 
have been shown to differentiate into odontoblastic-like cells and produce 
ectopic dentine. However, SHEDs were unable to produce similar dentine-
pulp complexes, but could induce bone formation by host cells, a property 
not associated with DPPCs (Miura et al., 2003). How such differences in the 
potential of SHEDs and DPPCs for mineralised tissue formation may 
translate to neural tissue regeneration is unclear.  Regardless, these in vivo 
SCI studies demonstrate that glial differentiation of progenitor cells from the 
dental pulp can help improve functional outcome in experimental models of 
SCI. 
This study reports, for the first time, the development of a protocol for the 
specific differentiation of oligodendrocytes from DPPCs in vitro. Due to 
similarities with OPCs in the expression of PDGFR-α, SOX10, A2B5 and 
CNPase, a differentiation medium similar to that used in the culture of 
oligodendrocyte cells was adopted (O’Meara et al., 2011; Jagielska et al., 
2012). Four DPPC clones were cultured in OPC medium and changes in 
morphology observed over 7 days before the cells were fixed for 
immunocytochemistry. Clones with low levels of nestin mRNA expression 
(19_8A2A and 10_11BNA3A) showed lower attachment and reduced 
branching under the differentiation conditions than stronger nestin-
expressing clones (Figure 5.4). All four clones stained positive for Olig2 and 
MOSP following differentiation (Figures 5.5 and 5.7), whereas only the 
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stronger nestin-expressing 7_10BA1B and 7_10BA2C were positive for MBP 
(Figure 5.6). This suggests that nestin expression may be indicative of 
DPPCs potential for oligodendrocyte differentiation. Although not traditionally 
associated with cells of the oligodendrocyte lineage, nestin expression may 
be identified along with A2B5 in some subtypes of proliferating OPCs, and is 
downregulated upon maturation (Almazán et al., 2001). Despite the 
expression of MBP and MOSP in differentiated DPPCs, there was no 
observation of the membranous sheets associated with the production of 
myelin by mature oligodendrocytes in vitro (Dyer and Matthieu., 1994; 
Jagielska et al., 2012). This suggests that the differentiated DPPCs are not 
terminally differentiated, but are of a less mature pre-myelinating phenotype. 
The production of myelin membrane sheets in vitro requires perfectly 
optimised culture conditions and, as such, further work is needed to 
determine the precise conditions required to achieve this with DPPCs. 
7_10BA2C, as the clone with the most highly-branched oligodendrocyte-like 
morphology and MBP-positivity was selected for further investigation and 
optimisation. It was found that 7_10BA2C demonstrated greater attachment 
and a more complex branched morphology when differentiated on poly-l-
lysine-coated plastic culture surfaces, as an alternative to glass (Figure 5.8). 
This observation conflicts with recent work by Jagielska et al. (2012) who 
demonstrated the importance of culture surface mechanical properties on the 
attachment, survival, migration and differentiation of OPCs. They found that 
OPCs adopt a more complex branched phenotype, with enhanced MBP 
expression, when differentiated on stiffer substrates, such as glass. 
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However, both glass and plastic represent culture surfaces that are many 
orders of magnitude stiffer than the extracellular matrix of the CNS. The 
authors additionally investigated different concentrations of polyacrylamide 
hydrogels to cover a physiological range of mechanical stiffness. Optimal 
OPC attachment, survival, proliferation and differentiation was found on gels 
of stiffness equivalent to that of CNS tissue. The use of similar polymers in 
the differentiation of DPPCs may provide the optimisation required to elicit a 
membranous myelinating phenotype. 
Oligodendrocyte transcription factor Olig1 was found to be induced in 
7_10BA2C following differentiation (Figure 5.9). Olig1 expression is essential 
for the remyelination of demyelinated CNS axons in a multiple sclerosis 
model (Arnett et al., 2004) and, thus, its presence in differentiated DPPCs 
indicates potential for remyelination of the injured spinal cord. Furthermore, 
Olig1 was not localised exclusively within the nucleus of differentiated 
DPPCs, but also found within the perinuclear cytoplasm (Figure 5.9 B). 
Cellular localisation of Olig1 varies with oligodendrocyte developmental 
stage: being found exclusively nuclear in progenitor cells but almost 
completely cytoplasmic in mature myelinating cells (Arnett et al., 2004). Both 
nuclear and cytoplasmic expression of Olig1 in differentiated DPPCs 
provides further evidence that the cells are of an intermediate pre-
myelinating stage, prior to terminal differentiation, and may require further 
differentiation steps. The closely related Olig2 was expressed by 7_10BA2C 
prior to, and after, differentiation (Figure 5.10 A). Olig2 is one of three factors 
that have recently been used to convert fibroblasts to induced 
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oligodendrocyte precursor cells via direct lineage conversion, along with 
SOX10 and Zfp536 (Yang et al., 2013). Expression of both Olig2 and SOX10 
(Figure 5.2 and 5.3) by undifferentiated DPPCs provides further evidence of 
an inherent capacity for oligodendrocyte differentiation. Olig1 and Olig2 are 
involved in the specification of motor neurons and oligodendrocytes that may 
arise from a shared precursor within the spinal cord (Lu et al., 2002; Zhou 
and Anderson, 2002). Genetic deletion of both Olig transcription factors 
results in the ablation of motor neurons and oligodendrocytes. However, 
when knocked out separately, loss of Olig2 results in the loss of motor 
neurons and Olig1 deletion delays oligodendrocyte maturation (Lu et al., 
2002). Based on these findings and the presence of other oligodendrocyte-
associated markers in differentiated DPPCs, expression of Olig2 does not 
indicate motor neuron differentiation in this case. The only previous report of 
oligodendrocyte differentiation of DPPCs in vitro (Aanismaa et al., 2012) 
identified small numbers of GalC-positive cells when subjected to a 
previously published neuronal differentiation protocol (Király et al., 2009). 
However, none of the oligodendrocyte-like cells identified by Aanismaa et al. 
were found to express Olig2, unlike DPPCs differentiated using the specific 
protocol for oligodendrocyte derivation developed in this chapter. 
No staining of GFAP, a marker of astrocytic differentiation, was observed 
either before, or after, differentiation (Figure 5.11). S100b staining was 
identified in undifferentiated DPPCs (Figure 5.11 A), but not following 
differentiation (Figure 5.11 B). qPCR confirmed the downregulation of S100b 
mRNA over 10 days differentiation (Figure 5.12). The non-expression and 
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downregulation of astrocytic genes in combination with an up-regulation of 
oligodendrocyte-associated CNPase (Figure 5.12) confirms that during 
differentiation, DPPCs are favouring a differentiation pathway towards an 
oligodendrocyte-like phenotype. 
Progenitor cells isolated from tissues other than the CNS could provide 
further alternative sources of glial-like cells. Bone marrow stromal cells can 
be readily encouraged to differentiate into Schwann cells using a well-
defined protocol (Someya et al., 2008; Park et al., 2010a; Kamada et al., 
2011). Unlike oligodendrocytes differentiated from DPPCs, BMSC-derived 
Schwann cells are bipolar in morphology and can be stained 
immunocytochemically for GFAP. In contrast to observations from this study 
(Figure 5.12), RNA expression of CNPase and S100 does not change during 
Schwann cell differentiation of BMSCs (Park et al., 2010a). Transplantation 
of these cells into SCI models reduces size of injury sites via increased 
neuronal survival, promotes remyelination and improves hindlimb locomotion 
recovery (Someya et al., 2008; Kamada et al., 2011). Alternatively, CNPase 
and MBP-expressing cells with oligodendrocyte-like morphology, capable of 
myelinating neurons in co-culture, can be selectively isolated from umbilical 
cord stem cells by gradient centrifugation and selective culture media (Tracy 
et al., 2008). Circulating foetal mesenchymal stem cells can be encouraged 
to adopt oligodendrocyte-like morphology and marker expression using 
neuroblastoma cell line-conditioned medium (Kennea et al., 2009). The 
dental pulp represents a more easily accessible source of progenitor cells 
than bone marrow or umbilical cord blood, as it is often discarded following 
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routine orthodontic treatment. Furthermore, the relative simplicity of the 
protocol for oligodendrocyte differentiation of DPPCs gives the dental pulp a 
distinct advantage as an alternative source of myelinating glial cells as a 
treatment for SCI. 
Although not traditionally viewed as a neurotrophin-secreting cell type, 
literature suggests that oligodendrocytes may function in this capacity. Rat 
embryonic cortical and forebrain-derived primary cultured neurons 
demonstrate enhanced survival and increased axonal length when grown in 
medium conditioned by primary cultured oligodendrocytes. These effects can 
be attenuated by antibodies to BDNF, NGF, NT-3 (Dai et al., 2003), GDNF 
(Wilkins et al., 2003) or IGF-1 (Wilkins et al., 2001). Similar neurotrophic 
effects are observed using hESC-derived OPC-conditioned medium 
containing measurable levels of BDNF, NGF, NT-3, IGF-1, TGFβ-1 and 
VEGF (Zhang et al., 2006b). Changes in mRNA expression of these factors 
were investigated during the differentiation of DPPCs into oligodendrocytes 
(Figure 13). The observation that GDNF expression is downregulated during 
differentiation contrasts with previously published work where detectable 
levels of GDNF are observed in mature oligodendrocyte-cultured medium but 
not in OPC-conditioned medium (Wilkins et al., 2003). It may be that GDNF 
is already released at high levels by DPPCs prior to differentiation and 
downregulation results in levels that are comparable with mature 
oligodendrocytes. Based upon the methods used for detecting GDNF release 
into culture media in the literature, it is not possible to perform such a direct 
comparison at this time. GDNF release by undifferentiated DPPCs has been 
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quantified through ELISA assays (Soria et al., 2011), whereas GDNF release 
by OPCs and mature oligodendrocytes was determined by western blotting 
(Wilkins et al., 2003). Using an identical method on each cell type during 
differentiation would allow a valid comparative analysis of changes in GDNF 
production to be made. IGF-1 expression levels, on the other hand, remain 
unchanged between oligodendrocytes and OPCs (Wilkins et al., 2001), 
which is replicated by the DPPC differentiation data from this current study 
(Figure 5.13 B). TGFβ-1 was identified as the growth factor showing the 
largest change in expression level during the differentiation of DPPCs into 
oligodendrocyte-like cells. This observation is supported by previous reports 
of increased mRNA transcript expression for TGFβ-1 by mature 
oligodendrocytes compared to OPCs (McKinnon et al., 1993). The same 
study reports that TGFβ-1 inhibits OPC proliferation and promotes their 
differentiation. This suggests that, in addition to trophic effects on neuronal 
cells, growth factor release may help to modulate oligodendrocyte maturation 
via auto/paracrine mechanisms. 
 Based on observations from this study the production of neurotrophins and 
growth factors by oligodendrocytes derived from DPPCs should not be 
overlooked when considering the use of DPPCs as a treatment for SCI. Not 
only does this suggest potential for DPPCs to act as a cell replacement for 
oligodendrocytes to remyelinate axons, but the cells could simultaneously 
promote endogenous regeneration through trophic mechanisms. Such 
observations have been made following the transplantation of hESC-derived 
OPCs into an in vivo SCI model to promote functional recovery (Keirstead et 
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al., 2005). Only 55% of oligendrocyte-remyelinated axons were physically 
associated with transplanted cells, suggesting the recruitment of native 
oligodendrocytes to the injury site. In the same manner, transplanted DPPCs 
may possess the potential to act synergistically to improve functional 
outcome. 
5.6 Summary 
 Murine dental pulp progenitor cells were found to express a range of 
markers associated with astrocytes, Schwann cells and 
oligodendrocytes. 
 DPPCs cultured in OPC medium adopt a highly branched 
oligodendrocyte-like morphology and express mature oligodendrocyte 
markers. 
 Astrocyte marker expression is downregulated during differentiation, 
confirming an oligodendrocyte-like phenotype. 
 Neurotrophic factor release by DPPCs may be altered as a result of 
oligodendrocyte differentiation and will prove important in considering the 
use of DPPCs to treat SCI. 
 This is the first report of a protocol developed for the specific 
differentiation of oligodendrocyte-like cells from DPPCs. 
  
 
 
 
 
 
 
 
 
 
 
Chapter 6: The behaviour of dental pulp 
progenitor cells transplanted into spinal 
cord ex vivo and in vivo models
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6.1 Introduction 
Undifferentiated DPPCs have been reported to respond well to CNS 
transplantation, surviving over sustained periods and exerting influences 
upon endogenous cells whilst simultaneously responding to environmental 
cues (Huang et al., 2008; Arthur et al., 2008 and 2009). Functional 
improvements mediated by DPPC transplantation have been reported for in 
vivo models of stroke (Yang et al., 2009; Sugiyama et al., 2011; Fang et al., 
2013; Yamagata et al., 2013) and spinal cord injury (de Almeida et al., 2011; 
Sakai et al., 2012). In these studies, the protective/regenerative effects 
appear to be mediated by neurotrophic and/or growth factor release rather 
than direct cell replacement. The differentiation of transplanted DPPCs into 
neurons in vivo has not yet been confirmed, although oligodendrocyte-like 
(Sakai et al., 2012) and astrocyte-like (de Almeida et al., 2011) phenotypes 
have been observed.  
Pre-differentiation of cells prior to transplantation enables researchers a 
degree of control over cell fate, restricting the potential for differentiation into 
undesirable cell types. Directing cells partially down a specific lineage allows 
the possibility of natural maturation in response to endogenous 
environmental factors ex vivo/in vivo.  This approach to cellular 
transplantation has only been investigated in one DPPC in vivo study. 
DPPCs, neuronally pre-differentiated using the protocol described by Király 
et al. (2009), retain a degree of electrophysiological functionality, as 
measured by patch clamp recordings, following injection into the 
cerebrospinal fluid of newborn rats (Király et al. 2011). This suggests that the 
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pre-differentiation of DPPCs prior to spinal cord transplantation may prove a 
viable option for investigating whether DPPCs truly can act as a direct cell 
replacement option for SCI therapy. 
Ex vivo tissue culture systems are a valuable research tool to provide 
multiple insights at the cellular and tissue levels. Spinal cord slice cultures 
are a well established model and have been used in a range of investigations 
into aspects of neuroscience as diverse as: electrophysiology (Yoshimura 
and Nishi, 1993), inflammatory and neurodegenerative disease processes 
(Zhang et al., 2011; Ravikumar et al., 2012) and cellular migration (Meng et 
al., 2012). Ex vivo spinal cord slice cultures serve as a useful “stepping 
stone” before progressing onto in vivo SCI models, allowing researchers to 
obtain large amounts of data with reduced costs, time requirements and 
animal numbers. Such model systems also allow the live imaging and 
monitoring of cells within the spinal cord which is not possible in vivo. 
Three techniques are commonly used to generate in vivo models of SCI. 
Compression injury models, such as that used by de Almeida et al. (2011), 
are induced by the application of a vascular clip to the exposed spinal cord. 
Injuries can be generated by transection of the cord with a surgical scalpel, 
mimicking a laceration type injury, such as the approach used by Sakai et al. 
(2012). As spinal cord contusion is the type of injury most commonly 
observed among humans, the most clinically relevant method of generating 
in vivo models involves a direct impact onto the cord itself. This may be 
performed with a simple weight-drop set-up or an electronically-driven impact 
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device that allows precise control over force and speed parameters to create 
a highly reproducible model, as used in this investigation. 
The timing of cellular transplantation following SCI is important in 
determining whether any functional improvement is through protective or 
reparative mechanisms. Transplantation of cells immediately following injury, 
as performed by Sakai et al. (2012), suggests that improvements are likely to 
be a protective effect. True regeneration is more likely to be observed 
following stem cell grafting a number of days post-injury. This approach was 
adopted by de Almeida et al. (2011). In this investigation, DPPC 
transplantation 7 days after spinal cord contusion represents a clinically 
feasible timeframe and ensures that any improvements will be a result of true 
spinal repair. 
6.2 Objectives 
 To explore the behaviour of DPPCs injected into ex vivo spinal cord slice 
models. Three conditions will be investigated: undifferentiated cells, 
DPPCs pre-differentiated into oligodendrocyte-like cells using the 
protocol developed in chapter 6, and DPPCs neuralised as described in 
chapter 5. 
 To develop and transfer these findings to a clinically relevant in vivo 
mouse model of contusive SCI, as a pilot study, and determine if any 
hindlimb functional recovery can be attributed to direct cell replacement 
with transplanted DPPCs. 
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6.3 Materials and methods 
6.3.1 Ex vivo spinal cord slice model 
6.3.1.1 Preparation of ex vivo spinal cord slice cultures 
Spinal cord slice cultures were prepared as previously described (Meng et 
al., 2012). Briefly, complete spinal cords were dissected from 4 week old 
C57BL/6 mice on ice. Meninges were carefully removed, so as not to 
damage the cord, under a dissecting microscope. A McIlwain Tissue 
Chopper (Mickle Laboratory Engineering, UK) was used to slice the cords 
into 500µm thick sections. Intact slices were selected and transferred to the 
centres of 35mm tissue culture dishes, two per dish. 30µl of Matrigel (BD 
Biosciences, UK) was pipetted over the slices in each dish and the plates 
transferred to a tissue culture incubator for 1 hour until the Matrigel 
polymerised. 1.5ml of pre-warmed DMEM/F-12 medium containing 25 mM 
HEPES buffer and 20% heat-inactivated FBS (all Life Technologies, UK) was 
added to each dish, ensuring the surface of the slices remained exposed to 
the air. Spinal slice sections were then returned to the incubator for 24-72 
hours before cell injection. 
6.3.1.2 Preparation of cells for injection 
To allow for easy identification of transplanted cells, DPPCs were isolated 
from transgenic mice expressing green fluorescent protein (GFP) under 
control of the chicken β-actin promoter (Okabe et al., 1997). Cells were 
isolated and purified using the fibronectin adhesion assay, as previously 
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described (sections 3.3.1 and 3.3.2). A mixed population of fibronectin-
adherent cells was used for all experiments in this chapter. 
Three culture conditions were investigated for transplantation into ex vivo 
spinal cord slice cultures: undifferentiated cells grown in standard DPPC 
culture medium (section 2.2.1.1), cells pre-differentiated in OPC culture 
medium for 5 days (sections 5.3.1 and 5.3.2) and cells neuralised in NSC 
medium for 5 days (section 4.3.2). 
6.3.1.3 Injection of cells into spinal cord slice cultures 
Prior to injection, cells were dissociated from culture surfaces and counted, 
as previously described (section 2.2.1.2), and the cell pellet resuspended at 
a concentration of 100,000 cells/µl in DMEM/F12 +20% FBS. 2µl of cell 
suspension was injected per slice using a 10µl Hamilton syringe (Hamilton 
Company, USA). Before loading with cells, the syringe was sterilised by 
washing through with 70% (w/v) ethanol (Sigma-Aldrich, UK) three times. 
Traces of ethanol were then removed by washing through a further 5 times 
with sterile Hank’s Balanced Salt Solution (Life Technologies, UK). 10µl cell 
suspension was then loaded into the syringe and 2µl carefully injected at the 
junction between grey and white matter on the right hand side of one slice 
per dish. The remaining slice in each dish was left as a non-injected control. 
Injected slice cultures were maintained for 10-14 days, with medium changes 
every other day, before fixation for immunohistochemistry. 
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6.3.1.4 Immunohistochemical staining of spinal slice cultures 
Before staining with antibodies, spinal slice cultures were fixed with a 
paraformaldehyde and gluteraldehyde fixative. Culture medium was removed 
from the dishes and the slices were washed three times for 10 minutes on a 
see-saw rocker with PBS, pre-warmed to 37°C so as not to melt the matrigel. 
Slices were then immersed for 1 hour in a fixative solution composed of 2% 
(w/v) paraformaldehyde and 0.1% (w/v) gluteraldhyde (both Sigma-Aldrich, 
UK) in PBS, also pre-warmed to 37°C. After two further 10 minute PBS 
washing steps, aldehyde autofluorescense was quenched by immersion of 
the slices in 50mM ammonium chloride (Sigma-Aldrich, UK) for 2 hours. 
Slices were then washed with PBS for 10 minutes before a ring was created 
around each slice using a hydrophobic pap pen (Sigma-Aldrich, UK) in order 
to minimise antibody wastage. Slices were permeabilised by bathing in 0.5% 
(v/v) Triton X-100 and 1% (w/v) BSA for 30 minutes. Permeabilisation 
solution was then removed and unreacted groups blocked by incubating in 
0.3% (v/v) Triton X-100 and 3% (w/v) BSA overnight at 4°C. The following 
day, blocking solution was removed and replaced with antibodies against 
βIII-tubulin or synaptophysin, alongside respective isotype control antibodies 
(Tables 2.2 and 2.3) diluted in blocking solution. Spinal cord slices were 
returned to the fridge and incubated for 3 days. After three days, primary 
antibody solution was removed and the slices washed with PBS 4 times for 
30 minutes. Dishes were then incubated at 4°C overnight with 
complementary matched secondary antibodies (Table 2.4) diluted in blocking 
solution. The following day, after 5 x 30 minute PBS washes, the dishes were 
filled with PBS and the slices taken for confocal and/or two-photon imaging. 
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6.3.1.5 Imaging of spinal slice cultures 
6.3.1.5.1 Live imaging 
Phase contrast and fluorescent images of live cells and slice cultures were 
captured using an Olympus IX71 inverted microscope with an automated 
stage system and camera (Applied Precision, USA). The imaging equipment 
was enclosed within a custom-designed temperature control chamber that 
maintained conditions at 37°C. Photography was controlled using Deltavision 
imaging software with X/Y/Z multiple position recording (Applied Precision, 
USA). 
6.3.1.5.2 Confocal microscopy 
Laser scanning confocal imaging of both live and fixed slice cultures was 
performed using a Leica SP5 Confocal Microscope and LAS AF imaging 
software in a temperature controlled environmental chamber (Leica 
Microsystems, Germany). 
6.3.1.5.3 Two-photon microscopy 
The two-photon setup consisted of a MaiTai DeepSee tunable Ti:Sapphire 
laser (Newport Spectra Physics, UK) and a movable objective microscope 
(Sutter Instruments, USA). R6357 photomultipliers were used (Hamamatsu, 
Japan). Freeware ScanImage software (developed by Karel Svoboda and 
colleagues) was used for data acquisition and scanning control.   
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6.3.1.5.4 Image processing 
Acquired images and Z stacks were processed and analysed using ImageJ 
software. 
6.3.2 In vivo spinal cord contusion injury model 
6.3.2.1 Animals and drug dosage regimen 
Adult female C57Bl/6 mice weighing 19-23g (mean = 20.7g) were used in 
this study. Two days prior to surgery, Enrofloxacin antibiotic solution (Baytril 
(Bayer Healthcare, UK)) was added to the drinking water at a concentration 
of 0.04% (v/v) and administered until 10 days after cellular transplantation. 
Starting one day prior to impact surgery, until 10 days after cell 
transplantation, mice were subcutaneously injected daily with Meloxicam 
anti-inflammatory analgesic (Metacam (Boehringer Ingelheim, UK)) at a 
dosage of 1mg/kg (Figure 6.1). 
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6.3.2.2 Surgical procedure 
Mice were anaesthetised in an induction chamber to which 4% isofluorane in 
a continuous oxygen flow of 2l/min was applied. Once anaesthetised, 
animals were maintained on an anaesthetic mask with 2% isofluorane in a 
continuous oxygen flow of 2l/min. The dorsal area between the neck and 
hindlimbs, extending ~1cm bilaterally from the spine, was shaved and 
disinfected with Clorhexadine surgical scrub (Hydrex (EcoLabs, UK)). Using 
sterilised surgical instruments a longitudinal dorsal midline incision was 
made on the skin and underlying muscle layers to expose the spinal column 
from T7-T11. A laminectomy was then performed using fine-point scissors to 
remove the dorsal portion of the vertebrae and expose a single segment of 
the spinal cord between T8-T10. An Infinite Horizons IH-0400 spinal cord 
impactor (Precision Systems and Instrumentation, USA) was used to deliver 
contusion injuries of a controlled 50kdyn force through a 1.3mm impactor tip 
with 1 second dwell time on the cord. Following impact, the muscle and skin 
layers were sutured separately using absorbable Vicryl sutures (Johnson and 
Johnson, UK) and sealed externally using Vetbond tissue adhesive (3M, 
UK). 0.5ml saline solution was injected intraperitoneally to account for fluid 
loss during surgery and animals were then placed in a recovery chamber and 
monitored closely until fully alert. As a surgical control group, sham impact 
animals underwent laminectomy without subsequent spinal cord impact. 
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6.3.2.3 Post-operative care 
Following surgery, mice were caged individually on warm paper bedding with 
a wet mash diet. Animals were monitored closely and bladders manually 
emptied twice daily.  
6.3.2.4 DPPC transplantation 
Cell transplantations were performed in the sub-acute phase of injury, 7 days 
after spinal contusion (Figure 6.1). Prior to transplantation, GFP mDPPCs 
were neuralised in NSC medium for 5 days, as previously described. 
Following harvesting, cells were resuspended in PBS at 200,000cells/μl and 
placed on ice. Mice were anaesthetised, as described previously, and the 
injury site re-exposed. 5μl of cell suspension (1 x 106 cells) was injected at 
two locations on the spinal cord midline: 1-1.5mm rostral and 1-1.5mm 
caudal to the impact. Cells were injected to a depth of between 0.5 and 1mm 
at a rate of 1μl/minute controlled by a Quintessential Stereotactic Injection 
system (Stoelting Co, USA) mounted on a manipulable platform. Following 
completion of each injection, 1 minute was allowed before withdrawal of the 
10μl Hamilton syringe to prevent leakage of cells. After both injections, the 
muscle and skin layers were sutured individually and the animals allowed to 
recover. As a vehicle control group, injured animals were injected with 5μl 
PBS alone. 
6.3.2.5 Experimental groups 
Mice were randomly assigned to three experimental groups used in this 
experiment: A) Sham impacts (n = 3) underwent laminectomy surgery 
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without impact. At the time of cellular transplantation, injury sites were 
surgically exposed but no injections performed before resuturing the wound. 
B) GFP mDPPC transplants (n=3) underwent laminectomy and contusion 
injury with DPPC transplantation 7 days later. C) PBS control animals (n=3) 
underwent laminectomy and contusion injury surgery before injection with 
PBS alone after 7 days. 
6.3.2.6 Analysis of hindlimb locomotor function 
Hindlimb motor function was assessed using the Basso, Beattie and 
Bresnahan (BBB) locomotor scale (Table 6.1) (Basso et al., 1995). Two 
observers recorded BBB scores for each individual animal twice weekly. 
Mean scores ± standard error were calculated for each treatment group. 
Statistical analysis was performed using repeated-measures ANOVA with 
Tukey’s multiple comparison tests at each time point.  
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Bas 
0. No observable hindlimb (HL) movement                           
1.  Slight movement of one or two joints, usually the hip and/or knee 
2.  Extensive movement of one joint or extensive movement of one joint and slight movement 
of one other joint 
3. Extensive movement of two joints 
4. Slight movement of all three joints of the HL 
5. Slight movement of two joints and extensive movement of the third 
6. Extensive movement of two joints and slight movement of the third 
7. Extensive movement of all three joints of the HL 
8. Sweeping with no weight support or plantar placement of the paw with no weight 
support 
9. Plantar placement of the paw with weight support in stance only (i.e., when 
stationary) or occasional, frequent, or consistent weight-supported dorsal stepping 
and no plantar stepping 
10. Occasional weight-supported plantar steps; no FL–HL coordination 
11.  Frequent to consistent weight-supported plantar steps and no FL–HL coordination 
12. Frequent to consistent weight-supported plantar steps and occasional FL–HL 
coordination 
13. Frequent to consistent weight-supported plantar steps and frequent FL–HL 
coordination 
14. Consistent weight-supported plantar steps, consistent FL–HL coordination, and 
predominant paw position during locomotion is rotated (internally or externally) 
when it makes initial contact with the surface as well as just before it is lifted off at 
the end of stance; or frequent plantar stepping, consistent FL–HL coordination, and 
occasional dorsal stepping 
15. Consistent plantar stepping and consistent FL–HL coordination and no toe 
clearance or occasional toe clearance during forward limb advancement; 
predominant paw position is parallel to the body at initial contact 
16. Consistent plantar stepping and consistent FL–HL coordination during gait and toe 
clearance occurs frequently during forward limb advancement; predominant paw 
position is parallel at initial contact and rotated at lift off 
17. Consistent plantar stepping and consistent FL–HL coordination during gait and toe 
clearance occurs frequently during forward limb advancement; predominant paw 
position is parallel at initial contact and lift off 
18. Consistent plantar stepping and consistent FL–HL coordination during gait and toe 
clearance occurs consistently during forward limb advancement; predominant paw 
position is parallel at initial contact and rotated at lift off 
19. Consistent plantar stepping and consistent FL–HL coordination during gait, toe 
clearance occurs consistently during forward limb advancement, predominant paw 
position is parallel at initial contact and lift off, and tail is down part or all of the time 
20. Consistent plantar stepping and consistent coordinated gait, consistent toe 
clearance, predominant paw position is parallel at initial contact and lift off, and 
trunk instability; tail consistently up 
21. Consistent plantar stepping and coordinated gait, consistent toe clearance, 
predominant paw position is parallel throughout stance, and consistent trunk 
stability; tail consistently up 
  
Table 6.1  – Basso, Beattie and Bresnahan (BBB) locomotor scale 
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6.3.2.7 Preparation of spinal cord tissue samples for cryosectioning 
Four weeks after cellular transplantation, animals were sacrificed by CO2 
asphyxiation and transcardially perfused with PBS followed by 4% (w/v) PFA 
solution. Complete spinal cords were carefully dissected and post-fixed 
overnight at 4°C in 4% PFA. The following day, cords were washed for 3 x 10 
minutes in PBS and then transferred to 30% (w/v) sucrose (Sigma-Aldrich, 
UK) solution for 3 days to provide cryoprotection. Spinal cord tissue was then 
mounted in OCT embedding matrix (Thermoscientific, UK) and stored at -
80°C before cryosectioning. 16μm-thick transverse sections were cut using a 
Leica CM3050 S cryostat (Leica Microsystems, Germany) and mounted onto 
0.01% (v/v) poly-l-lysine-coated glass microscope slides (Sigma-Aldrich, 
UK). Glass slides were stored at -80°C until required for 
immunohistochemical staining. 
6.3.2.8 Immunohistochemical staining of cryosections 
Slides were removed from the -80°C freezer and air dried at room 
temperature for 20 minutes. Sections were post-fixed in a 1:1 mixture of 
acetone and methanol (both Sigma-Aldrich, UK), pre-cooled to -20°C, for 2 
minutes. Acetone/methanol solution was then removed and the slides 
allowed to air dry for 15 minutes. Following a 5 minute wash with PBS, 
sections were incubated in 50mM ammonium chloride for 5 minutes. After a 
further 5 minute PBS wash, non-specific antibody binding was blocked with 
3% (w/v) BSA and 1% (v/v) Triton X-100 in PBS for 1 hour. Glass slides were 
then incubated overnight at 4°C with primary antibodies against 
synaptophysin and βIII-tubulin (Table 2.2) alongside appropriate isotype 
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controls (Table 2.3) diluted in 0.1% (w/v) BSA and 0.1% (v/v) Triton X-100 in 
PBS. The following day 3 x 5 minute washes were performed before 
incubation with complementary alexa fluor-594 conjugated secondary 
antibodies (Table 2.4) diluted in 0.1% BSA and 0.1% Triton X-100 for 1 hour 
at room temperature. Sections were then washed 4 x 5 minutes with PBS 
before mounting. Fluorescent (section 2.1.3.2) and confocal (section 
6.1.3.5.2) images were then acquired of the stained spinal cord tissue.  
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6.4 Results 
6.4.1 Injection of DPPCs into ex vivo spinal slice cultures 
Progenitor cells were isolated from the dental pulps of 4 week old transgenic 
“GFP mice” (Okabe et al., 1997) and purified using the fibronectin 
preferential adhesion assay. Mixed populations of adherent cells 
characterised as CD90+/CD45-/Nestin+/SCA1+ (see Appendix III) were micro-
injected into ex vivo spinal cord slice cultures prepared from 2-4 week old 
mice. 200,000 cells were injected per slice and cultured for 14 days. 
Undifferentiated GFP mDPPCs were found to survive within spinal slice 
cultures, showing signs of proliferation (Figure 6.2), migration (Figure 6.3) 
and varying morphology (Figure 6.4). 
One day after injection, small numbers of cells were typically observed 
localised to the site of injection (Figure 6.2 B and C). During culture these 
visibly increased in density, suggesting cellular proliferation, and spread from 
the initial injection site (Figure 6.2 E and F). 
Cells were found to follow distinct migratory pathways within spinal slices. In 
instances where injected cells did not initially adhere within the tissue, but 
rather embedded within the matrigel adjacent to the slice, cells were 
identified migrating into the spinal tissue (Figure 6.3 A – D). Cells appeared 
to migrate along pre-defined pathways in a column-like fashion. Confocal 
scanning microscopy identified cells migrating in 3D, indicating that migration 
was through the tissue as opposed to over the surface of the slice (Figure 
6.3 E and F). 
  
Fi
gu
re
 6
.2
 –
 P
ro
lif
er
at
io
n
 o
f 
m
D
P
P
C
s 
in
 s
p
in
al
 c
o
rd
 s
lic
e
 c
u
lt
u
re
s 
P
h
as
e 
co
n
tr
as
t 
(A
 &
 D
) 
an
d
 c
o
rr
es
p
o
n
d
in
g 
gr
ee
n
 f
lu
o
re
sc
en
t 
ch
an
n
el
 (
B
, C
, E
 &
 F
) 
im
ag
es
 o
f 
ex
 v
iv
o 
sp
in
al
 c
o
rd
 s
lic
e 
cu
lt
u
re
s 
in
je
ct
ed
 w
it
h
 G
FP
 m
D
P
P
C
s.
 
A
–C
) 
O
n
e 
d
ay
 a
ft
er
 i
n
je
ct
io
n
, 
sm
al
l 
cl
u
st
e
rs
 o
f 
co
n
ce
n
tr
at
e
d
 G
FP
 m
D
P
P
C
s 
w
e
re
 v
is
ib
le
. 
D
 –
 F
) 
B
y 
d
ay
 1
0
 a
ft
er
 i
n
je
ct
io
n
, 
in
cr
ea
se
d
 n
u
m
b
er
s 
o
f 
ce
lls
, 
w
h
ic
h
 h
ad
 s
p
re
ad
 f
ro
m
 t
h
e 
o
ri
gi
n
al
 s
it
e 
o
f 
in
je
ct
io
n
, 
w
e
re
 o
b
se
rv
ed
. 
C
 &
 F
) 
H
ig
h
er
 m
ag
n
if
ic
at
io
n
 i
m
ag
es
 o
f 
re
gi
o
n
s 
re
p
re
se
n
te
d
 b
y 
b
o
xe
s 
(B
 &
 E
, 
re
sp
ec
ti
ve
ly
).
 S
ca
le
 b
ar
s 
= 
1
00
μ
m
. 
   Figure 6.3 – Migration of mDPPCs in spinal cord slice cultures  
Phase contrast (A & C) and corresponding green fluorescent channel (B & D) images of 
ex vivo spinal cord slice cultures. A & B) On day 1 following injection, no GFP mDPPCs 
were visible directly within the slice but a cluster of cells could be seen growing in the 
matrigel on the periphery (arrowheads). C & D) Over 10 days culture, mDPPCs were 
observed migrating into the slice following clearly-defined pathways (arrows). E) 
Maximum projection image of migrating cells acquired from confocal Z scan over a 
depth of 144μm. F) Image 20 of 72 of the Z stack (E), including XZ and YZ axes, 
demonstrates migration on different planes, and therefore, through the tissue and not 
over the surface.  Scale bars = 100μm.  
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Following injection into spinal cord slices, a range of different cellular 
morphologies were identified amongst GFP mDPPCs. A proportion of cells 
adopted the branched appearance of astrocytes (Figure 6.4 A), while other 
cells remained bipolar and fibroblastic-like, typical of undifferentiated DPPCs 
(Figure 6.4 B). Some interneuron-like long bipolar cells with branched 
terminals were also identified (Figure 6. 4 C – E). 
After 14 days culture, injected spinal slices were fixed and 
immunohistochemically stained with antibodies against βIII-tubulin to 
visualise endogenous axonal architecture. Injected DPPCs typically aligned 
parallel with axons and could be identified interspersed amongst 
endogenous neuronal cells (Figure 6.5). Long axonal-like projections from 
DPPCs (Figure 6.5 B, arrowhead) were consistent in size and direction with 
endogenous neuronal fibres, but βIII-tubulin counter-staining could not be 
confirmed.
   
Figure 6.4 – Varied morphologies of mDPPCs in spinal cord slice cultures  
10 days after injection into ex vivo spinal cord slices GFP mDPPCs were found to adopt a 
range of different morphologies including: (A) highly-branched astrocyte-like cells, (B) 
fibroblast-like cells and (C) long bipolar interneuron-like cells. D) Maximum projection 
image of long bipolar cells acquired from confocal Z scan over a depth of 108μm. E) 20° 
rotations of a 180° 3D reconstruction of confocal Z scan shown in (D). Scale bars = 
100μm.  
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6.4.2 Injection of oligodendrocyte pre-differentiated DPPCs 
into ex vivo spinal slice cultures 
To investigate the effect of pre-differentiation, GFP DPPCs were pre-
differentiated into oligodendrocyte-like cells for 5 days prior to injection into 
spinal cord slices. 
As with the injection of undifferentiated DPPCs, concentrated clusters of cells 
were localised to the site of injection one day after transplantation (Figure 6.6 
C and D). However, these cells failed to survive within ex vivo spinal slices, 
reducing in number until only small  numbers of viable cells remained after 
12 days (Figure 6.6 E and F). 
 Figure 6.6 – Injection of oligodendrocyte pre-differentiated DPPCs into spinal cord slices  
Phase contrast (A) and GFP (B) images of mDPPCs pre-differentiated in OPC medium for 5 
days prior to injection into ex vivo spinal cord slices. C & D) One day after injection large 
clusters of cells were visible at the injection site. E & F) By day 12 only small numbers of 
pre-differentiated cells were left. Scale bars = 100μm.  
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6.4.3 Injection of neuralised DPPCs into ex vivo spinal slice 
cultures 
As an alternative to oligodendrocyte pre-differentiated cells, GFP DPPCs 
neuralised in NSC medium for 5 days were also injected into spinal slice 
cultures. Neuralised cells survived and, over 12 days culture, spread from 
the site of injection (Figure 6.7). 
To investigate the integration of injected neuralised cells, after 14 days slice 
cultures were immunohistochemically stained for synaptophysin, a synaptic 
vesicle protein, to identify neuronal synapses. In non-injected slices, 
synaptophysin expression was identified projecting radially from the grey 
matter (Figure 6.8 A). Synaptophysin expression was more evenly spread 
throughout the grey matter of injected slices, particularly in regions densely 
populated with neuralised GFP DPPCs (Figure 6.8 B – D). Higher 
magnification imaging confirmed the localisation of synaptophysin staining at 
sites where injected cells came together in close contact, but could not 
confirm expression by transplanted cells (Figure 6.8 E). 
   
Figure 6.7 – Injection of neuralised mDPPCs into spinal cord slices 
Phase contrast (A) and GFP (B) images of mDPPCs neuralised in NSC medium for 5 days 
prior to injection into ex vivo spinal cord slices. C & D) One day after injection large 
clusters of cells were visible. E & F) By day 12, the transplanted cells were seen extending 
from injection sites in clearly defined pathways (arrows). Scale bars = 100μm.  
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6.4.4 Injection of neuralised DPPCs into an in vivo model of 
mouse spinal cord injury 
As neuralised DPPCs showed signs of promise in ex vivo spinal cord slice 
cultures, surviving and becoming associated with neuronal synapses, this 
transplantation approach was adopted for an in vivo model of spinal cord 
injury as a pilot study. One week after the induction of a spinal contusion 
injury in mice, 1 x 106 neuralised GFP DPPCs were stereotactically injected 
at two locations, rostral and caudal to the site of injury. Hindlimb motor 
functionality was assessed over 4 weeks post-transplantation before spinal 
tissue was removed and processed for immunohistochemistry. 
One day following the induction of SCI, BBB scores of 0 or 1 indicated 
hindlimb paralysis and, therefore, successful impact surgery (Figure 6.9). No 
significant reduction in score was observed for the sham surgical treatment 
group, confirming that paralysis was a result of the impact rather than the 
surgical procedure itself. One week after impact, no increase in BBB scores 
was observed and the paralysed mice were randomly divided into two 
groups: those that received injections of DPPCs and those that were injected 
with sterile PBS, as a vehicle control. Over 4 weeks following cellular 
transplantation, locomotor function was found to marginally improve in both 
DPPC and PBS groups, indicated by increased BBB scores (Figure 6.9). No 
statistically significant difference in recovery was observed between the 
groups at any time point. 
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Following tissue harvest and cryosectioning, DPPCs were easily identified as 
having survived within the injured spinal cord for 4 weeks (Figure 6.10). 
Large clusters of cells were observed localised at the grafting site (Figure 
6.10 A – E). Additionally, small numbers of cells were seen to have migrated 
laterally, over relatively large distances (arrowheads, Figure 6.10 B and D). 
Cryosections of spinal tissue were stained immunohistochemically with 
antibodies against βIII-tubulin and synaptophysin to identify neuronal 
cells/axonal fibres and synaptic connections, respectively (Figures 6.11 and 
6.12). Transplanted neuralised DPPCs were found to stain positive for the 
neuronal marker βIII-tubulin (Figure 6.11 A – C). Endogenous axonal fibres 
were identified passing through the grafting site densely populated with 
transplanted DPPCs (Figure 6.11 A) and appearing to project towards 
individual cells (Figure 6.11 B and C). As with ex vivo cultures (Figure 6.5), 
GFP mDPPCs were observed to align parallel with endogenous neuronal 
fibres (Figure 6.11 D). Synaptophysin was associated with transplanted cells 
(Figure 6.12). However, synaptophysin was not expressed by the DPPCs, 
but rather localised around individual cells (Figure 6.12 B – D). 
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Figure 6.11 – βIII-tubulin staining of transplanted DPPCs 
Cryosections prepared from the spinal cords of SCI mice transplanted with neuralised 
DPPCs were immunohistochemically stained with antibodies against βIII-tubulin (red) 
and images acquired using confocal microscopy. A) Injected DPPCs were found to stain 
positive for the neuronal marker βIII-tubulin. B & C) Higher magnification images show 
endogenous axonal fibres projecting towards transplanted cells. D) DPPCs were 
identified aligning parallel with neuronal fibres. Isotype controls and images for sham-
treated mice can be found in Appendix V. Scale bars = 50μm (A) and 10μm (B – D). 
 
 Figure 6.12 – Synaptophysin positivity associated with transplanted DPPCs 
Cryosections prepared from the spinal cords of SCI mice transplanted with neuralised 
DPPCs were immunohistochemically stained with antibodies against synaptophysin (red) 
and images acquired using confocal microscopy. A) Synaptophysin staining was detected 
amongst injected DPPCs. B – D) Higher magnification images identified synaptophysin 
localised around individual transplanted cells but not expressed by the DPPCs 
themselves. Isotype controls and images for sham-treated mice can be found in 
Appendix V. Scale bars = 50μm (A) and 10μm (B – D). 
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6.5 Discussion 
This chapter provides the first detailed investigation into the cellular 
behaviour of DPPCs, both undifferentiated and pre-differentiated, 
transplanted into spinal cord tissue. This was made possible through the 
adoption of ex vivo slice cultures to allow live imaging of cells. Such regular 
observations were not possible in previous in vivo SCI DPPC studies where 
detailed analysis could only be performed following tissue harvest at 
experimental end-points (de Almeida et al., 2011; Sakai et al 2012). 
Undifferentiated DPPCs survived within spinal cord slices showing signs of 
apparent proliferation, migration, and changes in morphology to suggest 
differentiation (Figures 6.2 – 6.4). Similar observations have been found after 
the injection of DPPCs into various regions of the rodent and avian CNS at 
different developmental stages (Huang et al., 2008; Arthur et al., 2008 and 
2009; Király et al., 2011; Fang et al., 2013). 
GFP mDPPCs appeared to proliferate within spinal cord slices over 14 days 
culture, as suggested by increased cellular density at the site of grafting 
(Figure 6.2). Contrastingly, DPPCs isolated from rhesus monkeys showed 
signs of apoptosis following injection into the mouse hippocampus, indicated 
by decreases in graft size between days 5 and 30, together with cellular 
fragmentation (Huang et al., 2008). Ex vivo slice cultures are avascular and 
as such, reduced apoptosis as a result of inflammatory defence responses 
may be expected. A technique, such as BrdU uptake and labelling, would 
provide scientific confirmation of whether the GFP DPPCs truly did proliferate 
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within spinal cord slice cultures. This method was adopted by Huang et al., 
and no labelling of transplanted DPPCs was identified. In a neonatal rat 
model of cerebral ischaemia, on the other hand, BrdU staining of 
transplanted DPPCs was observed (Fang et al., 2013). The survival and 
proliferation of DPPCs within the CNS will be dependent upon many 
environmental factors. Their ability to do this within spinal slice cultures, 
which mimic hostile conditions of the damaged spinal cord, offers promise for 
SCI treatment. 
Transplanted DPPCs migrated within spinal slice cultures, spreading from 
the site of injection (Figure 6.3). Often, cells were observed to migrate over 
long distances along linear clearly-defined pathways (Figures 6.3 and 6.5 D 
and F). At this stage, it is only possible to speculate on the mechanism 
promoting such a distinct pattern of migration. One possibility is migration 
along the border separating the white and grey matter of the spinal cord. 
Certainly, DPPCs are able to sense and respond to endogenous migratory 
cues as demonstrated by the localisation of transplanted cells amongst 
regions of migrating cranial neural crest cells in the developing avian 
hindbrain (Arthur et al., 2008). Similarly, DPPCs injected into cerebrospinal 
fluid settle and localise within neurogenic regions of newborn rats when 
healthy (Király et al., 2011) or in a model of cerebral ischaemia (Fang et al., 
2013). The coating of culture plastics with laminin, a major constituent of 
CNS extracellular matrix, increases the migratory capacity of DPPCs in vitro 
(Howard et al., 2010). Additionally, DPPCs produce a number of matrix 
metalloproteinases (Suri et al., 2008; Miyagi et al., 2012) that may assist in 
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three-dimensional migration through tissues. These could potentially help 
transplanted DPPCs to penetrate the glial scar, of which collagen is a major 
component (Klapka and Mϋller, 2006), and enter the site of injury. If the 
precise mechanisms controlling the observed migration of DPPCs through 
spinal cord tissue can be elucidated, they could perhaps be harnessed to 
direct transplanted cells to where they will prove most effective at promoting 
repair. 
Three different morphologies were identified amongst the undifferentiated 
DPPCs injected into spinal cord slice cultures: branched astrocyte-like cells 
(Figure 6.4 A), bipolar fibroblastic-like cells (Figure 6.4 B) and long bipolar 
neuronal-like cells (Figure 6.4 C – E). Although unconfirmed by 
characterisation techniques, it appears that a proportion of cells may have 
spontaneously differentiated into astrocytes and neurons, while others 
remained undifferentiated. The differentiation of astrocyte-like cells, based 
upon expression of GFAP and/or S100, from DPPCs transplanted into the 
CNS in vivo has been previously reported (de Almeida et al., 2011; Fang et 
al., 2013) and so this would not be unexpected. Bipolar neuronal-like cells, 
similar in appearance to those observed in this chapter, have been identified 
amongst DPPCs grafted into developing chicken embryos (Arthur et al., 
2008). Furthermore, these cells express the neuronal markers βIII-tubulin 
and NF. When ex vivo spinal slice cultures were similarly stained with βIII-
tubulin antibodies, its expression by transplanted cells could not be 
confirmed using this immunohistochemical protocol (Figure 6.5). Instead, 
injected DPPCs were found aligning parallel alongside endogenous neuronal 
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fibres stained with βIII-tubulin (Figure 6.5 A) and were seen to extend axon-
like projections consistent in size and directionality with resident axons 
(Figure 6.5 B). Further optimisation of the staining protocol would help to 
confirm whether or not the DPPCs had spontaneously differentiated into βIII-
tubulin-positive neuronal-like cells, as their appearance suggests. No 
differentiation of cells oligodendrocyte-like in morphology was observed in 
spinal slice cultures. DPPCs expressing oligodendrocyte-associated 
markers, such as GalC and 04, have been identified following the 
transplantation of DPPCs into in vivo models of SCI (Sakai et al., 2012) and 
stroke (Fang et al., 2013). 
The pre-differentiation of progenitor/stem cells prior to transplantation 
enforces a lineage restriction, reducing the potential for differentiation into 
cell types that may prove detrimental. This approach is commonly adopted 
with ESCs which may be pre-differentiated into oligodendrocyte (Keirstead et 
al., 2005; Sharp et al., 2010) or motorneuron (Deshpande et al., 2006; Lee et 
al., 2007) precursor cells prior to injection into SCI models. This methodology 
provides the advantage that cells partially pre-differentiated can be allowed 
to mature naturally and integrate in response to endogenous environmental 
conditions. This study explored the possibility of using a similar approach 
with DPPCs for SCI. Cells were pre-differentiated for 5 days into neuronal-
like cells and oligodendrocyte-like cells using the protocols developed in 
chapters 4 and 5, respectively, prior to injection into ex vivo spinal cord 
slices. 
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Oligodendrocyte differentiated DPPCs failed to survive over 12 days in spinal 
slice cultures (Figure 6.6). Pre-differentiation of DPPCs for 5 days may have 
resulted in a phenotype that is too mature to withstand the stresses involved 
in dissociation from culture surfaces and transplantation into spinal tissue. 
Similar to DPPC derived oligodendrocyte-like cells (chapter 5), hESC-derived 
oligodendrocyte precursors express SOX10, PDGFRα, A2B5 and Olig1 
(Nistor et al., 2005; Sharp et al., 2010). However, the bipolar morphology of 
the ESC-derived cells would suggest that they are of a more immature 
phenotype in comparison to the highly-branched DPPC-derived cells. A 
shorter period of pre-differentiation in future work could potentially result in 
greater cell survival, allowing further research into interactions between 
DPPC-derived oligodendrocyte-cells and the spinal cord. 
Neuralised DPPCs, on the other hand, fared better within spinal slice 
cultures and survived up to 14 days culture in large numbers (Figure 6.7). 
The neuronal pre-differentiation of DPPCs prior to transplantation has only 
been described once prior to this study (Király et al., 2011). DPPCs, pre-
differentiated using a previously published protocol (Király et al., 2009), were 
injected into the cerebrospinal fluid of neonatal rats. Transplanted cells were 
found to settle within NSC-associated niches and retained a degree of 
electrophysiological functionality. The authors reported expression of 
synaptophysin, a protein associated with vesicle release at synapses, nearby 
grafted cells to suggest integration into neuronal networks. Similarly, 
following immunohistochemical staining of spinal slice cultures injected with 
neuralised DPPCs, synaptophysin expression was identified amongst grafted 
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cells localised at sites of cell-cell contact (Figure 6.8). This expression did not 
correlate spatially with GFP fluorescence suggesting that it is the 
endogenous neuronal cells that are trying to form connections with 
transplanted cells. Synaptophysin expression is associated with the mid-late 
stages of synaptogenesis (Knaus et al., 1986; Liebau et al., 2007) and its 
expression near to transplanted DPPCs suggests a possible integration 
within neuronal networks. 
The ex vivo spinal cord slice system used in this chapter proved invaluable 
for early investigations into the behaviour of transplanted DPPCs and their 
potential ability to act as a direct replacement for neural cells. However, the 
model is not without its limitations. During culture, a handful of slices showed 
signs of significant tissue degradation. This, in itself, does not prove a 
problem for investigations focusing on neurodegeneration and improving 
neuronal cell survival (Cho et al., 2009; Ravikumar et al., 2012). For the 
exploration of cellular differentiation and replacement, on the other hand, the 
endogenous tissue architecture should remain intact and therefore spinal 
cord slices were only maintained in culture for a maximum of 14 days. In 
addition to the tissue degeneration associated with ex vivo slice cultures, no 
information can be gathered regarding how the findings translate to 
functionality at the whole body level. In vivo animal models allow a longer 
timeframe for cellular differentiation and integration, as well as enabling the 
assessment of hindlimb locomotor recovery. As neuralised cells had 
demonstrated the most promise ex vivo, showing signs of potential neuronal 
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integration, this pre-differentiation approach was selected for transplantation 
into a murine in vivo model of sub-acute contusive SCI. 
In the pilot in vivo study, no improvements in hindlimb functional recovery 
were observed as a result of neuralised DPPC transplantation over vehicle 
controls (Figure 6.9). This contrasts with other studies where functional 
improvement was observed following the transplantation of DPPCs into SCI 
injured rodents (de Almeida et al., 2011; Sakai et al., 2012). Of importance 
when trying to compare with these reports are the different models of SCI 
used, the timing of cellular transplantation and the numbers of experimental 
animals.  
Sakai et al. (2012) adopted a model where rat spinal cords were subjected to 
a complete transection injury. Cellular transplantation was performed 
immediately following the injury and so the improved functional outcomes are 
almost certainly achieved through neuroprotective mechanisms, rather than 
regeneration and/or cellular replacement. de Almeida et al. (2011) induced 
an injury in mice through the application of a vascular clip to the exposed 
spinal cord for 1 minute. Cell transplantation was then performed in the sub-
acute (7 days post-injury) or chronic (28 days post-injury) stages. As such, 
the improvements seen were likely mediated through cell replacement and/or 
regeneration.  
In each of these studies, larger numbers of animals were used for each 
experimental group than the 3 per group in this chapter. This proves of 
significance when looking at individual differences between animals of the 
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same treatment group in the pilot study described in this chapter. At the end 
of the experiment, 4 weeks after transplantation, each of the 3 vehicle control 
mice scored BBB ratings of 4 or 5. Mice in the neuralised DPPC transplant 
group, on the other hand, showed less consistency with scores of 1, 5 and 9 
introducing a degree of uncertainty and explaining the large error bars 
(Figure 6.9). The use of larger numbers of animals would reduce the 
magnitude of error and allow the identification and removal of any outliers 
within each group, thereby increasing the chance of finding statistical 
significance. 
The ability of transplanted DPPCs to migrate over large distances in ex vivo 
spinal cord tissue (Figure 6.3) was replicated in vivo (Figure 6.10). In addition 
to large numbers of cells found at the site of grafting (Figure 6.10 E), small 
groups were identified having migrated laterally from the injection site 
(arrowheads, Figure 6.10 B and D). Similar observations have been made 
following transplantation of DPPCs into models of cerebral ischaemia (Yang 
et al., 2009; Sugiyama et al., 2011). 
Immunohistochemical staining of cryosectioned spinal cord tissue identified 
βIII-tubulin positivity of transplanted DPPCs (Figure 6.11) suggesting early 
stage neuronal differentiation. A comprehensive characterisation of the 
expression of more mature neuronal markers, such as Map2, NF, NeuN or 
specific neurotransmitter synthesis/receptor proteins, would help to confirm 
differentiation. This is the first report of the expression of neuronal markers 
by DPPCs transplanted into the injured spinal cord. Previously, expression of 
astrocytic and Schwann cell (de Almeida et al., 2011) or oligodendrocytic 
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(Sakai et al., 2012), but not neuronal markers, has been detected. 
Neuralising the cells prior to transplantation will have restricted the potential 
for differentiation down lineages other than neuronal. This approach could 
prove feasible for the replacement of dead/damaged neuronal cells with 
DPPCs in SCI. 
As with ex vivo spinal cord tissue (Figure 6.8), synaptophysin expression 
was detected around transplanted neuralised DPPCs (Figure 6.12). This, 
together with the projection of endogenous axonal fibres in between and 
towards injected cells (Figure 6.11 A – C), re-enforces the suggestion that 
endogenous cells are trying to form synaptic connections with transplanted 
DPPCs. Such a phenomenon has been observed following the 
transplantation of NSCs into the injured mouse spinal cord, where 
synaptogenesis with grafted cells resulted in hindlimb functional 
improvement (Cummings et al., 2005). If the neuralised cells truly are 
integrating within neuronal networks, as this may suggest, then this 
demonstrates great potential for the use of neuralised DPPCs to repair 
damaged neuronal-signalling pathways following SCI. 
6.6 Summary 
 Undifferentiated DPPCs survive within ex vivo spinal slice cultures 
showing signs of proliferation, aligning parallel with endogenous axonal 
fibres and adopting astrocyte-like and neuron-like morphologies. 
 Oligodendrocyte pre-differentiated DPPCs fail to survive following 
injection into spinal cord slices. 
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 Neuralised DPPCs survive and may integrate with endogenous cells of 
the ex vivo spinal cord. 
 No improvement in functional recovery was observed in a pilot study 
investigating the transplantation of neuralised DPPCs into an in vivo 
model of mouse SCI. 
 Nevertheless, the expression of βIII-tubulin and synaptophysin suggests 
that DPPCs have neuronally differentiated and may have integrated with 
endogenous neuronal cells. 
  
 
 
 
 
 
 
 
 
 
 
 
Chapter 7: General Discussion
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This project set out to identify the ability of DPPCs to directly replace 
neuronal and oligodendrocyte cells, thereby restoring functionality following a 
spinal cord injury. Although this question has not been fully answered, 
significant progress has been made to demonstrate that, at the very least, 
DPPCs possess great potential to function in this manner. Novel protocols 
have been developed showcasing the ability of DPPCs to differentiate in vitro 
into oligodendrocyte-like and immature non-functional neuronal-like cells. 
Using an ex vivo model, live imaging of DPPCs injected into spinal cord 
tissue was performed for the first time, providing fascinating insights into their 
behaviour. Transplanted DPPCs were demonstrated to possess the ability to 
proliferate, migrate in response to environmental cues, align parallel with 
endogenous axonal fibres and adopt neuronal and glial-like morphology, 
suggesting spontaneous differentiation. Although oligodendrocyte pre-
differentiated cells failed to survive post-transplantation, neuronally pre-
differentiated cells fared better. Identical observations were made in a 
clinically relevant in vivo model of SCI where transplanted neuralised DPPCs 
survived following injection into the injured spinal cord and maintained 
expression of early stage neuronal markers. Endogenous axonal projections 
towards grafted cells and the expression of synaptophysin suggested 
possible integration into neuronal signalling pathways, albeit without an 
associated statistical functional improvement. 
The first chapter focused on the isolation and characterisation of both mixed 
and clonal populations of progenitor cells from the murine dental pulp. 
Individual differences in the potential for odontoblastic differentiation of clonal 
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DPPC cultures has previously been reported (Gronthos et al., 2002). With 
regards to neuronal differentiation, individual populations within 
heterogeneous cultures have been reported to reach different stages of 
maturity, with only a small proportion (reported as 5 out of 38 cells tested) 
acquiring the most highly developed phenotype (Király et al., 2009). 
Similarly, outcomes may differ between patient samples subjected to the 
same differentiation protocol (Aanismaa et al., 2012). The extensive 
characterisation of DPPCs at the clonal level presented in this thesis has, for 
the first time, enabled the identification of a possible means of distinguishing 
those cells with enhanced neural differentiation capabilities. DPPC clones 
with comparatively higher levels of nestin mRNA expression showed greater 
potential for both neuronal-like and oligodendrocyte-like differentiation, based 
upon morphology and marker expression. However, the use of single cell-
derived clones is unlikely to be therapeutically applicable due to scalability 
issues within short timeframes. Therefore, in the final chapter of this thesis, 
focusing on the translational aspects of the work, a heterogeneous 
population of DPPCs, selected for fibronectin adherence properties was 
used. The isolation and culture methods used in this study were shown to 
derive mixed populations with much higher proportions of nestin-expressing 
cells than the 3.5% previously described for whole pulp cultures (Takeyasu 
et al., 2006). Despite this, cells with little to no nestin expression still 
remained within the heterogeneous cultures. The ability to purify cells with 
high levels of nestin mRNA expression immediately following pulpal 
extraction would provide a population of cells that possess greater potential 
for functional replacement of neuronal and oligodendrocytes. However, as an 
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intracellular structural protein, nestin is an unsuitable target for traditional 
antibody-based fluorescent or magnetic sorting techniques. A potentially 
similar alternative could be provided by the cell surface antigen A2B5 which 
is expressed by glial progenitors (Rao and Mayer-Proschel, 1997), neuronal 
progenitors (Nunes et al., 2003) and DPPCs. Selection of DPPCs based on 
expression of this antigen immediately following pulpal extraction may 
provide a heterogeneous population of cells with greater potential for 
neuronal and oligodendrocytic differentiation that may not suffer from 
scalability issues.  
Previous studies have reported functional characteristics of neuronally 
differentiated DPPCs (Arthur et al., 2008; Király et al., 2009; Aanismaa et al., 
2012), but no action potentials or spontaneous electrical activity has been 
recorded. This project was unsuccessful in the specific objective of 
developing a definitive protocol for deriving truly functional neuronal-like cells 
from DPPCs, despite achieving appropriate morphology and marker 
expression. The initial neuralisation stage of the protocol resulted in 
downregulation of mesenchymal markers while neuronal-like characteristics 
concurrently increased. However, the subsequent maturation step failed to 
elicit an appropriate induction of neurogenic markers. Further optimisation 
and/or the addition of extra steps to the protocol may be required to induce 
full functionality. One such possibility would be natural maturation in 
response to the environmental conditions of the CNS. This was explored in 
the final chapter by injecting neuralised DPPCs into spinal cord tissue ex vivo 
and in vivo. The expression of βIII-tubulin, outgrowth of axonal-like 
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projections and apparent integration within endogenous neuronal pathways, 
based upon synaptophysin co-localisation, suggests there may be a degree 
of functionality in transplanted neuralised DPPCs. Although technically 
challenging and requiring complicated set-ups, patch clamp recordings can 
be taken from specific cells within ex vivo spinal slice cultures (Yoshimura 
and Nishi, 1993; Deng and Xu, 2012; Mitra and Brownstone, 2012). Applying 
such methods to injected ex vivo spinal cord slices would provide definitive 
evidence for whether neuralised DPPCs are capable of replacing, and 
functionally compensating, for dead neurons following SCI. Certainly, further 
characterisation of the transplanted cells is required and cryosectioned tissue 
from the in vivo experiment remains available for this purpose. 
This thesis presents the first described protocol for the specific differentiation 
of oligodendrocyte-like cells from DPPCs. Oligodendrocyte-like differentiation 
in vitro has only ever been previously reported as a side effect of neuronal 
differentiation (Aanismaa et al., 2012). This is a significant finding in 
demonstrating the potential of DPPCs to differentiate into a further cell 
lineage, additional to mesenchymal cell types, reinforcing their multipotent 
characteristics. The functionality of the DPPC-derived oligodendrocyte-like 
cells has yet to be elucidated, although MBP-positivity shows promise for this 
aspect. The development of a co-culture system with primary neuronal cells, 
similar to that described by O’Meara et al. (2012), would help to determine 
the ability of oligodendrocyte-like cells to attach to and insulate axons with 
myelin, demonstrating their functionality. One intriguing prospect would be 
exploring the possibility of DPPC-derived oligodendrocyte-like cells to 
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myelinate DPPC-derived neuronal-like cells. Although such a system could 
prove technically challenging to derive, it would demonstrate great potential 
for promoting spinal repair through functional cellular replacement. The co-
transplantation of ESC-derived oligodendrocyte progenitors and motorneuron 
progenitors has proven more effective at improving functional outcomes in a 
rodent model of SCI than either cell type individually (Erceg et al., 2010) and 
this approach could be replicated for DPPC transplantation. 
DPPC-derived oligodendrocyte-like cells failed to survive for any significant 
length of time following injection into ex vivo spinal cord tissue. 
Oligodendrocytes are particularly susceptible to apoptosis within the CNS, 
being one of the first cell types lost following injury, and can be identified 
apoptosing at long distances away from actual site of injury (Li et al., 1999; 
Grossman et al., 2001). If a method of promoting their survival within spinal 
slice cultures can be devised, and subsequently applied in vivo, enabling the 
myelination of endogenous axons, DPPC-derived oligodendrocyte-like cells 
may not only prove successful for promoting recovery after SCI, but could 
also be applied in demyelinating disorders, such as multiple sclerosis. 
Optimising the duration of pre-differentiation would provide a solid starting 
point for increasing transplanted oligodendrocyte-like cell survival in ex vivo 
slice cultures. The addition of growth factors, such as PDGF-aa, may also 
potentially reduce transplanted cell death. Nevertheless, the development of 
a specific protocol to derive oligodendrocytes from DPPCs is a significant 
finding. Not only does it provide a potential new source of cells for CNS 
transplantation therapies, but it also serves as a useful model for 
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investigating new mechanisms and roles that DPPCs can play in promoting 
CNS repair and regeneration. 
Previous reports of improved outcome following the transplantation of 
DPPCs into rodent models of SCI have demonstrated 
neuroprotective/regenerative effects through the release of soluble factors 
(de Almeida et al., 2011; Sakai et al., 2012). The pre-differentiation of 
DPPCs prior to transplantation, in order to facilitate their ability to directly 
replace endogenous cells, will not necessarily hinder such paracrine 
mechanisms of repair. This study has demonstrated changes in the mRNA 
expression of a range of neurotrophic and growth factors during in vitro 
differentiation into neuronal-like and oligodendrocyte-like cells. Thus, the 
growth factor release profile of transplanted DPPCs would be altered by pre-
differentiation, leading to changes in the precise trophic mechanisms of 
repair. Quantitative techniques, such as ELISA, should be used to confirm 
the release of growth factors in vitro by DPPCs and the changes that occur 
as a result of pre-differentiation. 
The small scale of the pilot in vivo study presented in this thesis did not allow 
the detection of any statistical improvements in hindlimb function as a result 
of neuralised DPPC transplantation. This does not mean to say that the cell 
transplantation was ineffective, rather that more animals may be required for 
differences to become apparent. If such an experiment was to be performed, 
alternative avenues of investigation, such as the seeding of cells on a 
biocompatible scaffold, could be explored as a technique for enhancing the 
regenerative effects of transplanted DPPCs. 
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Embryonic stem cells, neural stem cells and bone marrow and adipose 
tissue-derived mesenchymal stem cells have demonstrated promise in 
promoting spinal repair, primarily through trophic neuroprotective actions, 
and have been subject to phase I clinical trials (Keirstead et al., 2005; Ra et 
al., 2011; Gupta et al., 2012; Park et al., 2012). DPPCs possess a distinct 
advantage over each of these cell types due to the ability to access pulp 
tissue during routine dental procedures and cryogenically preserve to provide 
a pool of patient-matched progenitor cells available for use if required 
(Woods et al., 2009). However, a number of challenges remain for the future 
application of the work presented in this thesis.  
In the short term, priority should be given to advancing DPPC 
oligodendrocyte differentiation to demonstrate their functionality and ability to 
survive within spinal cord tissue.  This work has the potential to open up a 
range of exciting novel avenues of research. At the same time it would be 
beneficial to investigate the effects of the differentiation protocols developed 
in this study on human DPPCs. Although limited experiments have been 
performed on human cells during these investigations, the differentiation 
protocols remain to be fully optimised and validated. Transferring to the use 
of primarily human DPPCs will drastically shorten the length of time between 
any potential translation of the work into a more clinical setting. 
The challenges faced over the long term are less well defined but can be 
equally applied to the wider research field of stem cells and their potential 
applications in promoting spinal repair. Namely: the upscaling and isolation 
of purified stem cells, together with identifying the optimal approach for 
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cellular transplantation into the injured spinal cord. Progenitor cells represent 
only a minute fraction of the total pulpal population, and those with potential 
for neuronal and oligodendrocyte differentiation, based upon expression of 
nestin, even less so. Reliable ways of extracting, purifying, and expanding 
cells with these desirable properties on a therapeutic scale have to be 
devised. Although using neuronally pre-differentiated cells demonstrated 
promise in the in vivo pilot study, this may not be the most effective DPPC 
phenotype at promoting functional recovery. Undifferentiated or 
oligodendrocyte pre-differentiated DPPCs represent alternative cell 
populations that remain to be explored in this model. It may be that co-
transplantation of DPPCs at a number of different stages of differentiation, or 
even in combination with a completely different cell type, such as NSCs, 
could prove optimal. Despite the need for such future investigations, taken 
together the results presented in this thesis provide a strong case for DPPCs 
being able to facilitate functional recovery following SCI through direct cell 
replacement mechanisms. 
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 Appendix I: qPCR dissociation curves 
 
 Appendix II: qPCR product sizes 
 
 
 Appendix III: GFP mDPPC characterisation 
 
 
 
  
A) In DPPC culture medium, isolated GFP mDPPCs expressed the mesenchymal 
markers CD90 and SCA1 in addition to the early stage neural marker nestin, confirming 
their progenitor status. No expression of CD45 was identified confirming no 
contamination with haematopoetic cells. B) Phase contrast and (C) corresponding 
fluorescent image confirming ubiquitous expression of GFP. Scale bars = 100μm  
 Merged images for (A) mouse IgG isotype control and (B) rabbit IgG isotype control 
stained ex vivo spinal cord slice cultures demonstrating the specificity of secondary 
antibody staining for synaptophysin & βIII-tubulin, respectively. 
Appendix IV: ex vivo isotype controls 
 
 
  
 Appendix V: In vivo 
immunohistochemistry controls 
 
Bright field (A & E) and corresponding fluorescent images (B & F, respectively) for rabbit 
IgG (A & B) and mouse IgG (E & F) isotype control stains demonstrating specificity of 
secondary antibody stains. Low (C & G) and high (D & H) magnification images showing 
patterns of βIII-tubulin (C & D) and synaptophysin (G & H) staining in sham group tissue 
sections. Scale bars = 100μm 
